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Abstract 
 
The focus of this thesis was to develop new highly porous (>90% porosity) Bioglass
®
-based 
glass-ceramic scaffolds (fabricated by the foam replica method) in order to enhance the 
scaffold cellular response and biological performance and to improve the scaffold suitability 
for future clinical applications by adding new functions. 
 
In the first part of the project, techniques were developed to introduce or engineer nanoscale 
topography on the surfaces of 3D scaffolds, these included: i) carbon nanotube (CNT) coating 
(by electrophoretic deposition), ii) polymer demixing and iii) water treatment. 
 
In the second part of the project, aiming at further improving the functionality of scaffolds, a 
system with drug delivery capability was developed. To this aim, multi-functional poly(3-
hydroxybutryate) microsphere (PMS) coated Bioglass
®
-based composite scaffolds were 
fabricated and characterised. Tetracycline-encapsulated PMSs (< 2 µm in diameter) were 
made using a solid-in-oil-in-water emulsion solvent extraction/evaporation technique. The 
scaffolds were coated with PMSs by slurry-dipping, producing a uniform PMS coating 
throughout the 3D structure. By studying tetracycline release kinetics, it was found that the 
drug release from the coated scaffolds was slow and controlled. 
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Chapter 1 Introduction 
 
Using three-dimensional scaffolds made from natural or artificial biomaterials, the scientific 
field of tissue engineering (TE) focuses on creating replacement tissues for damaged body 
parts [1]. Bioactive silicate glass-ceramics have been shown to be outstanding materials for 
making scaffolds for applications in bone tissue engineering. They exhibit excellent 
osteoconductivity and bioactivity, and the ability to stimulate angiogenesis and 
vascularisation [2, 3]. This PhD project builds from previous works on 45S5 Bioglass
®
-based 
glass-ceramic scaffolds developed by Boccaccini et al. [3-5]. Highly porous glass-ceramic 
scaffolds can be fabricated by the foam replica technique, which has been established as a 
convenient, simple and reproducible method for scaffold manufacture [4]. The macroporous 
structure of this scaffold type and its compressive strength values have been shown to be very 
similar to those of spongy bone [4]. However, the surface properties of this type of scaffold 
has not been optimised yet to enhance cell adhesion and growth, which are initial steps for 
the further success of the application in vivo. In addition, it is recognised that besides the 
intrinsic bioactivity of the material (e.g. formation of hydroxyapatite (HA) surface layers in 
contact with physiological fluid), there is no other functions the current scaffolds can deliver 
to enhance new tissue formation. 
 
Surface nanotopography of biomaterials has been shown to have positive effects on cell 
attachment and proliferation; therefore the controlled roughness of the scaffold surface on the 
nanoscale can facilitate this process significantly [6]. Moreover one important function that 
advanced scaffolds should have is the ability to deliver therapeutic drugs or growth factors at 
the site of tissue regeneration. Suitable drugs can fight infection after the implantation at the 
local injury site and growth factors can provide signals allowing progenitors and 
inflammatory cells to migrate and trigger the healing process [7]. Therefore, incorporating 
these biomolecules into TE scaffolds is considered to be highly beneficial for the success of 
scaffold-based TE approaches. Therefore the ultimate goal of the present research project has 
been to develop multi-functional Bioglass
®
-based glass-ceramic scaffolds exhibiting surface 
nanotopography and drug delivery capability for bone tissue engineering applications. A 
comprehensive range of experimental characterisation approaches were explored to achieve 
the set goals of the project, including microstructural analysis, mechanical properties 
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determination, bioactivity studies in simulated body fluid and drug delivery kinetics 
investigation. 
 
Electrophoretic deposition (EPD) is a convenient processing method to manipulate micro and 
nanoparticles in suspension. In this technique, charged particles suspended in a liquid 
medium migrate under the influence of an electric field (electrophoresis) and are deposited 
onto an electrode [8]. EPD is a promising technique for nano-material processing, because it 
involves simple equipment, low fabrication costs, short formation time and few substrate 
shape restrictions. EPD is very useful to produce coatings and films of homogeneous 
microstructure and controlled thickness on a wide variety of substrates of different shape and 
dimensions [9]. The EPD method was therefore adapted in this project to fabricate a multi-
walled carbon nanotube (CNT) coating on the 3D scaffold surface in order to create 
nanoscale topography and to introduce electrical conductivity (considering that electric fields 
have the potential to improve cell-cell signalling and interaction [10]). Two more methods to 
induce surface nanotopography on 3D scaffold surfaces were investigated: polymer demixing 
and chemical leaching. The nanoscale features delivered by the different methods were 
characterised by a range of techniques. The bioactivities of all scaffold systems were 
compared to that of the as-sintered original scaffold. 
 
There has been limited previous work on the combination of polymer carriers with drug 
delivery function and 3D bone scaffolds for biomedical applications; therefore the 
combination of Bioglass
®
-based glass-ceramic scaffolds and drug delivery vehicles was 
especially explored in this project. Poly(3-hydroxybutryate), P(3HB), is a natural 
biocompatible and biodegradable polymer synthesised from bacteria, which has been used in 
drug delivery applications in the form of microspheres [11]. In this project, drug 
(tetracycline)-encapsulated P(3HB) microspheres were fabricated and optimised in terms of 
size and drug load concentration, and coated onto Bioglass
®
-based scaffolds in order to 
develop composite scaffolds with added functionality, such as improved mechanical 
competence, suitable bioactivity as well as drug delivery capability. Microsphere coatings 
also increased the surface roughness after HA was formed on the surface of the scaffold struts. 
The kinetics of drug release from the tetracycline-encapsulated microspheres was 
investigated. 
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The thesis has been structured as follows. Chapter 2 presents a comprehensive literature 
review, which covers fundamental information and state-of-the-art of the research areas of 
relevance for this project in order to rationalise the materials and methods adopted in the 
project. Chapter 3 summarizes the aims and objectives of the project; it is followed by 
Chapter 4, which includes a detailed description of the materials and methods applied. 
Chapter 5 describes the optimisation process of fabricating Bioglass
®
-based scaffolds by 
foam replica using polyvinyl alcohol as the binder. Chapter 6 focuses on the fabrication of 
CNT-coating on the scaffold employing EPD, while Chapter 7 summarises the development 
of drug-encapsulated P(3HB) microspheres and the production of composite scaffolds 
incorporating these microspheres in the 3D Bioglass
®
-based scaffolds. In Chapter 8, two 
further techniques used to create nanoscale surface topography throughout 3D scaffold 
surfaces are presented and discussed in their suitability to be applied on the present glass-
ceramic scaffolds. Finally, the thesis finishes with a concluding summary and the description 
of suggested future work for the progress of this research field, which are included in Chapter 
9. 
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Chapter 2 Literature survey 
 
2.1 Tissue engineering 
 
2.1.1 Tissue engineering approaches 
 
It is widely acknowledged that the modern term of tissue engineering (TE) was first 
suggested in the United States of America in 1987 [12], since then, it has made significant 
contributions to the progress of the medical sciences. In tissue engineering, the goal is to 
apply the principles of engineering and life sciences towards the development of biological 
substitutes that restore, maintain or improve tissue function that has been impaired by illness 
or injury with the final aim of regenerating whole organs [13]. 
 
One strategy within the issue engineering approach involves mimicking the natural milieu by 
placing cells and growth factors in synthetic scaffolds made from engineering materials 
which will act as a temporary extracellular matrix (ECM) and will be the substrate for cells to 
attach and proliferate [1]. Stem cell biology involving embryonic stem cells gives further 
promise for tissue engineering. In a conventional cell culturing approach, cells are grown in 
an artificial environment where they can then thrive and replicate to form larger colonies of 
cells for different applications. The cells will then be transferred to the scaffolds for further 
remodelling [14]. 
 
There are two main challenges which remain in tissue engineering using scaffolding. One is 
the understanding of how cells behave in the environment of the engineered synthetic ECM 
(scaffold), and their mass transfer requirement, including the vasculation potential of the 
construct. The other one is the design and fabrication of the scaffold itself and the type and 
quality of the biomaterials used for scaffold fabrication. 
 
Chemical and physical configurations of many biomaterial candidates for scaffolds have been 
studied since the era of tissue engineering began. These materials can be permanent or 
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biodegradable, but all must be compatible with living systems and with living cells in vitro 
and in vivo [1, 2, 4]. 
 
The material of the scaffold is not the only determining factor for its application in tissue 
engineering, the biologic signalling to induce cell and therefore tissue growth and 
regeneration is also very important. Without proper signals, the cells can dedifferentiate (i.e. 
become nonspecific cell types), become disorganized, and eventually die. Signalling 
molecules, such as growth factors (e.g. bone morphogenetic proteins) are usually introduced 
in cell culture to ensure that these negative effects will not happen [15-17]. 
 
2.1.2 Bone tissue engineering 
 
Currently, autologous bone graft represents a highly successful standard procedure for bone 
reconstruction [18]. This procedure involves removing bone from the patient’s iliac crest and 
implanting it back to the patient’s defect site. Although it is a highly recognised procedure, it 
has some disadvantages, for instance, short supply and painful collection of the new bone 
piece, the risk of donor site morbidity and high infection possibilities caused by the need of 
two operations on the patients [18]. Furthermore, immune response and potentially transmit 
viral diseases can occur if the bone transplant was from a different donor host [18]. These 
problems have encouraged scientists to seek new methods to heal bone loss. 
 
Bone tissue engineering is one of many branches of TE that involves the principles of biology 
and engineering to develop viable substitutes that restore and maintain the function of human 
bone tissues. Bone tissue engineering offers a promising new approach for bone repair. This 
form of therapy is different from the standard drug therapy or the use of permanent implants 
in that the engineered new bone becomes fully integrated in the body, delivering a potentially 
permanent and specific cure of the disease state. Therefore, based on the principles of tissue 
engineering, a successful bone TE strategy should put the three major steps of bone 
morphogenesis into consideration. The first step is the chemotaxis and mitosis of 
mesenchymal cells, followed by the differentiation of the mesenchymal cells initially into 
cartilage, and finally, the replacement of the cartilage by bone [18]. 
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Hence, for bone tissue engineering, a porous three-dimensional matrix (or scaffold) made 
with biodegradable materials and designed such that it can mimic the ECM of desired bone 
must be introduced as shown in Figure 2.1. The goal is for the cells to attach to the scaffold, 
multiply, differentiate and organize themselves into healthy bone as the scaffold degrades. 
Recent development in scaffolds enables them not only to mimic the natural tissue, but also 
to combine them with stem cell technologies and growth-stimulating factors [18]. The 
scaffolds hence are developed to be dual functioned: to support and guide cell growth and to 
deliver growth-stimulating factors locally to the appropriate site. The latest scaffolds can also 
include additional functions such as drug-delivery capability or anti-bacterial behaviour. 
 
The extracellular matrix (ECM) is that part of natural tissues which gives them form and 
shape. Bone is made up of an ECM composed of a composite fibrous network of type I 
collagen (90% total protein content) [19] encased within a hard inorganic matrix of 
calcium/phosphorous in apatite crystalline structure containing also many impurities such as 
carbonate and magnesium [16]. Collagen is synthesised and secreted by osteoblasts and then 
deposited in the form of preferentially orientated layers called lamellae, and the apatite 
crystals are positioned around the collagen fibres and in the ground substance to give bone its 
rigidity and compressive strength [19]. Therefore, fabricating composites using inorganic 
materials, such as ceramics, and polymers is an effective approach to produce successful 
scaffolds for bone tissue engineering [20]. 
 
 
Figure 2.1 Schematic diagram of scaffold-guided bone tissue regeneration [21]. 
  
 
 
 
Cell culture 
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2.2 Materials for bone tissue engineering scaffolds 
 
Because it is a biological application with strict requirements, scaffolds must be made from 
biocompatible materials, whether they are natural or synthetic materials. The important 
scaffold design parameters and requirements are summarized in Table 2.1. 
 
A wide range of bioceramic and polymer materials for bone tissue engineering scaffolds have 
been investigated [22]. These materials include coralline hydroxyapatite (HA), calcium 
phosphates (CaP), bioactive glass and biodegradable polymers, such as poly(lactic acid) 
(PLA) [23] and poly(glycolic acid) (PGA) [24]. However, none of them can satisfy all the 
goals required for creating optimal scaffolding, including strength, toughness, 
osteoinductivity (the ability of a substance to initiate bone formation in a non-bony site), 
osteoconductivity (support bone growth and encourage the ingrowths of surrounding bone) 
[16] and controlled degradation. Therefore the combinations of materials in order to form 
composites have being increasingly considered [20]. In the following sections, the most 
popular biomaterials being investigated for bone tissue engineering are described. 
 
Table 2.1 Scaffold design parameters and requirements for bone tissue engineering [25, 26]. 
Parameters Requirements 
  
Porosity Maximum possible without compromising mechanical 
properties 
Pore size 200-400 µm 
Pore structure Interconnected 
  
Mechanical properties of the cancellous bone 
Tension and compression Strength: 5-10 MPa 
 Modulus: 50-100 MPa 
Mechanical properties of the cortical bone 
Tension Strength: 80-150 MPa 
 Modulus: 17-20 MPa 
Compression Strength: 130-220 MPa 
 Modulus: 17-20 MPa 
 Fracture toughness: 6-8 MPa m  
Degradation properties 
Degradation time Must be tailored to match the application on patients 
Degradation mechanism Bulk dissolution in medium 
Biocompatibility No chronic inflammation 
Sterilisability Sterilisable without altering material properties 
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2.2.1 Bioactive inorganic materials 
 
A major group of materials applied to the field of bone tissue engineering are bioactive 
ceramics. They can be separated into three groups: calcium phosphate ceramics, bioactive 
silicate glasses and glass-ceramics [27]. 
 
Calcium phosphates can be synthesised by mixing calcium and phosphate solution under acid 
or alkaline conditions, however, due to the high solubility, compounds with Ca/P ratio less 
than one are not suitable for biological implantation [27]. Hydroxyapatite (HA, 
Ca10(PO4)6(OH)2) and related calcium phosphates have been intensively investigated as major 
components of scaffold materials for bone tissue engineering [28] as they are chemically and 
structurally similar to the mineral component of bones and hard tissues in mammals. Around 
60 wt% of bone is made of HA [20]. The formation of HA related calcium phosphate phases 
is due to the imbalances in the Ca/P ratio. If the ratio is lower than 1.67, β-tricalcium 
phosphate (β-TCP) is usually present with HA, along with tetracalcium phosphate (TTCP). 
Calcium oxide will be present if the ratio is higher than 1.67. These extraneous phases may 
unfavourably affect the biological responses of implants and scaffolds [27]. A significant 
disadvantage of using hydroxyapatite is that dense hydroxyapatite does not have the 
mechanical strength and toughness to enable it to succeed in long term load bearing 
applications. This is in fact a drawback of all bioactive ceramics. Usually HA (and bioactive 
glasses) are used as coating, e.g. by plasma spraying [29], onto metallic implants to alter 
surface properties, and to introduce bioactivity (i.e. ability to form a direct chemical bond 
with surrounding tissue). 
 
2.2.2 Silicate glass-ceramics and bioactive glasses 
 
A glass-ceramic is polycrystalline solid prepared by the controlled crystallisation or 
devitrification of a parent glass [27]. It generally has a small volume of residual glass, which 
is amorphous, mixed with fine grain crystals of sizes ranging usually from 0.1 to 10 µm. 
These crystals can provide special properties to the material, such as tailored bioactivity and 
improved mechanical properties. 45S5 Bioglass
®
-based scaffolds fabricated using the foam 
replica technique exhibit a highly crystalline glass-ceramic structure [4]; this is the base 
material to be used in this research project. 
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Apatite-wollastonite (A-W) glass-ceramic is another frequently studied glass-ceramic for use 
as a bone substitute. Kokubo et al. demonstrated that MgO-CaO-SiO2-P2O5 glass can be heat 
treated to give a glass-ceramic containing crystalline apatite (Ca10(PO4)6(O,F)2) and beta-
wollastonite (CaO.SiO2) in an MgO-CaO-SiO2 glassy matrix. [30]. This material has good 
bioactivity and mechanical properties and has been successfully used in the load-bearing 
spinal area of the body. 
 
Ceravital
®
 is the trade name of a number of different compositions of glasses and glass-
ceramics [27]. The major advantage of this type of glass-ceramic is that its solubility can be 
adjusted by addition of metal oxides, such as MgO, Na2O and K2O, but with negative effect 
on the cellular function and influence on the development of ECM [27]. No highly porous 
scaffolds fabricated using this type of glass have been reported in the open literature. 
 
Bioverit
®
 is another developed bioactive glass-ceramic, it has a chemical composition in the 
SiO2-Al2O3-MgO-Na2O-K2O-F-CaO-P2O5 base glass system with special fuorophlogopite 
mica crystals (Na/KMg3(AlSi3O10)F2). It has been successfully applied in dental tooth fillers, 
nose, the middle ear,  jaw and in the general region of the head and neck [31]. However, to 
the author’s knowledge, it has not been used to fabricating 3D scaffolds. 
 
In comparison to glass-ceramics, the regularity (order) of the glass structure is only short 
range, i.e. glass is an amorphous material. Glasses are formed by rapidly cooling form the 
melting state, so there is no time for the atoms to arrange themselves in a periodic structure 
[27], and there is no formation of a crystalline structure. 
 
Bioactive glasses are categorised as class A biomaterials as they are osteoconductive and 
osteogenetic compared with class B biomaterials (such as HA) which are only 
osteoconductive [32]. Discovered in 1969 by Professor Larry Hench [33], bioactive glass is 
one of the most well-known and widely used bioactive inorganic material for bone tissue 
engineering. The basic constituents of most bioactive glasses are SiO2, Na2O, CaO, and P2O5 
[20]. Bioactive glasses are highly surface reactive and can rapidly produce a 
hydroxycarbonated apatite layer that can bond to biological tissue when immersed in 
biological fluid. 
 
30 
 
The HA formation on bioactive glass when it is in contact with a relevant fluid, e.g. simulated 
body fluid (SBF), is usually considered as the evidence of the bioactivity of the material. This 
surface reactivity can be described by a five stages process [33]. It starts with the rapid 
exchange of Na
+ 
or K
+ 
with H
+ 
or H3O
+
 from solution: 
 
Si-O-Na
+ 
+ H
+
 + OH
- 
           Si-OH + Na
+ 
(solution) + OH
-
 
 
The second stage is the loss of soluble SiO2 in the form of Si(OH)4 to the solution, resulting 
from breaking of Si-O-Si bonds and formation of Si-OH (silanols) at the glass solution 
interface: 
Si-O-Si +H2O           Si-OH + OH-Si 
 
Then, at the third stage, condensation and re-polymerisation of a SiO2-rich layer on the 
surface depleted in alkalis and alkaline-earth cations occurs: 
 
SiO3(OH) + SiO3(OH)            O3SiOSiO3 + H2O 
 
At stage four, Ca
2+ 
and PO4
3- 
groups migrate to the surface through the SiO2-rich layer, 
forming a CaO-P2O5-rich film on top of the SiO2-rich layer; this stage is followed by the 
further growth of the amorphous CaO-P2O5-rich film by incorporation of soluble calcium and 
phosphate ions from the solution. Finally, crystallisation of the amorphous Ca-O-P2O5 film 
takes place by incorporation of OH
-
, CO3
2-
, or F
-
 anions from solution to form a mixed 
hydroxyl, carbonate, or fluorapatite layer, respectively. 
 
Increasing the silica content of melt-derived bioactive glasses decreases their rate of 
dissolution because of the reduction in the number of network modifier ions present in the 
glass structure, which serve to promote network breakdown [34]. Only when the silica 
content is less than 60 mol%, melt-derived bioactive glasses can form a bond to bone. 
However, for sol–gel derived glasses, similar bioactivity can be achieved even when the 
silica content is increased to 90 mol% [35]. 
 
The first sol–gel bioactive glasses, labeled “58S”, were developed in the early 90s [35, 36]. 
58S is a porous bioactive glass of the SiO2-CaO-P2O2 composition (60 mol% SiO2, 36 mol% 
CaO, 4 mol% P2O5) derived by sol-gel processing [37]. It is typically fabricated by adding 
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triethyl phosphate and calcium nitrate tetrahydrate into phosphate and calcium, respectively, 
to form the ‘sol’. Once the sol undergoes polycondensation, it forms a silica network of Si–
O–Si bonds within three days, becoming a ‘gel’ [38]. The gel is then dried at a temperature of 
at least 600°C to remove by-products, such as water and ethanol [39]. 
 
Improved purity and homogeneity have been considered to be advantages of 58S bioactive 
glass over melt-derived glasses (such as 45S5 Bioglass
®
) for tissue engineering applications 
[37]. Sol–gel glasses contain a significant number of OH groups in the glass network, hence 
the network is not completely cross-linked. Therefore, several sol–gel silica-based glasses 
have nanoporosity, often microporosity. This leads to a typical surface area of around 200 
m
2
/g, which is two orders of magnitude greater than that of dense melt-derived glasses [40]. 
These nanoporosity and enhanced surface area make sol–gel glasses generally more bioactive 
than melt-derived glasses with similar composition. Moreover, sol-gel glasses have higher 
dissolution rates and faster reactions rate in the stages 1 and 2 of the bioactivity mechanism 
reactions. In addition to that, there are several Si–OH groups present on the unreacted sol–gel 
glasses that can quickly act as nucleation sites for HCA deposition, which causes the 
formation of HCA surface layer to occur more rapidly than on melt-derived glass surfaces 
[41]. 
 
It has been also shown that the surfaces of sol–gel glasses can be modified by different 
surface-chemistry methods. For example, when sol-gel glasses are treated with amine groups, 
a hydrophobic surface results, which is attractive to specific proteins such as laminin [42]. 
 
Cell-response studies on 58S [43] and 70S30C [44] foam scaffolds have found that primary 
human osteoblasts lay down mineralized immature bone tissue, without the requirement of 
additional signaling species such as dexamethasone and ß-glycerophosphate. These results 
thus indicate that silicon and calcium ions could stimulate bone cells to lay down 
extracellular matrix proteins and to induce subsequent mineralization of the matrix. The 
results seem to indicate that phosphate in the glass network may not be essential for bone 
matrix production and mineralization to take place. 
 
Sol-gel derived bioactive glasses can also be bioactive with fewer components. For example, 
sol-gel derived CaO-SiO2 bioactive glass, S70C30, contains only 70 mol% SiO2 and 30 
mol% CaO, but it has been reported that it exhibits the highest HA formation rate among all 
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bioactive glasses [34] due to its high Si-OH group content, which plays a key role in HCA 
layer nucleation [45]. 
 
The Ca
2+
 ion release rate of S70C30 powder is twice that of 58S powder. Thus the rapid 
initial dissolution rate of S70C30 is the greatest in comparison to both 58S and 45S5 
Bioglass
®
, due to its higher Ca content leading to faster network disruption [34]. It has also 
been shown that when S70C30 powders are immersed in SBF, the first four HA formation 
reaction stages occur within the first 30 min and the 5
th
 stage (crystallisation of an HCA 
layer) occurs between 3 and 6 hours. This indicates that the S70C30 gel-glass powder is a 
Class A bioactive material and it is comparable in bioactivity with 45S5 Bioglass
®
 and 58S 
gel-glass [34]. This finding also dispelled the original assumption that Na2O and P2O5 are 
essential components for making silicate glasses bioactive. In a relevant study, Bielby et al. 
[46] found that the P2O5 free S70C30 can provide a favourable environment for osteoblast 
proliferation and function. 
 
Chen et al. [47] reported recently that S70C30 derived glass-ceramic consisting of a nearly 
inert crystalline phase CaSiO3 and amorphous S70C30 transformed to CaSiO3 with minor HA 
formation when immersed in SBF under standard tissue culture conditions. In addition, a 
possible disadvantage of SiO2-CaO bioactive glasses is their poor mechanical properties in 
amorphous form. In contrast, sol-gel derived Na2O-containing glass ceramics, e.g. of 45S5 
Bioglass
®
 composition, exhibit enhanced mechanical capability and biological absorbability 
than Na2O-free bioactive glasses. 
 
In the present investigation, 45S5 Bioglass
®
 was the bioactive glass composition chosen for making 
scaffolds based on the available and robust scaffold fabrication method (foam replica technique) and 
on the extensive body of data regarding the biological effect of ion dissolution products from this 
glass. 
 
This bioactive glass composition can be tailored to deliver to deliver Si
+
 and Ca
2+
 ions at 
levels capable of activating complex gene transduction pathways leading to enhanced cell 
differentiation and osteogenesis. The effect of ionic products from the dissolution of 45S5 
Bioglass
®
, on the gene-expression profile of human osteoblasts was studied by Xynos et al. 
[48]. Microarray analysis of osteoblast gene expression showed that genes with known roles 
in processes relevant to osteoblast metabolism and bone homeostasis can be induced by the 
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ionic products of bioactive glass dissolution treatment, these genes include RCL, which can 
induce oesteoblast proliferation, CD44, which can perform differentiated functions and 
integrin β1, which promotes cell-cell and cell matrix attachment. 
 
Dissolution products of bioactive glass have also been shown to stimulate angiogenesis, 
which triggers vascularisation. Day et al. [49, 50] studied the possibility of using bioactive 
glass in soft tissue engineering and angiogenesis applications. 45S5 Bioglass
®
 coatings on 
polystyrene cell-culture plates using low concentration (0.01-0.2% wt/vol) bioactive glass 
slurries increased proliferation of fibroblasts cell line 208F. Moreover, the in vivo study in rat 
model of 45S5 Bioglass
®
-coated polyglycolic acid meshes revealed that neovascularisation 
into the meshes was significantly increased by the presence of the bioactive glass coating at 
28 and 42 days [49]. This effect should ensure an adequate blood supply for delivery of 
nutriens and oxygen into the neotissue. It was observed that fibroblasts adhered to the PGA 
meshes rather than directly to 45S5 Bioglass
®
 particles. 
 
Overall, reports in the literature indicate that beyond the physical and chemical interaction of 
bioactive glass and bone tissue, the dissolution products of bioactive glasses have a direct 
effect on osteoblast gene expression and angiogenesis, in addition to other unique property, 
such as providing support for enzyme activity [51], making this material a very convenient 
one for bone tissue engineering. Furthermore, as mentioned above, the foam replica 
technique used in this study is well-suited for melt-derived glass powders. Indeed 45S5 
Bioglass
®
 powders have been successfully used several times in the last years to develop 
reproducible scaffolds by the foam replica method, as reported in the literature [4, 52, 53], 
this being a reason why sol-gel derived powders were not selected for this study. Thus, based 
on the existing knowledge on the use of 45S5 Bioglass
®
 for scaffold preparation and 
considering the investigated benefits of 45S5 Bioglass
®
 dissolution products on bone 
formation, this material was chosen for the present investigation. 
 
2.2.3 Biodegradable polymers 
 
Biodegradable polymers are interesting candidates for tissue engineering application as they 
are biocompatible and can provide guidance that favors cell attachment [54-56]. These 
polymers can be classified into two types, the natural-based ones, such as starch, which is 
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from the family of polysaccharides, and synthetic ones, such as poly-α-hydroxy esters, these 
including poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and their copolymer 
poly(lactic-co-glycolide) (PLGA) [57]. These synthetic polymers are produced under 
controlled conditions and therefore exhibit in general predictable and reproducible 
mechanical and physical properties such as tensile strength, elastic modulus and degradation 
rate [20]. 
 
Another important group of biodegradable polymers are polyhydroxyalkanoates (PHA), 
which are composed of either 3-, 4-, 5- or 6-hydroxyalkanoic acid monomers. They are 
biodegradable and water-insoluble, produced by a variety of bacterial species under nutrient-
limiting conditions with excess carbon [11]. The applications of the PHAs vary depending on 
the monomer composition. For example, homopolymer of 4-Hydroxybutyrate, P(4HB), was 
used for tissue engineering heart valve scaffold and viable ovine blood vessels [58]. However, 
on the other hand, the industrial applications of polyhydroxybutyrate, P(3HB), have been 
limited due to its low thermal stability and excessive brittleness upon storage [59]. More 
details of this group of polymers will be discussed in section 2.5. 
 
Many forms of scaffolds can be fabricated using these polymers by various techniques. These 
techniques mainly include gas foaming [60], rapid prototyping [61], electrospinning [62], 
thermally induced phase separation [63], emulsion freeze-drying [64], solvent casting and 
particulate leaching [65] and supercritical fluid processing [66]. 
 
Although the use of biodegradable polymers as scaffold materials for bone tissue engineering 
represents a very popular choice, concern exists over immunogenicity (with natural polymers 
only), material impurities (potential causes of cytotoxicity and infections), lack of bioactivity 
and weak mechanical properties. Therefore, many composite materials made by combination 
of organic and inorganic materials are attracting increasing attention in research in order to 
overcome the problems that they have when used individually [20], and at the same time, to 
deliver novel materials with improved properties. 
 
 
 
35 
 
2.2.4 Composite scaffolds 
 
By combining polymers and inorganic bioactive materials, the advantage of the formability 
and the toughness of a polymer can be combined with the stiffness and bioactivity of the 
bioactive ceramic/glasses. The mechanical reinforcement of composite scaffolds can be 
achieved by inclusion of ceramics into polymers, and at the same time, the poor bioactivity of 
most polymers can be counteracted [20]. 
 
Several systems in order to fabricate such composites have been reported in the literature as 
reviewed elsewhere [20, 67]. One approach is to coat the ceramic scaffold with polymer in 
order to improve the mechanical properties of the brittle scaffold. This approach is inspired 
by the fact that nearly 60 wt% of bone is constituted of an inorganic phase (HA) and the rest 
is the organic phase (collagen) and water [68]. It is well known that the fracture behaviour of 
mineralised tissues such as bone (and dentin) is influenced by the optimal interaction of the 
inorganic and organic phases, and the toughness mechanisms induced by the presence of 
collagen fibrils in bone are starting to be elucidated [68, 69]. The polymer coating is usually 
achieved by slurry-dipping technique and a polymer layer can therefore be created on the 
surface of the three-dimensional scaffold matrix [5, 68]. Besides that, the approach has been 
extended to include scaffolds with interpenetrating network structures, where the polymer is 
added not only as a surface coating but is also made to penetrate and infiltrate the pore walls 
(struts) of the scaffold via remaining porosity or microcracks. The polymer filaments will 
bridge the cracks and even fragments during fracture hence increasing the scaffold toughness 
[68].  
 
The basic process developed to fabricate polymer-coated glass-ceramic scaffolds with 
interpenetrating network microstructures consists of infiltrating a sintered or partially sintered 
bioceramic scaffold with the polymer phase [68]. Conducted and reported in Chen et al.’s 
study, PDLLA was the first biodegradable polymer considered to coat 45S5 Bioglass
®
-based 
glass-ceramic scaffold. The compressive and three-point bending strengths were slightly 
increased by the PDLLA coating, and the toughness (determined by measuring the work of 
fracture) was considerably enhanced [70]. More recently, an alternative polymer based on a 
polyhydroxyalkanoate has been investigated as coating material [5]. Bretcanu et al. [5] used, 
for the first time, bacteria-derived P(3HB) to infiltrate 45S5 Bioglass
®
-based glass-ceramic 
scaffold. It was found that the polymer coating considerably increased the compressive 
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strength of the scaffolds. The polymer coatings did not inhibit the bioactivity of the scaffolds 
in both cases. Following Chen et al.’s work, Yunos et al. [68] investigated the infiltration of 
PDLLA phase into partially sintered 45S5 Bioglass
®
-based glass-ceramic scaffold, it was 
reported that the compressive strength of the coated scaffold was up to 7 times higher than 
the value for the uncoated ones. Mourino et al. [71] developed Bioglass
®
-derived glass-
ceramics scaffolds with prophylaxis effect against infections. The scaffolds were coated with 
sodium alginate crosslinked with Ga
3+
. Just like the other polymer-coated scaffolds that 
mentioned earlier, it was confirmed that the polymer coating did not affect the 
interconnectivity of the scaffold pore structure. The resulting composite scaffold exhibited 
antibacterial effect and improved mechanical properties as well as maintained its high 
bioactivity. Such advanced (multifunctional) scaffolds will be discussed in the next section. 
 
An alternative method is to fabricate hybrid polymer-ceramic composite scaffold. This can be 
achieved by foaming a mixture of polymer solution and bioactive glass sol-gel precursor 
solution [72]. Although a hierarchical (larger pores containing smaller pores on their walls) 
macroporous three-dimensional structure can be achieved, the porosity of the scaffold 
produced this way is usually 10-30% lower than the ones produced by foam replica method. 
Due to the higher content of the polymer, the mechanical property (in particular toughness) of 
this type of hybrid composite scaffold is therefore higher than the polymer-coated scaffolds 
fabricated by foam replica method, however, compressive strength values may be lower. 
 
Addition of the bioactive phase to bioresorbable polymers can alter the polymer degradation 
behaviour, by allowing rapid exchange of protons in water for alkali in the glass or ceramic 
[20]. The alkalinity of the inorganic filler can therefore neutralise the acidic autocatalytic 
degradation of polymers [73]. The combination of bioceramic and biopolymers can also 
increases the hydrophilicity and water absorption of the hydrophobic polymer medium, the 
surface and bulk properties of composite scaffolds are hence modified, so is the scaffold 
degradation kinetics [20]. 
 
Table 2.2 lists selected ceramic/glass-polymer composites, which were designed as 
biomedical devices or scaffold materials for bone tissue engineering and their mechanical 
properties [26]. 
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Bioactive inorganic materials and polymers are not the only materials used to produce 
composite scaffold. MacDonald et al. [74], for example, produced a collagen-carbon 
nanotube (CNT) composite that was cell-seeded by incorporating smooth muscle cells at the 
time of the gelation of the collagen/chemical functionalised SWCNTs mixture. Type I 
collagen was used in their study. When collagen fibrillogenesis (Type I collagen is produced 
by combining three cell types in the form of single, helical polypeptide chain to form a larger 
rope-like superhelix, fibrillogenesis takes place when the triple-helical molecules are further 
assembled into collagen fibrils), was initiated, CNTs became incorporated into the triple-
helical collagen molecules, or remained as a separate phase. In either case, CNTs became 
incorporated into the collagen fibril as fibrillogenesis proceeds, forming in-situ the collage-
CNT composite material. However, Raman spectroscopy confirmed that there was no strong 
molecular interaction between the collagen and CNT components, and this matrix did not 
significantly affect cell viability or cell proliferation as the cell number in CNT-contained 
constructs was lower than in control constructs which did not contain CNTs. CNTs are being 
considered in a number of tissue engineering scaffolds to produce surface nanotopography 
and other specific mechanical and functional properties to the scaffold [6, 75-77]. 
 
To conclude this section, it should be pointed out that material chemistry is not the only 
factor determining how cells attach to the scaffold, the surface roughness; hence the 
topography of the scaffold is also a crucial factor effecting cell attachment and further cell 
behaviour, as explained in the next section. 
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Table 2.2 Biocomposites designed for bone tissue engineering [26]. 
 
Biocomposites    Compressive (C),     
  Percentage of Porosity Pore Size Tensile (T), Flexural  Ultimate Toughness 
Ceramic Polymer Ceramic (%) (%) (um) Strength (F) (MPa) Modulus (MPa) Strain (%) (kJ/m
2
) 
Dense composites         
HA fiber PDLLA 2-10.5 (vol.) Not applicable 45 (F) 1.75-2.47x10
3
   
 PLLA 10-70 (wt.)   50-60 (F) 6.4-12.8x10
3
 0.7-2.3  
HA PLGA 40-85 (vol.)   22 (F) 1.1x10
3
  5.29 
 Chitosan 40-85 (vol.)   12 (F) 2.15x10
3
  0.092 
 Chitosan+PLGA 40-85 (vol.)   43 (F) 2.6x10
3
  9.77 
 PPhos 85-95 (wt.)       
 Collagen 50-72 (wt.)       
 PPF 25 (wt.)   7.5-7.7 (C) 191-134   
A/W PE 10-50 (vol.)   18-28 (F) 0.9-5.7x10
3
   
Ca3(CO3)2 PLLA 30 (wt.)   50 (C) 3.5-6x10
3
   
Human cortical bone     50-150 (T) 12-18x10
3
   
     130-180 (C)    
Porous composites         
Amorphous CaP PLGA 28-75 (wt.) 75 >100  65   
β-TCP Chitosan-Gelatin 10-70 (wt.)  322-355 0.32-0.88 (C) 3.95-10.88   
HA PLLA 50 (wt.) 85-96 100-300 0.39 (C) 10-14   
 PLGA 60-75 (wt.) 81-91 800-1800 0.07-0.22 (C) 2-7.5   
 PLGA  30-40 110-150  337-1459   
Bioglass
®
 PLGA 75 (wt.) 43 89 0.42 (C) 51   
 PLLA 20-50 (wt.) 77-80 ~100 1.5-3.9 (T) 137-260 1.1-13.7  
    ~10     
 PLGA 0.1-1 (wt.)  50-300     
 PDLLA 5-29 (wt.) 94 ~100 0.07-0.08 (C) 0.65-1.2 7.21-13.3  
     10-50     
Phosphate glass A/W PLA-PDLLA 40 (wt.) 93-97  0.017-0.020 (C) 0.075-0.12   
 PDLLA 20-40 (wt.) 85.5-95.2 98-154     
Human cencellous bone     4-12 (C) 100-500 1.65-2.11  
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2.2.5 Advanced scaffold: Multi-functionality 
 
As the developments of TE scaffold progress in recent years, besides structured and 
mechanical support for cell growth, the needs for additional functions for the scaffolds 
become more and more important. With problems such as post-operation infections and the 
action of growth factors that provide signals at local injury sites allowing progenitors and 
inflammatory cells to migrate and trigger the healing process [78, 79], functions like 
antibacterial and drug delivery should also be added to a scaffold. 
 
One of the most common strategies to introduce such functions is to fabricate a composite 
scaffold consisting of a ceramic body and a polymer coating. Many studies have shown the 
improvement of the mechanical strength of the scaffold after polymer coating [20, 68, 70]. In 
addition, by incorporating drugs or/and growth factors into the polymer coating, they can be 
gradually released into the surrounding media in a desired time frame when the polymer 
coating is degrading to treat bone disorders or to act on the surrounding tissues with an 
adequate therapeutic concentration level. Figure 2.2 shows a schematic representation of the 
most common strategies to deliver drugs from three-dimensional scaffolds in bone TE [7]. 
 
The increasing volume of work dealing with this approach is leading to the establishment of 
an emerging field which has been termed TE therapeutics [80]. Mourino et al. [7] has 
presented a very comprehensive review on controlled drug delivery in three-dimensional 
scaffolds. A summary of works carried out on this subject is presented in Table 2.3 [7]. 
 
One major problem with antibiotics is that the bacteria can become resistant to them; silver or 
copper ions are therefore used as alternative agents in order to overcome that problem. The 
ions have high surface to volume ratio due to their small size, which leads to the antibacterial 
effect [81]. This close interaction causes the ions to be incorporated into the bacteria’s cell 
membrane and causes the intercellular substances to leak out, hence leading to cell death [81]. 
The positive charge of the ions is another factor contributing to their antibacterial effect. 
Bacteria cell walls are negatively charged, positive ions therefore are attracted to them and 
punch in, causing the intercellular substances to leak out. This charge effect is more relevant 
to copper ions, as they are larger than sliver ions [82]. 
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Silver ions have been introduced into silica based glass-ceramics by Akkopru et al. [83], and 
in phosphate based glass-ceramic by Ahmed et al. [84], in both cases via sol-gel technique. 
On the other hand, the molten salt ion exchange technique has been applied to introduce 
silver ions into glass waveguides for optical applications [85].
 
Di Nunzio et al. [86] 
demonstrated that using the molten salt ion exchange method silver ions can be introduced 
into bioactive silicate glasses. In this technique, the silver was incorporated into the glass 
network by exchanging the sodium ions in the glass with silver ions in the melt [86]. The 
method usually ensures a constant sliver ion content and diffusion profiles in the glass and 
offers a simple and low cost way to introduce silver into a scaffold after it has been sintered 
[86]. 
 
Copper ions also have the ability to enhance angiogenesis [87]. In bone defects, growth 
factors such as vascular endothelial growth factors (VEGF), fibroblast growth facor-2 (FGF-2) 
and hypoxia-inducible factor-1 (HIF-1) can trigger angiogenesis; copper ions can stimulate 
the production of VEGF by activating the major transcription factor, VEGF can then go on to 
regulate HIF-1 [88]. Copper can be introduced into scaffolds via molten salt ion-exchange 
method as well, and this method has been used to introduce copper into silicate glasses for 
waveguides for the past 20 years [85]. 
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Table 2.3 Selected experimental trials carried out for three-dimensional bone scaffold, both in vivo and in 
vitro, with a combination of controlled drug release. Modified from literature [7]. 
Drug Target Composition Scaffold 
shape 
Methodology Ref. 
 
 
 
 
 
 
 
 
Gentamicin 
 
 
 
 
 
 
 
 
Osteomyelitis 
Β-TCP 
/CP/chitosan 
 
 
 
Bioactive 
glass 
 
 
 
 
HMS-HA 
/PLGA 
microspheres 
Porous 
matrix 
 
 
 
Mesoporous 
bioactive 
glass/ 
bioactive 
glass 
 
Porous 
matrix 
Thermally induced phase-
separation technique + 
immersion in drug-
containing PBS solution 
 
Polyurethane sponge 
technique + immersion in 
drug-containing PBS 
solution 
 
 
Tensiactive template to 
obtain HMS-HA + double-
emulsion evaporation 
technique to obtain GS-
loaded PLGA 
microspheres + 
sinterisation at 70
o
C 
[89] 
 
 
 
 
 
[90] 
 
 
 
 
 
[91] 
Tetracycline Bacterial infections Bioactive 
glass/β-
cyclodextrin 
Bioactive 
glass pieces 
Sol-gel [92] 
Vancomycin Infections caused 
by Gram-positive 
bacteria 
β-
TCP/agarose 
Porous matrix Freeze-drying and heat 
desiccation at 37
o
C 
[93] 
Polymyxin B Gram-negative 
infections 
Calcium 
phosphate 
Ceramic 
pieces 
Compaction [94] 
Gatifloxacin Bacterial enzymes 
DNA gyrase and 
topoisomerase IV 
β-TCP/PCL Porous matrix Compaction + sintering + 
immersion in drug-loaded 
PCL slurry 
[95] 
Ciproflozacin  HA/β-
TCP/PLA 
Porous matrix Compression [96] 
 
 
 
Dexamethasone 
 
 
Local inflammation 
Starch/PLA 
 
 
Chitosan 
Porous matrix 
 
 
Porous matrix 
Supercritical phase-
inversion technique 
 
Freeze-drying + drug 
impregnation by 
supercritical fluid 
technology 
[97] 
 
 
[98] 
Ibuprofen Inflammation, 
Arthritis 
Bioactive 
glass/MCM-
41 
Porous matrix MCM-41 spheres + 
melting and sintering at 
high temperature to obtain 
bioactive glass scaffold + 
drug impregnation 
[99] 
Alendronate Osteoporosis Silica (SBA-
15) 
Mesoporous 
silica matrix 
Triblock copolymers 
technique + 
functionalization + 
immersion in drug-
containing buffer aqueous 
solution 
[100] 
Zoledronate Paget’s disease, 
tumour-induced 
hypercalcaemia, 
metastatic bone 
diseases and 
osteoporosis 
CDA Pellets Suspension of CDA in 
drug-containing water 
solution 
[101] 
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Figure 2.2 Schematic representation of the most common strategies to deliver drugs from three-
dimensional scaffolds in bone TE. Drugs may be adsorbed onto the pore surface of the scaffolds in either 
their unprotected (a) or their protected (microsphere/ matrix) (b) forms. Alternatively, drugs may be 
entrapped in the scaffold structure in either their unprotected (c) or their protected (microsphere/matrix) 
(d) forms [7]. 
 
2.3 Fabrication of micro- and nanoscale topography in tissue engineering 
scaffolds 
 
Having reviewed topics related to multifunctional scaffolds in the previously sections, this 
present section will focus on another relevant topic in the present thesis: the development of 
engineered topographies on 3D scaffolds surface. 
  
Although cells have micrometre dimensions, they grow in vivo in close contact with the ECM, 
which has topographical and structural features of nanometer size [102]. Moreover cells have 
many structures at the nanoscale, such as filopodia and cytoskeletal and membrane proteins 
that interact with the environment surrounding them [103]. Cell response is affected by the 
physicochemical parameters of the biomaterial surface, such as surface energy, surface 
charges and chemical composition. In addition, topography is one of the most decisive 
physical cues for cells [102]. There is increasing interest in mimicking the nanoscale 
topographical features presented to a cell, emerging evidence indicates that these nanoscale 
surface features can promote functions such as cell adhesion, cell mobility and cell 
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differentiation [104]. In some applications, it is essential to use topography to guide the cell 
orientation in order to achieve a functional tissue, such as tendons, nerves and intervertebral-
disc regeneration. It is now well established that the contact guidance of cells by micro- and 
nano-topographical patterns is a promising perspective requiring however the development of 
three-dimensional nanostructured scaffolds [105]. 
 
A number of techniques can be used to create ordered and unordered nanoscale topographies 
for cell scaffolding. Electron beam lithography [106] and photolithography [107] are two 
standard techniques for creating ordered features, however only in two-dimensions, e.g. on 
flat surfaces. Phase separation and colloidal lithography are other techniques suitable to 
create unordered surface patterns on flat surfaces. Polymer demixing and chemical etching 
however are used to create unordered surface patterns in both two-dimensional and three-
dimensional structures [103]. In the following sections, the techniques available for 
topography engineering of biomaterial surfaces are described. 
 
2.3.1 Photolithography 
 
Photolithography is a standard fabrication method for micro-scale topographies, as precise 
geometries and patterns can be created. This process involves exposing a silicon wafer coated 
with a photoresist to a near-UV light source (typically 365 or 405 nm in wavelength) through 
a mask that has the desired pattern on it, which selectively allows light through to the wafer 
thereby the pattern is recreated in the photoresist. Due to the limitation of this method, 
nanometer-size topographies cannot be created [103]. However, recent developments use 
shorter wavelength lasers can allow the exposure of even smaller features using 
photolithography. Wavelengths in the deep UV (157 nm) and ‘soft’ X-ray regions (2-50 nm) 
may allow extending the current lower limits of photolithography to the natural limit of 
complementary metal–oxide–semiconductor-based devices [107]. However that technique 
has not yet been applied to create nanoscale topography in tissue engineering scaffolds to our 
knowledge. Photolithography is now often used in combination with other methods to create 
desired nanoscale patterns. Wood et al. [108] created patterned colloidal nanopillared 
topographies by combining and utilizing natural lithography and conventional 
photolithography techniques, which made possible to devise a method where planar and 
nanopillared surfaces can lie collaterally on the same device with ease. Kenar et al. [109] 
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used photolithography technique (with UV light) generated microgrooves and micropits on 
single crystal silicon wafers that were coated with positive photoresist to create a variety of 
templates for studying the influence of pattern types on cell adhesion. Poly(3-
hydroxybutyratre-co-3-hydroxyvalerate) (PHBV) films were prepared using solvent casting 
on the master templates, and hence generated negative replication of the master patterns. 
Their study showed that the micotopographies can improve osseointegration when combined 
with fibrinogen, and selective osteoblast adhesion and alignment can be guided by the 
microgrooves and cell adhesive protein lines on the PHBV films. 
 
2.3.2 Electron Beam lithography (EBL) 
 
This technique involves the use of high-energy electrons to expose a positive or negative 
electro-sensitive resist [106], and the negative resists result in lower feature resolution. The 
mask used in photolithography is not required to pattern the surface with the beam of 
electrons in this case, since the pattern is programmed into the unit in order to precisely 
control how the beam travels over the resist-coated surface. EBL has the ability to create 
single surface features down to about 3-5 nm [110]. However, single features are not of 
practical use in studying cellular growth and behaviour, in contrast to that, high density arrays 
of a single feature such as posts or channels are used, which allows for enough surface area to 
be covered with the pattern to observe a cell population’s response to the surface features. 
Vieu et al. [110] dropped the limit of EBL to approximately 30-40 nm in order to create a 
relatively large surface area with arrays of features, Figure 2.3. 
 
 
Figure 2.3 SEM image of a 20-nm line and space array obtained by EBL, the exposure dose was 11 nC/cm 
[110]. 
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2.3.3 Polymer demixing 
 
This technique is used to obtain randomly organised patterns on inorganic material surfaces. 
It is based on spontaneous phase separation of a polymer blend under the spin-casting process 
onto a substrate [111], such as silicon and glass. Different shapes, for example, pit, island and 
ribbon, and the size of the features can be modulated by the careful adjustment of the 
polymer ratio or the polymer concentration, respectively, [102], [103]. 
 
This is a fast and inexpensive method for creating cell culture surfaces with nanoscale 
features. These features are somewhat uncontrollable in the horizontal direction, and neither 
in the vertical direction, as the features appear randomly placed over the surface area (Figure 
2.4). Due to the lack of control over the patterns organisation, polymer demixing therefore is 
not an ideal method for creating model surfaces to study the interaction between cells and 
their nanoscale topography surroundings. Despite this limitation, some previous studies have 
shown fibroblast filopodia interacting specifically with 10 nm high islands on the surface 
[112]. Although fibroblasts are seen to interact quickly and strongly with these nano-islands, 
when the height of these features reaches up to above 27 nm, the cells start to remain motile 
on top of the islands instead of strongly in contact with the material as they do on a flat 
surface. Dalby et al. observed that with 27 nm high nano-islands produced by polymer 
demixing, there was an rapid adhesion and cytoskeletal formation of InfinityTM Telomerase 
Immortalised human fibroblasts on the islands at 4 days of culture, however, after 30 days of 
culture, the cells grew less well on the nano-islands compared to flat control [113]. 
 
Unlike the other two techniques described in sections 2.3.1 and 2.3.2, which might only be 
used to create nanoscale patterns on a flat, two-dimensional surface, with the current method, 
nano topographies in a three-dimensional structure can be created. Berry et al. [114] 
demonstrated that nanoscale islands can be created inside some thin tubes by using polymer 
demixing technique. First of all, a 2 wt% solution of a polymer blend (20% polystyrene and 
80% polybromostyrene) in toluene was injected into some standard grade nylon tubing (1.5 
mm ID, 50-100 cm in length) using a syringe. Then, the solution was blown all the way 
through the tube by nitrogen at a pressure of 1 – 1.5 psi. to leave a thin layer of solution on 
the substrate surface. The solution layer then rapidly lost its solvent to give a polymer film, 
and as the polymer phases separated, nanosacle islands started to appear on the interface of 
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the tubes. They have also observed that this topography influences the adhesion, spreading, 
and cytoskeletal organization of human primary bone marrow cells in their study. 
 
 
 
Figure 2.4 Atomic force and scanning electron microscopical images of polymer demixed, 10 nm high, 
nano-islands. (a) Shows a typical size distribution histogram for the flat control. (b) Shows a typical SEM 
image of the 10 nm high islands. (c) Shows a typical AFM image of the 10 nm high islands. (d) Shows a 
typical size distribution histogram for the 10 nm high islands [112]. 
 
2.3.4 Chemical etching 
 
This method involves soaking either glass/ceramic scaffolds or polymeric scaffolds in an 
etchant in order to produce nanoscale features on the scaffold surface. Etchants including 
hydrofluoric acid (HF) and sodium hydroxide (NaOH) are often used. As the materials are 
etched away, surface is roughened creating depths and protrusions at the nanometer scale 
[103].  
 
It has been demonstrated that by using this technique, nanoscale topography can be created 
on silicon wafers by using HF. Fan et al. [115] showed that the native layer of SiO2 (10 nm in 
thickness) on the Si wafer can be removed by exposure to the HF solution or HF/HNO3/H2O 
(1:3:1, v/v), but was allowed to reform during the later exposure to air. The range of average 
roughness was from 2 to 810 nm. It was observed that cell adhesion improved only in the 
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range of 20-50 nm, when the average roughness was less than 10 nm and above 70 nm, cell 
adhesion was negatively affected. This result can be explained based on the theory that 
Schakenraad et al. [116] published in 1996. The theory states that the correlation between 
roughness and cell adhesion can be considered with respect to the interface energy. The 
physical behaviour of hydrolyzed living cells might be regarded as a drop of liquid [115]. The 
adhesion of the cell soma, which behaves like the liquid, changes due to the increased or 
decreased contact area, which is proportional to the solid-liquid interfacial adhesive force. On 
the surface with a suitable roughness, the cell soma can achieve the maximum contact area, 
and therefore the interfacial force that will benefit cell adhesion and spreading on the surface 
of the substrate. Fan et al.’s study was completed by comparing the unordered patterns 
created by chemical etching with an ordered patterned surface with horizontal and vertical 
bars (10 μm in width) enclosing squares of 50 x 50 μm that were created by photolithography. 
Selected regions of the grid were etched to an average roughness of 25 nm, while the 
enclosed squares kept the original polished wafer surface with 3 nm average roughness. Cells 
which were originally spread uniformly across the surface of the wafer gradually migrated 
and aggregated to the etched grids after a few days. This provided great evidence that cells 
interact much better with the surface having the appropriate nanoscale topography. 
 
The above example thus demonstrated a flat, two-dimensional surface with nanoscale 
topography created by the chemical etching technique. Pattison et al. [117], however, created 
three dimensional PLGA scaffolds (synthesised using a solvent casting/salt leaching process) 
with nanometer-size features on every surface of the scaffold using a modified version of 
Thapa’s method [118]. The method involves soaking the PLGA scaffolds in various 
concentrations of NaOH solution over various periods of time until the desired surface 
roughness was achieved. The nano-roughness of the PLGA scaffolds was achieved by 
etching the scaffolds in 10 N NaOH solution for 10 min at room temperature, the obtained 
feature dimensions were smaller than 100 nm. The porosity of the scaffold with the nanoscale 
features was increased two-fold over conventional PLGA scaffolds, and a 2.2-fold increase in 
average pore diameter was also observed with the nano-dimensional PLGA scaffolds. As 
expected, both pore diameter and percent porosity increased as chemical etching 
concentration and time increased. In their study, because bladder smooth muscle cells were 
used, all the control cells were placed in an incubator and subjected to one atmosphere 
pressure, while experimental cells were placed in a pressure chamber and subjected to a 
sustained pressure of 10 cm H2O. Not only the improvement of cell adhesion and 
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proliferation was observed, but it was also confirmed that exposure to pressure did not alter 
cellular adhesion, growth or extracellular matrix protein production. 
 
Chen et al. [119] demonstrated that the morphology of three-dimensional bioactive glass 
(45S5 Bioglass
®
) scaffolds can also be modified in a similar manner. In their work, the 
surfaces of the scaffolds were functionalised/modified by either buffered water (pH=8) with 
3-aminopropylat-triethoxysilane (APTS) at 80
o
C for 4 hours or just simply by the buffered 
water on its own under the same condition. With APTS, pores of ~0.5 μm in diameter were 
created on the surface of the struts; they were formed by the remaining glass matrix after 
leaching of the Na2Ca2Si3O9 crystals from the scaffold (the scaffold was partially crystallised 
after sintering [119]). Spindle-shaped crystallites were observed on the surface of the water 
treated samples, this indicated a continuous dissolution of both glass and crystalline phases. 
The proposed mechanisms of these two processes are shown in Figure 2.5. Only micro-scale 
features were obtained by this method, but the modification of the surface was achieved all 
over the three-dimensional scaffold. It is possible that by controlling the size of the 
crystalline phase in the as-fabricated scaffold in the nanometre range, nanostructured 
topography can be obtained by this technique, which is simple and applicable to glass-
ceramics, have been investigated in the present project (Chapter 8, section 8.2.2). 
 
Figure 2.5 Proposed dissolution processes during silanization (a) and buffered water treatment (b) of 
bioactive glass scaffolds [119]. 
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2.3.5 Self-assembly approaches 
 
The self-assembly phenomenon relates to molecular physical and chemical interactions at the 
nanoscale that assemble primary building blocks into macroscopic structures [120]. These 
interactions include non-covalent bonds, such as hydrogen and ionic bonds, van der Waals 
forces and water-mediated hydrogen bonds. In the field of tissue engineering, investigations 
of self-assembly techniques have been focused on the use of peptide and other molecules 
[121-124]. Peptide-amphiphiles (PA), for example, can self-assemble to form nanostructured 
fibres for tissue engineering applications [121, 122]. However, the development of 3D 
(macroporous) TE scaffolds via molecular self-assembly is rather limited so far, one major 
limitation of this technique is the inability to form 3D structures containing macrosized pores. 
 
Sargeant et al.’s study [125] demonstrated a general strategy for altering the surface 
chemistry of nickel–titanium (NiTi) shape memory alloy substrates in order to covalently 
attach self-assembled PA nanofibres to achieve bioactivity (examined by the biological 
adhesion and proliferation of osteoblast and endothelial cell types). Primary bovine 
pulmonary artery endothelial cells (CPAE) and a mouse calvarial pre-osteoblastic cell line 
(MC3T3-E1) were used to demonstrate the cellular adhesion, spreading and proliferation on 
these functionalised metal surfaces [125]. The work demonstrated that covalent attachment is 
very important for creating robust PA nanofibre coatings, leading to confluent cell monolayer. 
 
In a recent investigation [126, 127], it was demonstrated that titanium alloy (Ti-6Al-4V) 
foams with 52.5% porosity can also be filled with self-assembling peptide amphiphile for 
bone repair. In this way, the bioactivity can be tailored by controlling the orientation and 
density of the bioactive peptide epitopes, this being the major advantage of this approach 
[126]. Under appropriate conditions, mineralisation of calcium phosphate phases with a Ca : 
P ratio that corresponds to that of hydroxyapatite can be nucleated by the nanofibres [126]. 
An in vivo experiment was performed using a bone plug model in the diaphysis of the hind 
femurs of a Sprague Dawley rat [127]. It was shown that de novo bone is formed adjacent to 
and inside the PA–Ti hybrid by week four, thus provided strong evidence of the 
osteoconduction of the hybrid surfaces, and the possibility to functionalise 3D scaffolds. 
 
The modification of the scaffold surface by innovative incorporation of self-assembled PA 
nanofibres has thus been confirmed as an attractive strategy to accelerate bone regeneration at 
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tissue/scaffold interfaces. However, similar approaches on biodegradable 3D matrices, e.g. on 
biopolymer or bioactive ceramic structures, have not been investigated as yet, to the author’s 
knowledge. 
 
2.3.6 Bacteria deposition 
 
Pommet et al. [128] used bacteria (Acetobacter xylinum) to deposit nanoscale bacterial 
cellulose on the surfaces of natural sisal or hemp fibres, with the aim to improve the 
wettability of the fibres and to induce nanotopography. They achieved fibre modification in 
either small-scale static cultures or an agitated 5L fermentor. Using Soxhlet extraction of the 
fibres in acetone for 1 h, which removed the hydrophobic layer, such as waxes and other 
organic compounds, the wettability of the fibre was improved. This pre-treatment hence 
resulted in bacterial cellulose fully covering the fibres. A high number of hydrogen bonds 
formed between the bacterial cellulose and the fibres are the cause of the additional adhesion. 
The introduction of nanosized bacterial cellulose could be used to control the interaction 
between the modified fibres with a polymer matrix, which will open new opportunities for 
novel polymer composites in the field of tissue engineering. As revealed by Pommet et al. 
[128], from apparent interfacial shear strength tests, the bacterial cellulose modified fibres 
showed much higher adhesion strength in cellulose acetate butyrate (CAB) or polylactic acid 
(PLLA) polymer matrices than fibres without modification, due to the increase in surface 
roughness and the hydrogen bonding between the hydroxyl groups, present on the modified 
fibre surfaces and in CAB, and the carbonyl groups in PLLA. The fibres could be also used 
on their own to develop textile-type scaffolds exhibiting surface nanotopography, however, to 
the authors’ knowledge, no comprehensive research has been carried out in this field as yet. 
 
2.4 Nanoparticles and nanofibres 
 
2.4.1 Composite scaffolds with nanoparticles 
 
Besides creating nanoscale topographies using the techniques described above, materials with 
nanometre-scaled grains (d < 100 nm), also known as nanophase materials or nanoparticles, 
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can also be used to produce nanometre features on the surface of scaffolds in order to guide 
cell behaviour along a needed biological response [129]. 
 
Many nanophase materials are well known for their ability to increase osteoblast adhesion, 
proliferation and for improving the bioactivity and biocompatibility of materials they are 
coated on or mixed with. Table 2.4 presents several examples of nanoparticles and their 
applications in the biomedical field [102]. Bioactive glass nanoparticles [130], titania 
nanoparticles [131] and hydroxyapatite nanoparticles [132], for example, are used as 
reinforcing phase in composite materials for tissue engineering. HA nanoparticles are also 
being used as biomolecule carriers for drug delivery applications [132]. Studies have 
observed that bioactive inorganic materials and biocompatible polymer composite materials 
using nano-sized inorganic component are likely to be more bioactive than those using micro-
sized ones [130]. 
 
Webster et al. [133] observed large increases in protein adsorption and osteoblast adhesion 
when nanophase alumina (Al2O3) and titania (TiO2) were used rather than microscale ones. 
Loher et al. [134] demonstrated strong improvements of the mechanical properties, 
bioactivity, osteoconductive properties and degradation when nanoscale tricalcium phosphate 
particles were incorporated in PLGA, compared to pure polymer or composites containing 
microparticles. Misra et al. [130] showed that the mechanical and structural properties of a 
polyhydroxylkanoate/bioactive glass composite were much better when the glass particles 
were nanoscale rather than microscale. The smaller particle size also enhanced the adsorption 
of foetal bovine serum (FBS) protein; these are two desirable effects for the application of the 
composites in tissue engineering. The interface effects between the medium and nanoparticles 
increase when nanoparticles are used due to the larger specific surface area. The 
nanoparticles therefore contribute to improved bioactivity when compared to micro-size 
particles [134-136]. 
 
Although nanoparticles seem to have great potential for tissue engineering and other 
biomedical field, there has been only little progress in the attainment of effective results in 
current human therapy [102]. In the cellular environment, the large surface area of the 
nanoparticles makes them very reactive with the surrounding environment, and their small 
dimensions can allow them to penetrate through the lungs, skin or intestinal tract. Their 
ability of penetrating the cells membrane and reach the cell nucleus raises a potential risk that 
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is needed to be addressed [102]. It has been reported that CNTs could separate DNA because 
DNA strands wrap around CNTs, however, some reports have discussed the great potential of 
CNTs for separation purposes [102]. 
 
Table 2.4 Nanoparticles and proposed biomedical applications (modified from [102]). 
Nanoparticles   Applications (diameters) Reference 
Titania 
nanoparticles 
 
Hydroxyapatite 
nanoparticles 
 
Biodegradable 
polymer 
nanoparticles 
 
Stimuli-
sensitive 
polymeric 
nanoparticles 
 
Bioactive glass 
nanoparticles 
 
Silicon dioxide  
nanoparticles 
 
Iron oxide 
nanoparticles 
 
Copper oxide 
nanoparticles 
 
Zinc oxide 
nanoparticles 
 Reinforcing phase in composite materials for TE 
scaffolds (~34nm); Orthopedic coatings (<100nm) 
 
Reinforcing phase in composite materials for TE, 
biomolecule carriers (80nm) 
 
Targeted-delivery systems for TE, immunotherapy 
(10 – 1000nm) 
 
 
Biomolecule carriers (38.2 – 252.8nm) 
 
 
 
 
Bone tissue engineering scaffolds, dentistry and 
bioactive coatings (29nm) 
 
Reinforcing of biocomposites for TE (10nm) 
 
 
Reinforcing phase in composite for drug delivery 
(4.3nm, 9.5nm), functional scaffolds for tissue 
engineering, e.g. magnetic (20 – 40nm, 200nm) 
 
Antibacterial coatings (15nm) 
 
 
Antibacterial coatings (15nm) 
[131] 
[137] 
 
[132] 
 
 
[138] 
 
 
 
[139, 
140] 
 
 
 
[130] 
 
 
[141] 
 
 
[142-144] 
 
 
 
[145] 
 
 
[146] 
 
2.4.2 Electrospraying method 
 
A technique based on electric field assisted processing which is suitable to fabricate 
nanostructures is electrospraying, also known as electrostatic atomization or 
electrohydrodynamic atomization. This is a versatile method that leads to liquid atomization 
by forcing the liquid to flow through a nozzle under a high electrical potential to produce fine 
droplets [147]. Electrospraying devices can operate under atmospheric conditions, and 
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therefore, droplet generation and droplet size can be controlled easily by the flow rate of the 
liquid and the voltage at the capillary nozzle, the size of droplets can range from 100 µm to 
several tens of nanometers. [148]. The main advantages of electrospray systems are ease of 
generating droplets and avoiding coalescence of droplets due to electric charge of the same 
polarity, ability to achieve a narrow size distribution of droplets via the cone-jet mode, 
simplicity of experimental set up, great flexibility in the choice of starting materials, which 
results in a broad range of compositions and morphologies, low operating costs, and high 
versatility [147-149].  
 
Electrospray has been used to develop well-defined surface topographies for cell patterning. 
Huang et al. [150, 151] used electrospraying to deposit nano-sized hydroxyapatite particles 
(n-HAp) onto glass substrates, showing the potential to create nanoscale surface topography 
and coverage using electrospraying for favourable cell response [150, 151]. Nano-sized 
silicon substituted hydroxyaptite particles (n-SiHAp) were also processed for electrostatic 
spray deposition by Huang et al. [152]. It was reported that n-SiHAp were able to promote 
better cell attachment than n-HAp [152]. Thian et al. [153] used electrospraying to produce 
microstructures made up of n-HAp. It was found that the cell proliferation rate was 
significantly enhanced on 2D patterned surfaces compared to non-patterned surfaces. Thian et 
al. [154] also fabricated various microstructures from apatite nanocrystals, carbonate-
substituted HA or silicon-substituted HA and investigated the effects of the topography and 
chemistry of these materials on osteoblast cell growth. In vitro cell culture studies showed 
that various surface topographies created using n-HAp by electrospray promoted osteoblast 
attachment, proliferation and differentiation. It was also reported that a printed line pattern 
can be chosen if unidirectional properties are required while a grid pattern is desirable for 
multidirectional properties. Among the studied apatite nanocrystals, silicon-substituted HA 
plays an important and significant role in directing cellular response, promoting osteoblast 
proliferation, differentiation, collagen synthesis as well as accelerating the biomineralisation 
processes. [154]. 
 
2.4.3 Nanofibrous scaffolds and electrospinning  
 
There have been recent interesting developments regarding the combination of nanofibrous 
topographies and 3D scaffold structures, which will be reviewed in this section. 
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Thermally induced phase separation (TIPS) is a well known technique used to develop 
porous scaffolds [155]. The method works by controlling the temperature of a biodegradable 
polymer solution, such as PLLA, resulting in an inhomogeneous solution which can be 
separated as polymer-rich and polymer-lean phases. Once the solvent is removed, the 
polymer-rich phase will undergo solidification via freeze-drying to form polymer foam 
structures while the polymer-lean phase will become the pores [155-158]. Ma and Zhang et al. 
[159] have pioneered the combination of phase separation and particle leaching methods to 
generate macroporous and nanofibrous 3D polymer scaffolds [159, 160]. Poly(L-lactic acid) 
(PLLA) matrices exhibting macropores have been prepared by combining phase-separation 
and porogen leaching techniques using PLLA tetrahydrofuran (THF) solution with sugar or 
salt particles of desired sizes or with other porogen elements, such as sugar fibres and sugar 
discs [159]. SEM images of the scaffolds fabricated in this way are shown in Figure 2.6. In 
order to prepare the matrices with pre-designed pore structures, the porogen components 
were organized into a desired architecture using porogen component assemblies. Some 
examples of porogen structures used are: uniaxially oriented sugar fibres, orthogonal sugar 
fibres, helicoidal sugar fibre assembly and multi-layer sugar disc and particle combinations. 
 
The scaffolds fabricated by this method have very high porosity (>90%) and the fibre 
diameter ranges from 50 to 500 nm [161]. Three different size scales are controlled in these 
PLLA scaffolds: macropore size; interfibre distance and fibre diameter. The macropore size 
is determined by the porogen particles size. The interfibre distance is given by the 
concentration of the polymer solution and the fibre diameter, which can be considered as the 
matrix morphology, is controlled by the phase-separation temperature, solvent used and 
processing variables. The macroporous architectural design enables cell seeding with ease, 
and it also provides channels for mass transport and neo-vascularization after being implanted 
in vivo while the nano-fibrous pore wall provides a nanoscale surface for cell adhesion, 
distribution and differentiation [156]. 
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Figure 2.6 SEM images of PLLA nano-fibrous matrix with macropores prepared from PLLA/THF 
solution and NaCl particles at (a) low and (b) high magnification [160]. 
 
Liu et al. [162, 163] surface modified nano-fibrous scaffolds fabricated by phase separation 
with gelatine using an entrapment method in order to mimic both the nano-fibrous structure 
and chemical composition of collagen fibres. In related developments, Wei et al. [164, 165] 
immobilised PLGA nanospheres onto PLLA macroporous and nano-fibrous scaffolds 
(fabricated using phase separation and sugar-leaching techniques) to introduce nanosized 
features onto the surface of the scaffolds (Figure 2.7) [164, 165]. The PLGA nanospheres 
were of 200-500 nm in diameter (Figure 2.7 (a)) and were produced using the double 
emulsion technique. These spheres are well known for their application in drug, protein and 
grow factor delivery, the biomolecule release from these spheres can occur in two stages, the 
first stage is an initial burst release when they are in contact with the surrounding medium, 
the second release stage is via the degradation of the polymer. More recently, Beskardes et al. 
[166] developed polycaprolactone (PCL) scaffolds consisting of self agglomerated 
microspheres with nanotopographic surface properties by the freeze-drying method. Cells 
attached and spread on the surface of PCL scaffolds which exhibited different surface 
nanotopography and surface chemistry [166]. 
 
Electrostatic spinning, also commonly known as electrospinning, is a method using a high-
voltage electric field, usually 10-20 kV, to form solid ultra-fine or even nanoscale (diameter 
lower than 100 nm) fibres from a suspended droplet of polymer melt or solution through a 
millimetre-scale nozzle. The process starts by applying an electrostatic field to the end of a 
capillary tube where a polymer is suspended. A polymer jet is formed when the surface 
tension of the droplet is overcome by the electrostatic charge. The solvent evaporates from 
the jet, which elongates and thins due to an instability process. An electrically charged 
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polymer is then left behind, solidified and collected on a grounded surface. Electospinning 
can efficiently fabricate fibres to assemble fibrous polymer mats [103, 167]. 
 
 
Figure 2.7 (a) SEM images of rhBMP-7 containing PLGA50-64K nanospheres; (b) macroscopic 
photographs of PLLA scaffolds before (left) and after (right) nanosphere incorporation; (c, d) scanning 
electron micrographs of PLLA nano-fibrous scaffolds before nanosphere incorporation at low (c) and 
high (d) magnification; (e, f) scanning electron micrographs of PLLA nano-fibrous scaffolds after 
PLGA50-64K nanosphere incorporation at low (e) and high (f) magnification [165]. 
 
Nanofibers are well known for their large surface area per unit mass and small pore size, and 
the electrospinning process can control the deposition of polymer fibres onto a target 
substrate, nanofibres with complex and seamless three-dimensional shapes could be formed 
[167]. Although this method usually falls in the class of creating an unordered scaffold matrix, 
with recent technology developments, the fibres can be aligned in order to provide cells or 
tissues with directional cues. Yang et al. [168] demonstrated that by collecting the PLLA 
fibre jets on a plate that is rotating in the opposite direction to the stationery, aligned 
electrospum fibre scaffolds can be made. Neural stem cells (NSCs) cultured on these 
a 
b 
c d 
e f 
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scaffolds showed elongation and neurite extension parallel to the fibres. Other method to 
fabricate aligned fibre scaffolds have been demonstrated by Zong et al. [169] for cardiac 
tissue engineering applications. In their method, poly(lactide)- and poly(glycolide)-based, 
unorganised fibres were collected first, and then uniaxially stretched to cause alignment of 
the fibres. A few other synthetic polymers have been used in this technique, such as 
poly(latide-co-glicolide) [170] and poly(ε-caprolactone) [171]. Natural polymers, such as silk 
[172] and the combination of chitosan and polyethylene oxide [173], can also be used to 
produce scaffolds via electrospinning. Studies have shown that human mesenchymal stem 
cells cultured on eletrospun nanoscale tricalcium phosphate/PLGA composites exhibited very 
high cellular activity and showed rapid differentiation, confirming an improved textural 
stimulation by the nanostructurred composites. [174]. 
 
The internal morphology and the surface structure of the fibres produced by electrospinning 
can be controlled in some cases. Bognitzki et al. [175] used their tubes-by-fiber templates 
(TUFT) process to coat the polylactic acid nanofibres produced by electrospinning with first 
poly(p-xylylene) using chemical vapour deposition, then these coated fibres were coated with 
aluminium. The polylactic acid nanofibres core is finally removed by degradation and 
polymer/metal hybrid nanotubes were fabricated. 
 
Carbon nanotubes which will be discussed in the next section have also been fabricated into 
fibres by electrospinning [167, 176, 177]. Ko et al., for example, co-electrospun a suspension 
of carbon nanotubes in polyethylene oxide solution, which resulted in nanocomposite fibrils. 
The mechanical property of this new composite was seen to be higher than plain polymer 
fibres due to the reinforcing effect of CNTs. 
 
2.4.4 Carbon nanotubes 
 
Carbon nanotubes (CNTs) are nanofibres that are attracting much attention in the material 
research field [178]. CNTs are well-known by their high mechanical strength and flexibility, 
high aspect ratio, excellent thermal and electrical conductivities and magnetic properties [76]. 
The Young’s modulus is of the order of 1000 GPa [179], making them ideal reinforcing 
elements in many composites. Hwang et al. [179] showed that silicon dioxide/CNTs glass 
rods of micrometer length can be synthesized by using cetyltrimethylammonium (C16TMAB) 
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dispersed CNT suspension with sodium silicate and sodium aluminate. These glass rods were 
then used as additives to reinforce inorganic ceramics made from sintered SiO2 powders. The 
mechanical strength of the SiO2-CNT rods/ceramic composite was enhanced by about 100% 
in the presence of 6 wt% of CNTs. 
 
A wide range of materials have been combined with carbon nanotubes, including polymers 
[180], metals [76] and ceramics [179]. The properties of these materials have enabled CNTs 
to be applied in many different fields, e.g. biomedical sensors [181], storage of gases [182], 
electrodes of supercapacitors [183] and field emissions devices [184], besides the recent 
developments addressing the biocompatibility between cells and CNTs  in tissue engineering 
[185, 186]. Since CNT will be used in the present project, this section reviews basic aspects 
of the processing characterisation and applications of CNTs. 
 
There are many forms of carbon, besides diamond and graphite, carbon nanotubes (CNTs) 
are the third allotropic carbon form added to this family when they were synthesised for the 
first time by Iijima in the early 1990s [187]. In fact, CNTs have been produced and studied 
under a variety of conditions prior to that. For instance, in 1976, a paper by Oberlin, Endo 
and Koyama [188] was published; it clearly showed hollow carbon fibres in nanometre scale 
which were obtained using a vapour-growth technique. This method produced carbon fibres 
by pyrolysing a mixture of benzene and hydrogen at about 1100°C. However, it was Iijima's 
discovery of CNTs in the insoluble material of arc-burned graphite rods that brought CNTs 
into the awareness of the scientific community all together. 
 
There are three methods currently widely used to fabricate CNTs, laser vaporisation [189-
191], arc-discharge [187, 189], and catalytic carbon vapour deposition [189]. These methods 
are used to synthesize the two major forms of CNTs: single-wall carbon nanotubes (SWCNTs) 
and multi-wall carbon nanotubes (MWCNTs). SWCNTs consist of one layer of the 
hexagonal graphite lattice trolled to form a seamless cylinder with a radius of up to a few 
nanometers, on the other hand, MWCNTs have a concentric arrangement of a number of 
graphitic cylinders. As synthesised, half of a fullerene like structure is capped at the ends of 
the CNTs  [192]. 
 
The CNTs used in the present study were fabricated using catalytic carbon vapour deposition 
process. This technique involves the pyrolysis of gas-phase carbon-rich molecules in the 
59 
 
presence of a catalyst at elevated temperatures (>700
o
C), and the subsequent conversion of 
the carbon-fragments into nanotubes [189]. Ni is a commonly used catalyst in this method, 
which had raised serious concerns about the possible use of these CNTs in biomedical 
applications due to toxicity. However, later development of this process demonstrated that the 
metal catalyst can be removed without degrading the CNTs structure at much higher 
temperatures (1800 – 3000oC) [193]. 
 
2.4.5 Fabrication of the macro-scale assemblies of CNTs 
 
The properties of CNTs have been well examined as many relevant tests have been done 
because macro-scale assemblies of CNTs can now be achieved. These studies therefore 
provided further knowledge on the mechanical behaviour and functionalities of CNTs. 
Typical techniques that can be used to fabricate macro-scale assemblies of CNTs include 
chemical vapour deposition [194] with/without ion sputter ink-jet printing [195], spraying 
[186, 196] and electrophoretic deposition [192]. 
 
2.4.5.1 Chemical vapour deposition 
 
Correa-Duarte et al. [194] used CNTs that were perpendicularly grown by chemical vapour 
deposition on a silicon substrate with Ni as the catalyst. Then the CNTs which were attached 
to the substrate were functionalized in a nitric/sulfuric (1:3) acid solution. This process 
introduced carboxylic groups at the ends and in the defect sites of the sidewalls of the CNTs. 
The acid solution also created capillary and tensile forces between the aligned tubes, which 
are involved in creating three-dimensional assemblies. The spatial distribution of the CNTs 
was modulated depending on their length. Pyramid-like structures and interconnected cavities 
with a volume large enough to harbour a cell type were observed, and typical structures are 
shown in Figure 2.8. 
 
In their study [194], there was no cytotoxic activity of the CNTs observed against mouse 
fibroblast cell line L929, and the results confirmed that three-dimensional structuring via 
cross-linking of CNTs plays an important part in the development of CNT-based scaffolds for 
tissue engineering. 
 
60 
 
  
  
Figure 2.8 Examination by SEM of the different MWCNT-based structures obtained by CVD. (A) 
Perpendicular aligned carbon nanotubes. (B) The latter after a physicochemical treatment forming 
pyramid-like structure with basal planes of ca. 3 μm. (C) Network of crosslinked carbon nanotube walls 
forming cavities [194]. 
 
Ago et al. [195] used an ink-jet technique to pattern the catalyst, Co nanoparticles prepared 
by a reverse micelle method (enable it to be dispersed in organic solvents), on the substrate. 
For chemical vapour deposition synthesis of CNTs with iron and molybdenum as supporting 
catalysts. Ink-jet only requires a small amount of the nanoparticle catalyst dispersion, and it 
allows it to be printed in any pattern at any position. Dots with a 15 – 20 μm diameter were 
printed on the substrate and the growth of the CNTs was only observed on the dots but 
nowhere else on the substrate. The catalyst preparation process was also combined with 
lithographic techniques, which enabled the formation of CNT bridging or crossing the 
catalyst patterns. 
 
2.4.5.2 Spraying 
 
In the study of finding the type of CNT that best supports bone formation, carbon nanotube 
coated glass coverslips were prepared by Zanello et al. [186]. As prepared multi-wall carbon 
nanotube and single-wall carbon nanotubes samples were sonicated in 95% ethanol and 
functionalized CNTs (SWCNT-COOH, SWCNT-Poly-(m-amino-benzene sulfonic acid) and 
SWCNT-poly ethylene glycol) were sonicated in water. The resulting dispersion was sprayed 
onto preheated (ca. 80
o
C) glass cover slips. However, the type of spraying technique and 
other process parameters were not mentioned in their paper. 
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By using rat osteosarcoma ROS 17/2.8 cells, it was confirmed that there was a degree of 
biocompatibility with AP-CNTs as the electrical activities of the osteoblast membrane were 
maintained, and Ca
2+
 channel functions improved, in cells grown on neutral CNTs. It was 
concluded that neutrally charged CNTs are able to sustain osteoblast proliferation.  However, 
cell count showed that negatively charged and zwitterionic CNTs had negative effects on cell 
growth, indicating that the presence of electric charges does not favour osteoblast growth and 
proliferation in culture. 
 
2.4.5.3 Electrophoretic deposition (EPD)  
 
EPD had been shown to be one of the most effective methods to produce macroscale CNT 
assemblies [76, 192]. In this technique, charged particles suspended in a liquid medium 
migrate under the influence of an electric field (electrophoresis) and are deposited onto an 
electrode [197]. This method can be used with any solid in particulate form with small 
particle sizes ideally less than 30 μm [192]. When an electric field is applied, the charged 
species migrate by the process of electrophoresis towards the electrode with the opposite 
charge. Negatively charged material is deposited on the positively charged electrode (anode). 
Positively charged material is deposited on the cathode which is negatively charged. 
 
The EPD technique was proved to be a promising method to deposit CNTs and other 
nanoparticles on different substrates, because it is a technique of low cost, short formation 
time and few substrates’ shape restrictions. Due to its simple experimental set-up, EPD is 
very useful to produce coatings and films of homogeneous microstructure and controlled 
thickness on different substrates [76, 192]. EPD was therefore the technique chosen in this 
project to fabricate CNT coatings on 3D scaffolds, as described in the next sections. 
 
Among the first researchers to develop EPD of CNTs, Du et al. [198] was one of them 
demonstrated the deposition of CNT on metallic substrates by EPD using ethanol/acetone as 
solvents. The quality of the coating in terms of homogeneity was however very poor, and the 
conductivity of the coating was not ideal. These results were caused by the hydrogen 
evolution on the cathode where CNT was deposited on. A homogeneous deposition of CNT 
with a high relative density (70–80%) using aqueous suspensions was then accomplished by 
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Thomas et al. [199]. The maximum thickness of the coating was 10 μm, it was obtained in 4 
min, at the optimal applied potential of 40 V. 
 
EPD also works with ceramic materials. The EPD shaping of complex silica glass and zironia 
components, for example, tubes, has been reported [200]. The high deposition rate allows 
shaping of large components with thick walls within minutes. A silica green body with a 
thickness of 12 mm was deposited within 3 min with a field strength of 10 V/cm. Bioactive 
glass coating have also been produced on stainless steel plates and Ni/Ti wires by EPD, as 
studied by Krause et al., who used a 20 wt% glass suspension, and a good quality coating was 
achieved under the condition of 5 V applied for 5 min [201]. 
 
Many composites were also fabricated using EPD. Chicatun et al. [76] demonstrated that by 
mixing CNT aqueous suspension with SiO2 nanoparticles, a network structure can be 
achieved using EPD, and layered CNT/SiO2 porous composites can also be obtained using 
sequential EPD deposition technique, the layered CNT/SiO2 structure was confirmed using 
scanning electron microscopy. CNT/TiO2 composite coating using EPD was studied by Cho 
et al. [202]. In his study, as well as co-deposition of CNT/TiO2 coating, sequential EPD was 
used to achieve a CNT-CNT/TiO2-TiO2 three-layer coating on stainless steel substrates. 
 
It has been previous reported that EPD can also be applied to produce uniform CNT deposits 
on the surfaces of highly porous bioactive glass three-dimensional scaffolds without 
impairing their bioactivity [6]. It was observed that the presence of CNTs can induce the 
ordered formation of a nanostructured CNT/HA composite layer when the substrates are 
immersed in simulated body fluid [6]. 
 
2.5 Polyhydroxyalkanoates/bioactive glass composite scaffolds 
 
There are several biopolymers being used in combination with bioactive glass for tissue 
scaffolds and drug delivery capability [7]. Numerous biocompatible materials have been 
investigated to use as scaffold materials in the field of tissue engineering. As mentioned 
earlier, natural and synthetic biodegradable polymers are often used due to their potential 
ability to enable cell adhesion, migration, proliferation and differentiated function [203]. In 
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this section, only studies involving polyhydroxyalkanoates (PHA) will be considered because 
this is the polymer to be investigated in the present project. 
 
2.5.1 Polyhydroxyalkanoates 
 
Polyhydroxyalkanoates (PHA) are polyesters of 3-, 4-, 5- and 6-hydroxyalkanoic acids 
produced by a variety of bacterial species under nutrient-limiting conditions with excess 
carbon [204]. The general chemical structure of polyhydroxyalkanoates is shown in Figure 
2.9 (a). It is a family of water-insoluble storage polymers that is suitable for tissue 
engineering applications due to their natural occurrence, proven biocompatibility and 
tailorable bioabsorbability [205]. The composition of the polymer synthesized is monitored 
by two major factors, one is the bacterial strain being used, and the other one is the carbon 
source utilized to grow the bacteria [11]. 
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Figure 2.9 (a) General structure of polyhydroxyalkanoates, x = 1-4 and n = 100-300,000 [11]. (b) The 
molecular structure of a poly(3-hydroxybutyrate) repeat unit. 
 
2.5.2 Poly(3-hydroxybutyrate) and its composites for bone tissue 
engineering 
 
Poly(3-hydroxybutyrate) (P(3HB))  is the best known and characterized, as well as the 
simplest polymer in the PHA family (Figure 2.9 (b)). This polymer has a high potential to be 
used as scaffold material in tissue engineering [203].  
 
P(3HB) is a natural thermoplastic polymer and it can be produced by many types of 
microorganisms without the use of any catalyst; the polymer can be extracted with high 
purity [203]. It was first identified and isolated from the genus Bacillus [11]. P(3HB) with 
low molecular weight occurs naturally in human blood [206], and it can decompose into 3-
hydroxybutyric acid, which is also synthesized in the liver from acetyl-CoA (C23H38N7O17P3S) 
in the human body. Moreover it can be used as an energy source by the brain when blood 
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glucose is low [206]. It has also been reported in a previous study that P(3HB) appears to 
have piezoelectric properties, which can stimulate bone growth and aid in bone defect healing 
[207]. This provides a great evidence of the biocompatibility and non-toxicity of this polymer. 
Further evidences were provided from previous studies that P(3HB) shows good 
compatibility when in contact with various cells, such as endothelium cells, osteoblasts and 
fibroblasts [203]. For these reasons, P(3HB) is considered to be an ideal candidate for various 
applications in tissue engineering, including scaffolds, as well as drug delivery platforms. 
 
However, the low strength and poor bioactivity of P(3HB) limits the application of P(3HB) in 
bone-tissue repair. Misra et al. [130, 203] have fabricated P(3HB)/bioactive glass composites 
to overcome this problem. A film was produced by incorporating different concentrations of 
bioactive glass into the polymer matrix using solvent casting technique. It was observed that 
the presence of bioactive glass led to an increase in the hardness of the composite. Nano-
sized bioactive glass particles were also investigated in combination with P(3HB) [130]. It 
was shown that the addition of nano-sized bioactive glass particles has a significant 
reinforcing effect by enhancing the elastic modulus. Partial nanotopography was introduced 
by the nano-sized bioactive glass, which improved in vitro bioactivity, as determined by 
simulated body fluid (SBF) immersion studies. However, there was no contrasting difference 
between micro-sized and nano-sized glass/polymer composites regarding the proliferation of 
MG-63 osteoblast cells. The fabrication of this type of P(3HB)-based composite containing 
carbon nanotubes has been also demonstrated [208]. By carrying out a four probe dc I-V 
measurement using a picoammeter/voltage source, it was found that the electrical resistance 
of the composite decreased as the concentration of CNTs in the composite increased. A SBF 
immersion study was performed on a composite of 20 wt% bioactive glass and 8 wt% CNTs 
in P(3HB) matrix, and it was observed that the bioactivity of the glass was not hindered by 
the presences of CNTs. 
 
2.5.3 Poly(3-hydroxybutyrate) in drug delivery 
 
P(3HB) polymers have been known for a long time for their application in drug delivery. 
Korsatko et al. [209] have reported the in vitro and in vivo release of 7-
hydroxyethyltheophylline (HET) from compressed pellets of drug and P(3HB), the release of 
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the drug as expected, was dependent of drug loading. It took 24 hours to complete the release 
of drug loadings of 60-80 %, and up to 50 days for a lower drug loading of 5-30 %. 
 
Bissery et al. [210] have fabricated P(3HB) and PLA microspheres (a term usually refers to 
small, dense or porous spheres of typically 1 to 500 μm in diameter [211]) using solvent 
evaporation (emulsion deposition) technique, which contained an anti-cancer agent, 
lomustine (CCNU). These microspheres exhibited great potential carriers for drug targeting. 
By labelling the spheres with 
14
C, the authors have observed that they were mainly stored in 
the lungs, liver and spleen after 7 days post-intravenous-injection. No pore was found on the 
surfaces of both types of spheres, and no explanation was offered why the release of CCNU 
from P(3HB) was faster than from PLA. 
 
Morphologies of poly-β-hydroxybutyrate (P(3HB)) spheres were studied by Embleton et al. 
[212]. The spheres were fabricated using a double emulsion solvent evaporation technique, 
which is also described in other study [213]. Embleton et al. found that the particles prepared 
from PHB with low molecular weight (Mw 43 000) had a wrinkled surface, but were not 
porous. However, with high molecular weight P(3HB) (Mw 540 000), microporous surfaces 
were observed. Although no drug release study was carried out by the authors, the presence 
of the micropores is an explanation of the different drug release rates from different 
microspheres. 
 
Emulsion polymerisation can produce spheres that are made of entangled polymer chains and 
stabilised by surfactants in aqueous solution [214]. Other techniques to prepare microspheres 
have also been reported, such as the use of microfluidic devices. Woodward et al. [215] 
created novel monodisperse polymeric oil-in-water emulsions of diameter 15-200 μm, 
stabilised by polymer and surfactants. A microfluidic device with three input channel was 
used, one channels to inject the polydimethylsiloxane oil, the other two to inject the aqueous 
phase which contained surfactant (sodium dodecyl sulphate, SDS) or the triblock copolymer 
pluronic F127 to break off the oil droplet. In this technique, the size of the emulsion droplet is 
determined by the retarding force of the viscous oil and shear rates that applied to cut off the 
oil droplet from the input channel. The more viscous the oil, the higher the surface tension, 
hence the droplet will grow while the aqueous flow force is trying to achieve droplet break-
off. Therefore, the less viscous the oil, the faster break-off, the smaller the droplets. 
Unfortunately, no application of this emulsion was mentioned by the author. 
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The application of polymer microspheres in bone tissue engineering as injectable scaffolds 
has been reported by Kang et al. [24]. Conventional oil/water emulsion and solvent 
extraction/evaporation techniques were used to prepare the 150 – 300 μm sized PLGA 
microspheres; they were then immersed and incubated in SBF with an inorganic ion 
concentration three times those of human blood plasma (in order to shorten the incubation 
period and still provide considerable amount of apatite coating) at 37
o
C. Newly formed 
apatite completely covered the spheres after 5 days of incubation in 3x SBF. The composite 
was tested in athymic female mice. It was found that the apatite-coated microspheres can 
deliver a significant amount of calcium, much higher than that delivered by the plain ones. 
Significant enhanced in vivo bone regeneration was observed, this could be explained by the 
nano-size (300 nm) nature of the apatite coating. The study also demonstrated the potential of 
the spheres to be used as three-dimensional cell culture matrices to overcome the problems of 
the two-dimensional culture system which need much more room and are hard to scale up. 
Moreover proliferation of osteoblasts after they adhered onto the apatite-coated spheres was 
observed during the in vitro culture. 
 
2.6 Summary of the literature survey 
 
Due to the increased relevance of tissue engineering and regenerative medicine, scaffolds 
required for bone tissue engineering are receiving great research interest. Many materials 
have been studied, such as biodegradable polymers, bioactive ceramics and their composites, 
in terms of their biocompatibility, bioactivity and mechanical strength to develop bone tissue 
scaffolds. It had been reported that the surface topography of scaffolds is also very important 
in determining scaffold performance, as better cell attachment and proliferation have been 
observed on nanoscale topographies. Besides being used to fabricate scaffolds, biocompatible 
polymers have many other uses in biomedical applications; drug delivery being one of them. 
There is limited literature on the combination of polymers carriers with drug delivery 
function and bioactive glass three-dimensional scaffolds for bone tissue engineering. There is 
also very little previous work on the development of nanoscale surface topography on three-
dimensional bioactive scaffolds. This constitutes a broad and novel research area in the field 
of advanced, multi-functional scaffolds for bone tissue engineering. In this project, methods 
to fabricate nanoscale topography, e.g. carbon nanotubes coatings in three-dimensional 
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bioactive glass-ceramic scaffolds, and polymers carriers that introduce additional functions, 
e.g. drug delivery will be explored with the overall aim of developing new, multi-functional 
and bioactive scaffolds for bone tissue engineering. 
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Chapter 3 Project objectives 
 
3.1 Main project aims and tasks 
 
Bioglass
®
 has been used to fabricate scaffolds for bone TE for many years now [4, 216]. In 
addition to the basic and essential scaffold functions, such as mechanical support, bioactivity, 
osteoconductivity and stimulation of angiogenesis, scientists have been considering ways to 
incorporate additional functions into scaffolds to improve their in-vivo performance. In this 
project, methods of introducing scaffold functions such as drug delivery capability and 
electrical conductivity were explored, as well as incorporation of nano-sized features on the 
surface of 3D scaffolds. 
 
This project uses as base scaffold structure 45S5 Bioglass
®
-derived glass-ceramic foams 
fabricated using the foam replica technique that was developed earlier in Boccaccini’s 
laboratory at Imperial College London [4]. 
 
The approaches used to try and achieve this new functionality can be summarised as follows: 
1. Scaffold with drug-encapsulated polymeric microsphere coating achieved by a slurry-
dipping technique; 
2. Scaffold with carbon nanotube coating achieved by electrophoretic deposition 
technique in order to introduce electrical conductivity and nanoscale topography; and 
3. Using polymer demixing and chemical leaching techniques to create nanoscale 
topography on the surface of the scaffold. 
 
In the first part of this project, natural polymer synthesised from bacteria, of the 
polyhydroxyalkanoates family, known as poly(3-hydroxybutyate) (P(3HB)), was fabricated 
in the form of microspheres by a solid-in-oil-in-water emulsion solvent 
extraction/evaporation technique. These microspheres have a diameter between 1.5 µm to 
2.0 µm, thought to be an ideal size to coat a 3D macroporous scaffold (e.g. with pore size > 
200 m), because they are small enough to form a homogeneous coating around the scaffold 
struts and to fill possible cavities present on the surfaces. Drugs can be encapsulated in the 
nano-pores inside these microspheres during their fabrication, allowing a controlled released 
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into the surrounding media. This is the first time such composite was fabricated using 45S5 
Bioglass
®
-based scaffolds. A comprehensive investigation of the bioactivity of this composite 
in SBF was carried out and compared to the standard scaffold. Tetracycline was chosen to be 
the model drug for this study, the drug release rates of the composite and free microspheres 
were measured using UV-Visible spectrometry and the link between drug release kinetics and 
scaffold structure was investigated. 
 
The second part of the project focused on achieving a carbon nanotube (CNT) coating on the 
3D scaffold in order to impart both electrical conductivity and nanoscale topography. These 
two functions were selected because they have the potential to improve cell attachment and 
proliferation [6]. 
 
The final part of the project focussed on assessing potential techniques for introducing nano-
topography on the surface of complex shaped scaffolds. Nanoscale features with the right 
morphology and arrangement in 3D can enhance cell attachment to the material surface. 
There are many techniques that can introduce nanoscale features on 2D surfaces, but very 
little has been investigated on 3D structures [217]. Polymer demixing and leaching 
techniques are two methods with potential to produce such coatings on complex 3D scaffolds. 
In this study both techniques are investigated using 45S5 Bioglass
®
-based scaffold as the 
basic template. The final aim is to fabricate a scaffold with homogeneous nanoscale features 
across the complete surface of the 3D porous matrix. 
 
3.2 Experimental Approach 
 
An overview of the design of the experiments used to achieve the aims of this project is 
presented below, followed by a detailed description of the full methodologies and techniques, 
which is given in Chapter 4, Experimental Methods. 
 
3.2.1 Optimisation of the scaffold fabrication method 
 
The 45S5 Bioglass
®
-based scaffolds used in this project were fabricated using a foam replica 
method developed originally in Boccaccini’s laboratory [4]. In an innovation introduced in 
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this project, instead of using dichloromethane (DCM) and poly(D,L-lactic acid) (PDLLA) to 
make the Bioglass
®
 powder slurry to fabricate the scaffolds, as indicated in the original 
publication [4, 218], a cheaper alternative material, polyvinyl alcohol (PVA), was used. 
Therefore, the slurry recipe and sintering conditions had to be altered and optimised. The 
concentration of the PVA solution, the amount of Bioglass
®
 powder in the slurry, the 
sintering time and the temperature were all therefore investigated in this study to fabricate 
optimal scaffolds. After using TGA-DSC to determine the sintering window, a trial and error 
approach was undertaken to optimise the fabrication method in order to obtain scaffolds of 
reproducible properties and microstructure in term of crystallinity, compressive strength, 
micro- and macro-structure porosity and bioactivity. 
 
3.2.2 CNT-coated Bioglass
®
 scaffolds 
 
This part of the projected was carried out expanding on preliminary work done by Boccaccini 
et al. in 2006 using EPD [192]. A mostly homogeneous CNT coating on the 3D scaffold can 
be achieved using an adaption of the EPD technique, placing the scaffold between the two 
electrodes in the EPD cell, so that when the CNTs migrate from one electrode to the other 
one under the influence of an external electric field, they will attach onto the wall of the 
scaffold, creating a relatively homogeneous coating. A commercially available CNT aqueous 
suspension was used in this project. Since this is a new CNT suspension system, optimisation 
of the EPD procedure needed to be done first. The size of the electrodes, the distance between 
the electrodes, the EPD time and the voltage all needed to be adjusted. The quality of the 
CNT coating, in term of its coverage of 3D scaffolds, thickness and homogeneousness, was 
examined using SEM. The bioactivity of CNT coated scaffolds was also assessed. Together 
with standard scaffolds (control), CNT-coated scaffolds were immersed in SBF for periods of 
up to 4 weeks, and the HA formation on the scaffold surface was analysed using SEM, XRD 
and FTIR. The electric conductivity of the CNT-coated scaffold was measured using a 
multimeter. 
 
3.2.3 P(3HB) microsphere-coated scaffolds 
 
The reason behind the development of P(3HB) microsphere coatings on bioactive glass based 
scaffolds is to integrate a drug delivery capability into the scaffold, e.g. localised 
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biodegradable microspheres as carriers of drugs. First of all, the size of the spheres was 
optimised by adjusting the parameters of the solid-in-oil-in-water emulsion solvent 
extraction/evaporation technique. Then the condition of the slurry-dipping technique used to 
fabricate the composite was optimised by controlling the conditions such as the slurry mixing 
method, concentration of the slurry and dipping time. The microsphere-coated scaffolds were 
characterised in terms of their mechanical property (compressive strength), microstructure 
and bioactivity and compared with the behaviour of the control scaffold. In order to 
investigate further the bioactivity of the composite, Bioglass
® 
pellets were also fabricated by 
pressing Bioglass
® 
powders and sintering under the same conditions used for the scaffolds. 
The same P(3HB) microsphere coatings were created on pellets, and the SBF bioactivity 
study was carried out. These pellets were used specifically for SEM and EDX evaluation. 
Tetracycline was the drug selected for this project, and it was encapsulated into the 
microspheres during microsphere fabrication, which was achieved by dissolving the drug into 
the water emulsion. UV-Visible spectrometry was used to determine the drug release kinetics. 
 
3.2.4 Introducing nanoscale features on the surface of 3D scaffolds 
 
It has been shown in the literature [159, 219] that cell attachment can be improved 
introducing nanoscale features on the surface of the biomaterial. Besides achieving it with 
CNT coating, other methods that might have the potential to be combined with bioactive 
glass based scaffolds were explored in this project. These methods were:  i) polymer 
demixing [113] and ii) chemical leaching (water treatment) [119]. In polymer demixing 
method, the scaffold is dipped in a poly(n-butyl methacrylate) (PnBMA) / poly(styrene) (PS) 
toluene solution, the solution form nano-islands on the surface of the scaffold while drying, 
hence nanoscale features are introduced homogeneously throughout the 3D structure. The 
ratio of the two polymers in solution and the concentration of the solution were investigated 
in order to produce the most desired nanoislands in terms of their size (height) and lateral 
arrangement. The dipping time and drying conditions were investigated too. The results on 
both 2D flat surfaces and on 3D scaffolds were studied and compared. The topographies 
achieved for each condition were analysed using SEM and AFM. The work on chemical 
leaching technique was carried out on both sintered scaffolds and pellets. These were 
immersed in water with different pH and for several time periods. The features on the 
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surfaces of both types of samples were analysed by SEM and EDX. Pellet samples were used 
for XRD analysis. 
 
An overview of the different tasks of this project is presented as a schematic diagram in 
Figure 3.1 and Figure 3.2. 
 
 
 
Figure 3.1 Schematic diagram showing an overview of the research methodology used in this project to 
fabricate novel multifunctional 45S5 Bioglass
®
-based scaffolds for bone tissue engineering. 
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Figure 3.2 Schematic diagram showing an overview of the characterisation methods involved using 45S5 
Bioglass
®
-based pellets in this project. 
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Chapter 4 Materials and methods 
 
4.1 Materials 
 
Melt-derived 45S5 Bioglass
®
 powder was kindly supplied by Dr. I. Thompson (King’s 
College London, UK).  The glass has a composition of 45 wt% SiO2, 24.5 wt% Na2O, 24.5 
wt% CaO and 6 wt% P2O5. Polyurethane (PU) foam of 45 pores per inch (ppi) was obtained 
from Recticel, England, and used as a template in the foam replica method. Polyvinyl alcohol 
(PVA), used as the binder in this method, was purchased from Sigma-Aldrich, UK. 
 
A commercial CNT suspension containing multi-wall carbon nanotubes produced via the 
catalytic carbon vapour deposition process (average 9.5 nm in diameter and 1.5 µm in length), 
AquaCylTM (AQ0101), was purchased from Nanocyl, Belgium, and it was used as received. 
Stainless steel foils AISI316L used as the electrodes in the EPD cell were purchased from 
Advent Research Materials Ltd., Oxford, England. 
 
Poly(3-hydroxybutyrate), P(3HB), was received from the Department of Bioscience at 
University of Westminster (London, UK). Chloroform (CHCl3) and PVA used in 
microsphere production, the chemicals used for simulated body fluid (SBF) preparation and 
tetracycline hydrochloride (TTC) were purchased from Sigma-Aldrich, UK.  
 
Polystyrene (PS, Mw ~280,000, Tg = 100
o
C), poly(n-butyl methacrylate) (PnBMA, Mw 
~337,000, Tg = 20
o
C) and toluene used for the polymer demixing study were purchased from 
Sigma-Aldrich, UK. 
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4.2 Methodologies  
 
4.2.1 Fabrication of 45S5 Bioglass
® 
scaffolds 
 
Scaffolds were fabricated using the modified foam replica technique, which is described 
elsewhere [3]. Briefly, this technique involves preparing a green body of the Bioglass
®
 foam 
by coating a PU foam with a Bioglass
®
 slurry. Due to the desired pore structure of the PU 
foam in terms of pore size and interconnectivity, it can serve as a sacrificial template for the 
scaffold production. The optimisation of the slurry recipe was carried out (it is presented in 
Chapter 5, section 5.2.1). The general steps involved in the scaffold fabrication are described 
in the present section. 
 
A slurry was prepared by adding 40 wt% Bioglass
®
 particles into an aqueous 6 wt% PVA 
solution and the mixture was stirred vigorously for one hour using a magnetic stirrer. To 
prepare the green body, a PU foam that was cut to the desired size was immersed and 
squeezed in the slurry, which consequently infiltrates the foam structure and glass particles 
adhere to the surfaces of the polymer foam. Extra slurry was squeezed out vigorously by hand 
after the foam had been taken out of the slurry to give a reasonably homogeneous coating 
(assessed by visual inspection). After drying the coated PU foam at 60
o
C for 12 h, scaffolds 
were sintered to produce partially crystallised Bioglass
®
-based scaffolds. 
 
The green bodies were then sintered in a furnace using different heat treatment programs 
under the condition that has been investigated in a previous study [221], see Figure 4.1. 
Firstly, the polymer was slowly burned out at 550
o
C in order to minimise the damages to the 
bioactive glass coating (micro-cracking). Once the polymer was removed, the bioactive glass 
struts were sintered to a desired density at 1100
o
C for 2 hours. 
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Figure 4.1 Heat treatment program designed for burning-out the porous PU templates and for sintering 
the 45S5 Bioglass
®
 green bodies for production of Bioglass
®
-based scaffolds. 
 
4.2.2 Fabrication of 45S5 Bioglass
® 
pellets 
 
Bioglass
® 
pellets were prepared using a uniaxial hydraulic press (Spectroscopy Central, UK). 
~0.5 g of as-received 45S5 Bioglass
® 
particles were added into a stainless steel cylindrical 
mould of 10 mm diameter. A plunger was then inserted gently into the mould until the glass 
particles were uniformly compacted in the die. The die was then placed in the centre of a 
uniaxial hydraulic press. The pressure was increased to ~5 tonnes after closing the valve of 
the press. After ~1 min, the valve was then opened to release the pressure, and the Bioglass
® 
pellet of height 5 mm was taken out of the die by applying manually a small pressure. The 
pellets were sintered under the same condition as the scaffolds, see Figure 4.1. 
 
4.2.3 Electrophoretic deposition (EPD) 
 
The CNT-coating on the scaffolds were achieved using the modified EPD technique, which is 
described elsewhere [202], a schematic diagram is shown in Figure 4.2. The optimisation of 
the process is presented in Chapter 6. 
 
Different concentrations of the CNT suspension were diluted with distilled water: 0.25 wt%, 
0.5 wt% and 1.0 wt% (as-received concentration). A scaffold of size 10 x 10 x10 mm
3
 was 
hung using a copper wire between the two electrodes in the EPD cell. The electrodes were 
made of stainless steel AISI316L foil with dimension of 20 x 10 x 0.02 mm
3
. The separation 
Room 
Temperature 
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distance between electrodes was 20 mm. The electrodes were connected to a DC power 
supply and a constant voltage was applied when the scaffold and electrodes were lowered 
into the CNT suspension. After certain time period, the scaffold and electrodes were 
withdrawn from the CNT suspension slowly in order to avoid the influence of the drag force 
between the suspension and the deposited wet CNT coating, which could lead to disruption of 
the coating. Finally, the scaffold was left to dry at room temperature in air. 
 
 
Figure 4.2 Schematic diagram of the electrophoretic deposition (EPD) cell used for obtaining CNTs 
coating on Bioglass
®
 scaffolds [6]. 
 
4.2.4 Preparation and optimisation of plain and drug-encapsulated P(3HB) 
microspheres 
 
The P(3HB) microspheres (PMSs) were fabricated using a oil-in-water emulsion solvent 
extraction/evaporation technique described elsewhere [213]. The optimisation of the process 
is presented in Chapter 7. The optimised recipe and experimental condition is described here. 
Quantities of 2 g of P(3HB) were dissolved in 8 ml of chloroform. This polymer solution was 
then transferred into 40 ml of 1 wt% aqueous PVA solution, and stirred at 1000 rpm for 3 
min using a magnetic stirrer. This emulsion was then added to 500 ml of 0.5 wt% aqueous 
PVA solution. This emulsion was stirred for 4 h at the same agitation speed as before to form 
P(3HB) microspheres. The resulting microspheres were isolated by centrifugation at 3680g 
for 5 min and then washed with distilled water three times, air dried and stored in a desiccator 
until further use.
 
 
Cu 
wire 
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suspension 
Electrode 
Bioglass
®
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V 
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Tetracycline (TTC)-loaded P(3HB) microspheres (TTCMSs) were also produced using the 
same method. The only difference is that the TTC solution at a final concentration of 0.2 wt% 
was added to the 40 ml of 1 wt% aqueous PVA solution before the addition of the P(3HB) 
chloroform solution. Once the microspheres were centrifuged they were freeze-dried and 
stored in a freezer for further use. 
 
4.2.5 Plain P(3HB) microsphere (PMS) coating on 45S5 Bioglass
® 
scaffolds 
 
The coating of PMSs on scaffold surfaces was achieved by simply using a slurry-dipping 
technique. The suspension of PMSs was prepared by mixing the PMSs and distilled water. 
Different approaches for producing the PMS slurry were investigated to achieve a high-
quality PMS coating on the scaffolds, as described next. 
 
4.2.5.1  Agitation 
 
The PMS slurry was prepared using distilled water and agitated using a mechanical stirrer for 
3 h; this was followed by immersing the Bioglass
®
 scaffold in the slurry with the help of a 
copper wire gently entwined in the pores of the scaffold. The coated scaffolds were then 
removed slowly from the slurry and allowed to air dry in a desiccator at room temperature. 
 
4.2.5.2  Sonication 
 
PMSs were placed in a beaker containing distilled water to make up the desired concentration; 
the suspension was then placed in an ultrasonic bath (USC300D VWR International, Leuven, 
Belgium) for 5 or 10 min to improve the dispersion of the microspheres by separating 
possible microsphere agglomerations. 
 
4.2.5.3  Immersion of the scaffold in aqueous PVA solution 
 
In an alternative approach, the scaffolds were immersed in the second PVA solution during 
PMS preparation. It was anticipated that the PMSs, while settling down, could penetrate 
through the scaffold pores and crevices, thoroughly coating the scaffold. The concentrations 
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of the P(3HB) in chloroform and aqueous PVA solution were varied in these experiments to 
assess if the amount of PMSs in emulsion would have an effect on the quality of the coating. 
 
After investigating the concentration of the PMS slurry and the dipping time, the optimum 
condition was found (see Chapter 7, section 7.2.2 for more detail). 1 wt% of aqueous PMS 
suspension in a container was placed in the ultrasonic bath for 5 min until the microspheres 
were well dispersed. The scaffolds were hung via copper wires and immersed in the 
suspension for 5 min. The scaffolds were then taken out slowly avoiding touching the wall of 
the glass container, and hung to dry in air at room temperature for at least 12 hours. 
 
4.2.6 Tetracycline-encapsulated P(3HB) microsphere (TTCMS) coating on 
45S5 Bioglass
® 
scaffolds 
 
To coat the 45S5 Bioglass
®
 scaffolds with tetracycline-encapsulated P(3HB) microsphere 
(TTCMS), a slurry of the drug-loaded microspheres (0.8 wt%) was made using the highly 
non-polar solvent (hexane) because tetracycline, being hydrophilic, would diffuse into the 
water phase if an aqueous slurry was used. The coating was obtained by adding TTCMS 
hexane slurry drops onto the scaffold using a pipette while the scaffold was hung in mid-air 
using a copper wire. Different concentrations and quantities of the slurry were investigated in 
order to produce the desired coating quality. This optimisation process is described in 
Chapter 7, section 7.2.8. 
 
4.2.7 Tetracycline loading on 45S5 Bioglass
®
 scaffold 
 
In an attempt to incorporate the drug directly onto the scaffold for the purpose of comparison 
in the drug delivery study, TTC aqueous solution at a concentration of 2 wt% was made and 
the scaffolds were hung using a copper wire in the drug solution for 5 min. The amount of 
drug loaded on the sample was estimated from the weight of the TTC solution in which a 
scaffold was contained after it was taken out of the solution. Upon addition of the solution, 
scaffolds were left to dry in the fridge, as the colour of TTC will fade in the light. 
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4.2.8 Microsphere-coating on Bioglass
®
 pellets 
 
A 1 wt% of aqueous PMS suspension was placed in an ultrasonic bath for 5 min until the 
microspheres were well dispersed. Pellets were immersed in the suspension for 5 min, and 
then taken out slowly avoiding touching the wall of the glass container. They were left to dry 
in air at room temperature on a Petri dish.  
 
A suspension of the TTCMS (0.8 wt%) was made using the highly non-polar solvent (hexane) 
in an ultrasonic bath for 5 min. A drop of the TTCMS hexane suspension was added onto one 
side of the pellets using a pipette.  They were then left to dry in air at room temperature on a 
Petri dish. 
 
All experiments carried out on these microsphere-coated Bioglass
®
 pellets were preformed on 
the side that was in contact with air only. 
 
4.2.9 Polymer demixing and optimisation on glass slides and 45S5 
Bioglass
® 
scaffolds 
 
The polymer demixing method was based on the study carried out by Berry et al. [114]. 
Blends of polystyrene (PS) and poly(n-butylmethacrylate) (PnBMA) with different 
proportions were dissolved in toluene at different concentrations in order to investigate the 
concentration of the mixture and the condition for the most desired coating. The optimisation 
process is described in Chapter 8, section 8.2.1. The polymer blend solution was casted on a 
glass slide for 2D analysis. For scaffold coating, scaffolds with size 5 x 5 x 5 mm
3
 were 
dipped in 5 ml of the polymer blend solution, then taken out slowly, they were then left to dry 
at room temperature in air.  
 
4.2.10  Chemical etching / water-treatment on 45S5 Bioglass
® 
pellets and 
scaffolds 
 
The preparation of the water-treated 45S5 Bioglass
®
 scaffolds and pellets was carried out 
according to a previously developed method by Chen et al. [119]. The pH value of 70 ml of 
distilled water was adjusted to 4 or 8 using sodium hydroxide (NaOH) solution, and heated to 
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80
o
C in an oil bath under stirring conditions. 10 x 10 x10 mm
3
 sized scaffolds or ~0.5 g 
sintered Bioglass
®
 pellets were placed in the solution. At 1, 2, 3, and 4h time points, three 
samples of scaffolds or pellets were taken out, cleaned for 5 min in 300 ml of distilled water 
and dried at room temperature in air.   
 
4.3 Materials characterisation 
 
4.3.1 Particle size analysis 
 
For particle size analysis, a Malvern Mastersizer particle size analyzer (Worcestershire, UK) 
was used to measure the particle size of the Bioglass
®
 powders and the microspheres. Small 
amount of particles were dispersed well in water in an ultrasonic bath first; the suspension 
was then added drop-wise to the analyser until the ideal concentration was reached, the 
particle size was then measured. 
 
4.3.2 Thermal analysis 
 
A simultaneous Thermal Analyser (STA, NETZSCH STA 449C), which runs heat flux 
Differential Scanning Calorimetry (DSC) and Thermo-Gravimetric Analysis (TGA) at the 
same time, was used to study the physical transformation of the Bioglass
®
 powder during 
heating. About 20 mg of powder were placed in a Pt crucible and heated from 25
o
C to 
1300
o
C in air, at a rate of 10
o
C per minute. Both the glass transition (Tg) and the 
crystallisation (Tc) temperatures were determined from the point of intersection of the curve 
tangents. 
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4.3.3 Determining the scaffolds porosity 
 
4.3.3.1  Measuring the density of 45S5 Bioglass
®
 powder 
 
A 25 ml pycnometer was used to measure the density of the 45S5 Bioglass
®
 powder with 
distilled water being used as an immersion fluid. The density of the glass powder was 
calculated using the following equation: 
 
)()(
)(
2314
12
pppp
ppL
glass
mmmm
mm
   Equation 1 
  
where ρglass is the particle density in grams per cubic centimetre, mp1 is the mass of the empty 
pycnometer in grams, mp2 is the total mass of the pycnometer that contained  approximately a 
third of its total capacity with the glass sample in grams, mp4 is the total mass of the 
pycnometer that contained its full capacity with the immersion liquid in grams, mp3 is the 
total mass of the pycnometer that contained both the sample and the immersion liquid in 
grams and ρL is the density of the immersion liquid at the measuring temperature in grams 
per cubic centimetre. The density of the immersion liquid was 0.99745 g/cm
3
, which was the 
density of the distilled water at 23.4 ± 0.1
o
C. 
 
4.3.3.2  Numerical determination of scaffold porosity 
 
The densities of the non-coated (ρscaffold) and composite (CNT or microspheres coated) (ρcoated) 
scaffolds were determined from the measurement of masses (m) and the volumes (V) of the 
scaffolds (ρ = m/V). The porosities of coated (Pcoated) and non-coated (P) scaffolds were 
determined using the formulae below [222]: 
 
P = 1 – (W1/ ρBioglass
®
 
.
 V1) = 1 – (ρscaffold / ρBioglass
®
)   Equation 2 
    
Pcoated = 1 – [W1/ ρcoated + (W2-W1) / ρCNT or ρP(3HB)] / V2  Equation 3 
 
 
83 
 
where W1 and W2 are the weights of the scaffolds without and with the coating respectively. 
V1 and V2 are the volumes of the scaffolds without and with the coating respectively, which 
were measured using a digital calliper (Mitutoyo, Germany). The theoretical density of 
Bioglass
®
 (ρBioglass
®
),
 
P(3HB) (ρP(3HB))
 and CNT (ρCNT) are 2.70 g/cm
3
 [32], 1.23 g/cm
3
 [223] 
and 1.3x10
-3
 g/mm
3
 (as quoted by Nanocyl
®
), respectively. 
 
4.3.4 Compressive strength tests 
 
The compressive strength values of uncoated and CNT- or microsphere-coated scaffolds were 
measured using a Zwick/Roell Z010 universal testing machine, as described elsewhere [5]. 
The scaffolds were carefully shaped to prismatic specimens of dimensions of 5 x 5 mm
2
 in 
cross-section and 10 mm in height. A load of 1 kN was applied onto the 5 x 5mm
2
 face until 
the compressive strain reached 70%. The crosshead speed was 0.5 mm/min. A Teflon film of 
0.05 mm thickness was used to cover the bottom and top platens of the machine to prevent 
the sample from slipping. 
 
 
Figure 4.3 A typical compressive stress-strain curve of the 45S5 Bioglass®-based scaffolds sintered at 
1100
o
C for 2 h (91.0% in porosity). 
 
The maximum stress before the densification of the scaffold was used as a value of the 
compressive strength of the scaffold in this study, as it is circled in Figure 4.3. This is in 
agreement with previous investigations on similar scaffold systems [4].   
 
Densification 
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4.3.5 Scanning electron microscopy (SEM) and energy dispersive X-ray 
(EDX) analysis 
 
Microstructural observations of all the uncoated and coated Bioglass
®
-based scaffolds were 
performed using a SEM JEOL 5610LV (JEOL, Japan) or SEM LEO 1525 (Carl Zeiss, 
Germany) at an acceleration voltage of 5-20 kV. SEM LEO 1250 produces higher resolution 
images and it was used mainly for the study of nanoscale features. SEM specimens were 
carbon-taped on aluminium stubs and sputter-coated with gold at 20 mA for 2 min using an 
EMITECH K550 coating device (EMITECH, UK), except the CNT-coated scaffolds, which 
were coated with chromium using EMITECH K575X (EMITECH, UK) at 65 mA current for 
1.5 min. SEM was also used to characterise the changes that occurred on the scaffold or pellet 
surfaces upon immersion in SBF. The sample preparation techniques and characterisation 
methods were the same used for microstructural observation. 
 
The surface elemental composition of a sample was carried out by energy dispersive X-Ray 
(EDX) analysis. Calibration was carried out using pure titanium pellet before conducting 
every EDX analysis. Sample preparation methods were the same used for the SEM specimens. 
The measurements were carried out at 10 or 20 kV in a field emission gun (FEG) SEM 
(Leo15). The data were processed using an INCA (Oxford instruments) program. Three 
measurements were taken, and the atomic percentages were averaged for each sample 
investigated.  
 
4.3.6 White light interferometry (Zygo
®
) 
 
The surface roughness of the planar specimens, e.g. Bioglass
®
 pellets, was measured using 
white light interferometry, using a Zygo
®
 instrument (New view 200 OMP 0407C). The 
instrument makes measurements at single points on the surface. To ensure a representative 
area of interest was tested, multiple measurements were made on one sample. The root mean 
square (RMS) of the analysed surfaces, measured in micrometres, was used to quantify the 
level of roughness of the sample surfaces. 
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4.3.7 X-ray diffraction analysis (XRD) 
 
X-ray diffraction (XRD) analysis was performed using a Phillips PW1700 series automated 
powder diffractometer. Cu Ka radiation of 40 kV and 40 mA, in the 2h range of 5 - 80
o
, with 
step size of 0.04
o
 and a counting time of 2 s, was used for the XRD analysis. Scaffold 
samples were grinded to fine powders and placed on a single-crystal silicon holder for the 
measurements. 
 
XRD analysis presented in Chapters 8 and 9 was carried out using PANalytical X’Pert MPD 
(Netherlands), with Ni filtered Cu Kα radiation operated at 40 kV and 40 mA, in the 2θ range 
of 5–90o, step size of 0.0334o. All scaffolds were ground into powders for XRD analysis 
using this instrument as well. 
 
4.3.8 Fourier transform infrared spectroscopy (FTIR) 
 
Similar quantities from each scaffold samples (~ 2.0 mg) were ground into fine powders and 
mixed with ~200 mg of KBr. The mixtures were then pressed in a uniaxial hydraulic press 
(Spectroscopy Central, UK) in order to produce pellets that are 13 mm in diameter for FTIR 
analysis. 
 
FTIR measurements were carried out using a Bruker spectrometer IFS 113v (UK) and the 
spectra were collected in the transmittance mode, in MIR region (400-5000 cm
-1
). Only 
selected regions of the spectra are presented in the results and discussion Chapters 5, 6, 7 and 
8. 
 
4.3.9 Zeta-potential measurements 
 
The zeta-potential of Bioglass
®
 particles and P(3HB) microspheres in aqueous suspension 
(2.0 wt%) was measured using an Agilent 7020 ZetaProbe (Foster City, USA). The zeta-
potential of the CNT suspension (0.5 wt%) was measured using a ZetaPALS Zeta Potential 
Analyzer (Brookhaven, Inst. Corp, Holtsville, USA). The zeta-potentials of the samples were 
measured as a function of pH. The pH of the suspension was adjusted by 1N hydrochloric 
acid. 
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4.3.10  X-ray micro-computed tomography (µCT) analysis 
 
A scaffold sample with dimensions of 5 x 5 x 10 mm
3
 was scanned using a commercial X-ray 
micro-computed tomography (µCT) unit (Phoenix X-ray System and Services GmbH, 
Wunstorf, Germany) at 80 KeV and 100 mA at a resolution of 5 µm voxel. The scanning 
process was conducted by collaborator (Prof. Peter Lee, Imperial College London, UK). The 
2D (Ortho Slice) and 3D images were generated using Amira
®
 software (Visage Imaging, 
USA). The surface area of the scaffold was also calculated using the same software.  
 
4.3.11  In vitro bioactivity / simulated body fluid (SBF) study 
 
Simulated body fluid (SBF) was prepared according to the standard procedure put forward by 
Kokubo at al. [224] (see Table 4.1). It was prepared by dissolving the reagent chemicals into 
deionised water at 37
o
C. The solution was buffered at pH 7.25 by charging it with 1N 
hydrochloric acid. 
 
Uncoated or coated Bioglass
®
 scaffolds of dimensions 10 x10 x10 mm
3
 or pellet samples 
were immersed in 30ml of SBF in clean centrifuge tubes separately. The pellets were then 
stored in an incubator at controlled temperature of 37
o
C. SBF was refreshed every three days 
following similar experiments in our laboratory [4].  Samples were extracted from the SBF 
after certain time points depending on the experiment. The samples were rinsed gently with 
deionised water after extracted from SBF, and left to dry at ambient temperature in a 
dessicator for further examination. 
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Table 4.1 Quantities of reagents for preparation of SBF [224]. 
Order Reagent Amount (g/L) 
1 NaCl 7.9960 
2 NaHCO3 0.3500 
3 KCl 0.2240 
4 K2HPO4.3H2O 0.2280 
5 MgCl2.6H2O 0.3050 
6 1N HCl 40 ml 
7 CaCl2.2H2O 0.2780 
8 Na2SO4 0.0721 
9 (CH2OH)CNH2 6.0570 
10  1N HCl To adjust pH to 7.25 
 
4.3.12  Measurement of the conductivity of CNT-coated scaffolds 
 
The electrical resistance of CNT-coated Bioglass
®
 scaffolds was measured using a FLUKE 
77 Series II Multimeter. The scaffold was connected to the multimeter by a spring loaded 
device; a schematic diagram of the experimental set up used for these measurements is shown 
in Figure 4.4. Ten measurements were taken at different locations of the scaffold, the average 
values were calculated. 
 
Figure 4.4 Schematic diagram showing the device to measure the electrical resistance of CNT-coated 
scaffolds. 
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4.3.13  Transmission electron microscopy analysis of CNT-coated Bioglass
®
 
scaffolds 
 
CNTs and CNT-coated scaffold fragments were analysed using a transmission electron 
microscope (TEM) FX 2000, JEOL (Japan) operated at 200 kV. A small amount of finely 
ground CNT-coated scaffold powders was mixed into 50 ml distilled water. A drop of this 
mixture was added onto a 3 mm Formvar-coated copper grid, once it was dried, it was used 
for TEM analysis. 
 
4.3.14  Atomic force microscopy (AFM) 
 
Atomic force microscopy (AMBIOS TECHNOLOGY Inc., Q-ScopeTM 250/400, NomadtM, 
US) was used to examine the topography of the 2D films produced by polymer demixing 
technique. All images were taken in contact mode (Z-height) using a silicon cantilever. The 
scan size was chosen in order to capture the images that are representative of the topography 
of interest, therefore meaningful data quantifying the surface roughness can be drawn. 
 
To calculate the Average Height ( ), the lowest point in the image is assigned the height of 
“zero”, and all other points in the image are higher than zero. The average height of the 
sample points is based on this reference arrangement, as explained in the instrument’s manual 
[225]. The equation of Average Height is shown in Equation 4, where N is the number of 
pixels (or data point) in the image, and Zn is the Z-axis value of a pixel, in another word, the 
height. 
    Equation 4 
 
Root Mean Square (Sq) is the standard deviation of the Z values in the image [225]. The 
equation of Root Mean Square is shown in Equation 5, where N is the number of pixels in the 
image, and Zn is the Z-axis value of a pixel. 
 
          Equation 5 
89 
 
  
Although the Root Mean Square is an indication of the surface roughness, very little about 
the actual topography features (e.g. spike or valley formation and shapes of these features) 
can be concluded. Therefore the two following factors were included to give a more 
comprehensive analysis on the topography of the samples. 
 
Skewness (Ssk) is a measure of the symmetry of the variation of the histogram profile above 
its mean line [225]. Surfaces with a positive skewness have fairly high spikes that stick out 
above a flatter average, while a negative skewness means the surface has fairly deep valleys 
in a smoother plateau. More random surfaces have a skew value near zero [225]. The 
equation used to determine Skewness is shown in Equation 6, where N is the number of 
pixels in the image, Zn is the Z-axis value of a pixel and Rq is the standard deviation of the Z 
values. 
 
   Equation 6 
  
Kurtosis (Skr) is a measure of the spikiness of the histogram profile above its mean line [225]. 
A positive kurtosis implies the spike features on the surface have sharply peaked distribution. 
If the Kurtosis is negative, this implies the spikes have a more flat-topped distribution. The 
equation used to determine Kurtosis is shown in Equation 7, where N is the number of pixels 
in the image, Zn is the Z-axis value of a pixel and Rq is the standard deviation of the Z values. 
 
   Equation 7 
 
4.3.15  P(3HB) microsphere characterisation 
 
4.3.15.1  Measuring P(3HB) microsphere porosity 
 
The porosity (ε) of the microspheres was measured according to Equation 8, using the liquid 
displacement method described elsewhere [226]. 
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where Vp is the volume of the pores, Vs is the volume of the polymer phase, w1 is the mass of 
the cylinder filled with ethanol before the immersion of the sample, w2 is the mass of the 
cylinder, ethanol and the sample after removing the excess ethanol above the 5 mL mark, w3 
is the mass of the cylinder and ethanol after removing the sample saturated with ethanol, ws is 
the mass of sample used in the measurement. 
 
4.3.15.2  Measuring the density of P(3HB) microsphere powders 
 
The density of microsphere powder (ρmsp) was determined using a 25 mL pycnometer and 
applying Equation 9: 
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where mp2 is the mass of the sample and the measuring container in grams, mp1 is the mass of 
the measuring container, mp4 is the mass of the specific amount of immersion liquid and the 
measuring container, mp3 is the mass of the specific amount of sample, the immersion liquid 
and the measuring container and ρL is the density of the immersion liquid at measuring 
temperature. The enclosed space (porosity) inside the particle is considered to be part of the 
individual particle by assuming that the spaces are fully dense. 
 
4.3.15.3  Nitrogen adsorption surface area analyzer 
 
The surface areas of plain and TTC-encapsulated P(3HB) microspheres were measured using 
a Quantachrome Autosorb Automated Gas Sorption system. The adsorptive gas was nitrogen, 
N2, of 99.999% purity. Sample weight was 0.10 g. The cross sectional area of adsorbed 
nitrogen molecules was taken to be 0.162 nm
2
. The experiment was carried out by 
collaborator (Dr. J. Jones group at Imperial College London, UK). The surface area was 
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evaluated using BET method which is based upon the measurement of quantities of gas 
physisorbed onto a surface at equilibrium pressure [227]. 
 
4.3.15.4  Transmission electron microscopy (TEM) 
 
The cross-sections of single microspheres and the crystallinity of the polymer were analysed 
by transmission electron microscopy (TEM) using a JEOL (Japan) TEM-2010 transmission 
electron microscope operated at 200 kV. The sample for TEM was prepared using the 
focused ion beam method (FIB; FEI FIB200-SIMS). The microspheres were coated first with 
gold, then with platinum. A Ga
+
 beam of 30 keV between 30 and 100 pA was used to cut the 
sample. Images were taken in secondary electron mode. Once the samples had been polished 
to the desired thickness, they were extracted using an ex situ lift-out technique onto a 3 mm 
Formvar-coated copper grid for TEM analysis. 
 
4.3.16  Drug-release study 
 
4.3.16.1  Measuring drug-encapsulation efficiency 
 
5 mg of the tetracycline-loaded P(3HB) microspheres (TTCMSs) was dissolved in 1 ml of 
chloroform, to which 5 ml of water was added after the microspheres were well dissolved. 
Tetracycline, being hydrophilic, separated into the water phase on vortexing. The water phase 
was then analysed for tetracycline content using UV-Visible spectrometer (U-2800A, 
HITACHI, UK). 
 
4.3.16.2  UV-Visible spectrometer 
 
The in vitro TTC release kinetics from the TTCMS-coated scaffolds, TTC-dipped scaffolds 
and free TTCMSs were measured using a UV-Visible spectrometer (U-2800A, HITACHI, 
UK) at 362 nm. All samples were immersed in 2 ml of SBF solution in a 2 ml capped 
Eppendorf tube in an incubator at 37
o
C over a period of 4 weeks. 1 ml SBF from each sample 
was collected at regular intervals for measurement. After the measurement, the 1 ml SBF 
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samples were returned into the respective Eppendorf tubes as a solution of overcoming the 
sensitivity issue of the instrument. Three samples of each test system were prepared and the 
readings were averaged at each time point. Scaffolds of dimensions 5 x 5 x 5 mm
3
 were used, 
and the free TTCMSs used had the same weight as the amount coated on the scaffolds. The 
amount of the TTC released was calculated against a standard curve (Figure 4.5) obtained by 
measuring a series different concentrations of TTC solutions. 
 
 
Figure 4.5 The standard curve for TTC calculation (n = 3). Graph represents one single experiment with 
3 replicates. 
 
 
4.3.17  Statistical analysis 
 
All data are expressed as mean ± standard deviation (SD). The data were compared using t-
test calculated in SigmaStat software, and differences were only considered significant at * 
p < 0.05. 
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Chapter 5 Fabrication, optimisation and characterisation of 45S5 
Bioglass
®
-based scaffolds 
 
5.1 Introduction 
 
It was indicated in Chapter 2 that for successful bone TE applications it is essential to have a 
3D interconnected porous scaffold which mimic the structure and properties of the bone 
extracellular matrix. Bioglass
®
-based 3D scaffolds can be fabricated by the foam replica 
method, which was first developed in 2006 at Imperial College London [3, 4]. This is a 
highly reproducible and simple technique that is easy to process, and in which size and 
porosity of the scaffolds can be adjusted by simply changing the sacrificial polymer (usually 
PU) foam. 
 
PDLLA has been used in foam replica technique as the binder of the glass slurry [4]. 
However, this is an expensive polymer. In order to reduce the cost, a cheaper polymer, 
polyvinyl alcohol (PVA) was chosen to replace PDLLA in the present project. Therefore the 
original recipe developed by Chen et al. [4] and Bretcanu et. al. [218] needed to be tested 
with the new binder and changes needed to be made to optimise the fabrication of scaffolds. 
This part of the project focuses on investigating how effective is PVA as a binder, and 
therefore necessary changes were introduced in order to fabricate the ideal scaffold. 
 
Mechanical properties of the scaffolds fabricated using the modified protocol during process 
optimisation were tested in order to evaluate the effectiveness of the new binder. Bioactivity 
of the new scaffolds was tested using the simulated body fluid (SBF) method, where the 
formation of hydroxyapatite on the surfaces of scaffolds immersed in SBF was characterised 
using SEM, XRD and FTIR techniques over several time periods. 
 
Microcomputed tomography (µ-CT) analysis has also been included in this Chapter for 
complete characterisation of the scaffolds. The technique allows the 3D structure of the 
scaffold to be visualised; it is a convenient method for determining the extent of 
interconnected pores in the 3D matrix. It is the first time that the surface area of Bioglass
®
-
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based scaffold fabricated by the foam replica method has been measured; it was achieved by 
analysing the µ-CT scanning data of the scaffold using Amira
®
 software. 
 
Optimising the scaffold manufacturing process is a crucial stage in the whole project, as all 
other parts of the project will be based on the scaffolds fabricated using the optimised 
procedure investigated in this Chapter. Materials and basic experimental details of scaffold 
fabrication are described in Chapter 4. The basic steps involved in the foam replica technique 
are described in Chapter 4, section 4.2.1. 
 
5.2 Results and discussion 
 
5.2.1 Optimisation of the foam replica method using polyvinyl alcohol 
(PVA) as the binder 
 
The average particle size of the 45S5 Bioglass
®
 used in this project was measured in an 
aqueous suspension using a Malvern
®
 Mastersizer Laser Particle Analyser. The particle size 
distribution graph is shown in Figure 5.1, and the average particle size of the glass powder 
was determined to be around 8 µm. More homogeneity in particle diameter means the glass 
powders can fuse together more effectively during the sintering process. 
 
 
Figure 5.1 Particle size distribution of the 45S5 Bioglass
®
 powder in water. 
 
Amount 
of 
particles 
(%) 
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In order to calculate the porosity of the scaffolds, which is a major factor determining 
whether or not the scaffolds fabricated meet the requirement for bone tissue engineering 
applications, the density of the 45S5 Bioglass
®
 powders needed to be measured. By using a 
pycnometer, the density of the glass powder was determined to be 2.66 g/cm
3
, which is very 
close to the theoretical density of 45S5 Bioglass
® 
of 2.70 g/cm
3
 [4]. 
 
Simultaneous Thermal Analyser (STA) which runs Differential Scanning Calorimetry (DSC) 
and Thermo-Gravimetric Analysis (TGA) simultaneously on the same sample under identical 
conditions was used to study the physical transformation of the Bioglass
®
 powder during 
heating. The results are shown in Figure 5.2. TGA shows two major weight lost events at 
100
o
C and 300-400
o
C, they can be ascribed to the lost of water and hydroxyl groups, 
respectively. When silicate glass particles are exposed to high temperature, their properties, 
such as coefficient of volume expansion and heat capacity, change sharply in a narrow 
temperature range, which for Bioglass
®
 is at around 550
o
C. This temperature is called the 
glass transition temperature (Tg) [228]. An endothermic effect which caused the base line of 
the DSC curve to shift at 550
o
C is due to the glass transition temperature (Tg). It is well 
known that the glass transition temperature is associated with the rate of rearrangements 
within the glass structure. Above Tg, these rearrangements occur rapidly, and glasses have 
the properties of a liquid. Below Tg, the glass structure is “frozen” and the material behaves 
like a solid when the rearrangements are slow [228]. This effect was followed by an 
exothermic peak in the DSC spectrum, which represents the crystallization temperature. In 
glasses, the temperature at which crystal nucleation takes place and a rapid crystal growth 
follows is the crystallization temperature. It started at 635
o
C (crystallisation onset 
temperature, Tc) and reached its maximum (peak crystallisation temperature, Tp) at 680
o
C 
due to the first crystallisation process. There appeared to be another exothermic peak right 
next to the Tg peak in the DSC spectrum. This peak could be the second crystallisation peak 
(Tp2). Although Tp2 is overlapped with the first one, its trace can be observed at 690
o
C (see 
insert of Figure 5.2). The second crystallisation peak (Tp2) is overlapped with the first one, 
but its trace can be observed at 690
o
C. The glass began to melt above 1050
o
C, the 
endothermic peak caused by this process reached its maximum in the range 1190 – 1220oC, 
and the two splits of this major endothermic peak may be attributed to the melting of two 
different crystalline phases. Overall, current STA results are in broad agreement with several 
previous investigations in the literature [3, 229-232], which states that for heating rates 
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between 5 and 30
o
C/min, the Tg varies in the range 500–550oC and the glass crystallises 
between 600 and 750
o
C.  
 
 
Figure 5.2 Simultaneous thermal gravimetric analysis-differential thermal analysis (TGA-DSC) results on 
Bioglass® powder, showing the different transformation temperatures. DSC and TGA plots are shown in 
blue and green, respectively. The insert shows a higher magnification of the marked area of the DSC 
curve. The glass transition temperature (Tg), crystallisation onset temperature (Tc) and two 
crystallisation peak temperatures (Tp and Tp2) are indicated by the arrows. 
 
The heat-treatment schedule to densify the scaffolds was designed based on information 
reported in the literature and the data of Tg and crystalisation temperature obtained in this 
research. Indeed the sintering and crystallization of Bioglass
®
 powders have been widely 
reported [3, 4, 6, 68, 218, 230, 232]. It is reported in the literature [232] that no sintering of 
Bioglass
®
 powders occurs below the glass transition temperature, and the first step of 
densification takes place soon after the glass transition temperature is reached, when sintering 
takes place by viscous flow and glass particles are connected through sintering necks [3]. 
That temperature was hence hold for 3 hours for enabling glass particles to start the 
densification process after the PU foam has been burn off completely. The second stage of 
densification occurs at temperatures above 850
o
C, e.g. after the onset of crystallisation 
(which occurs in the temperature range 600–750oC). It has been reported that at temperatures 
higher than 850
o
C, Bioglass
®
 powder compacts exhibit the second stage of sintering [232]. 
For example, Bretcanu et al. [232] reported that densification, which occurs by a viscous 
flow sintering mechanism in glass, increased significantly when the green body was heated 
Tg 
Tp2 
Tp 
DSC 
TGA 
Tc 
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up to between 950
o
C and 1100
o
C. It was observed that the wall of the strut was nearly fully 
densified after sintering at 1000
o
C for 1 hour, and gaps or crevices between the glass particles 
were minimised. The cell struts are also considerable thicker when sintered above 1000
o
C for 
up to 1 h than at 900–950oC for 2–5 h. Both results should potentially enhance the 
mechanical property of the scaffold. 
 
Bretcanu et al. [232] also reported that dilatometry data confirmed that the sintering 
temperature for 45S5 Bioglass
®
 powder compacts lies in the interval 1000–1100oC. The 
optimal sintering temperature can therefore be chosen within this gap when viscous flow 
sintering dominates. Although it was reported in the literature [232] that maximal 
densification of the glass powders can be achieved by sintering them at 1050
o
C for 140 min, 
from our own preliminary experimental results, we found that the 45S5 Bioglass
®
 powder 
used here could be sintered at 1100
o
C for 2 hours in order to maintain the scaffold porous 
structure while achieving densified struts. 
 
As it is well-known from the literature [4, 218] at the selected sintering temperature 
Bioglass
®
 will crystallise and the sintered scaffold will exhibit a highly crystalline structure. 
The combination of extensive densification and the presence of a crystalline phase in the 
struts of scaffolds are expected to lead to improved mechanical properties of these foams, 
which should maintain their trabecular architecture and maximum porosity to improve the 
penetration of biological fluids and cells. Reports in the literature have also confirmed [4] 
that the presence of the crystalline phase in the scaffold microstructure does not suppress the 
bioactive behavior of the material, but it merely slows down the bioactivity of the scaffold, 
i.e. it delays the onset of HA formation, which is a major disadvantage of having the 
crystalline structure. However, in our experiments, HA formation, the marker of bioactive 
behavior, was observed after 4 days of immersion in SBF (see Section 5.2.4 for more details), 
this provides the evidence that the crystallised scaffold developed here is still bioactive. 
 
Therefore, in order to achieve the optimized scaffold that unites the parameters of suitable 
surface topography in 3D, porosity and pore size, mechanical strength and bioactivity, the 
final heat treatment program was set as follow: the first condition imposes a slow heating rate 
(2
o
C/min) to an intermediate temperature (550
o
C) followed by a plateau for completing 
efficiently the removal of the PU sacrificial foam and for enabling the first densification 
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process. The second condition imposes a thermal treatment at 1100
o
C to eliminate micro-
porosity. 
 
Based on the finding described above and the original scaffold processing methods [4, 221], a 
few batches of scaffolds using the modified protocols with PVA were made; the different 
starting slurry compositions and sintering conditions are listed in Table 5.1. The differences 
between these batches of scaffolds are recorded and discussed in the following sections, and 
all the properties discussed in these two sections were taken into account when concluded 
which batch and sintering condition were the best to fabricate the ideal 45S5 Bioglass
®
 
scaffolds for bone tissue engineering application in the framework of the present project. 
 
Table 5.1 Different batches of scaffold fabricated at different starting slurry compositions and sintering 
conditions. 
Batch 
Number 
Bioglass 
(%) 
PVA 
(%) 
Maximum 
sintering 
temperature 
(
o
C) 
Sintering duration at 
max. temperature 
(hours) 
1 36 5.8 1100 2 
2 36 5.8 1150 2 
3 36 5.8 1100 3 
4 40 2.4 1100 2 
5 40 4.0 1100 2 
6 40 6.0 1100 2 
 
5.2.2 Characterisation of the different batches of 45S5 Bioglass
®
-based 
scaffolds 
 
The first observation made upon sintering of the scaffolds is that there is a 50% shrinkage in 
the dimensions of the foam, as determined by comparing the volumes of the sacrificial PU 
foam and that of the scaffold produced from it (VBG scaffold / VPU foam). 
 
The scaffold densities, average compressive strength and porosities of each batch of scaffolds 
are listed in Figure 5.3. It was not possible to obtain well-formed scaffolds under the 
condition of batch 2; the scaffolds were all melted during the process, as the maximum 
sintering temperature was too high, above the melting point of the glass. By comparing 
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batches 1 and 3, it was found that there is no significant advantage to increase the sintering 
duration from 2 hours to 3 hours, therefore it was decided to keep the sintering time as 2 
hours to reduce the whole processing time therefore reducing the fabrication costs. 
 
It can be observed that there is no significant difference in scaffold densities (Figure 5.3 (a)) 
and porosities (Figure 5.3 (c)) between all the scaffolds fabricated using different conditions, 
with the exception that batches 1 and 3 exhibit, expectedly, higher porosity levels (~94%) due 
to the fact that they were both made from a slurry with a lower glass powder concentration. 
The porosities of all scaffolds were above 90%, which is one of the specific criteria for ideal 
scaffolds for using in bone tissue engineering. However, it seems that the average porosities 
of batch 5 and 6 scaffolds were lower than that of other batches. This result could explain the 
increase in compressive strength (Figure 5.3 (b)) of those two batches compared to other 
batches, since less porous samples will have higher compressive strengths [5]. The low 
mechanical property of batch 4 scaffolds maybe caused by the low PVA concentration in the 
glass slurry. The result demonstrated that if there is not enough PVA (or other polymeric 
binders) in the slurry, the glass particles will not be suspended homogeneously throughout the 
green body, which leads to an inefficient coating of the PU foams and to poor particle-
particle contacts, hence a weaker scaffold structure is produced when sintered.  
 
A typical compressive stress-strain curve of a scaffold of batch 6 is shown in Figure 5.4. 
During the test, the thin struts of the scaffold crack first at stress-concentrating sites causing 
the stress to drop momentarily, but the whole scaffold can still bear higher loads, hence the 
overall stress rises. The repetition of this procedure is reflected in the jagged curve with a 
increasing strain; this phenomenon is typically observed in this type of brittle porous sample 
[4]. During loading, with increasing compressive stress, the scaffolds are compressed layer 
by layer, and the stress-strain curve can be separated into three major stages [4]. Stage one 
represents the increase in stress, showing a linear elastic behaviour. It is followed by stage 
two, in which stress decreases due to the failure of the scaffold. Starting from about 40% 
compression strain, densification of the foams occurs, which represents the stage three, which 
is a typical behaviour of highly porous scaffolds [4, 70]. The scaffolds completely crumbled 
to a fine powder at the end of testing. 
 
It should be pointed out that shearing could occur during the compression strength test, 
mainly caused by the edge effects imposed on the specimen during the test. If the faces of the 
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sample are not aligned well with the loading platen, large stress concentrations can occur 
causing local buckling, which in turn can lead to shearing and thus underestimation of both 
Young’s modulus and strength could occur [4, 233]. Therefore only the strength values 
obtained from the pure (valid) compression strength tests represent the full compressive 
strength of the scaffold. 
 
Although the average compressive strength of the scaffolds from batch 6 is not seem to be 
significantly higher than that of batch 5, the average of the values are higher. Therefore the 
most ideal recipe and sintering conditions to fabricate scaffolds using PVA as the binder was 
considered to be the ones used to fabricate batch 6. From this point onwards, the 45S5 
Bioglass
®
-based scaffolds mentioned in the thesis were fabricated following the recipe and 
conditions of batch 6, except otherwise specified. 
 
The macroporous network and the strut microstructure of a typical 45S5 Bioglass
®
 derived 
scaffold are illustrated in Figure 5.5. No significant difference was observed from the image 
analysis in terms of morphology of the struts surface among all the batches. Investigated 
SEM images confirmed that highly porous scaffolds were produced, and the microstructure is 
similar to that of scaffolds described in the literature which were made by the same technique 
but using other starting slurries [4]. The pores have a diameter of size in the range of 400 to 
600 µm, which is a favourable pore size for cell migration, vascularisation, waste transfer and 
new bone formation once the scaffold is placed in vivo. The average pore size remained 
almost constant among all the scaffolds from different batches, irrespective of slight 
differences measured in their level of porosity. From the SEM image in Figure 5.5 (b), fine 
crystalline grains of ~ 0.5 μm in diameter can be identified in the strut microstructure. This 
crystalline phase is embedded within the amorphous residual glass matrix. The strut 
microstructure is therefore that of a glass-ceramic material. A hollow tube that is marked by a 
arrow in Figure 5.5 (c) shows the typical hollow struts formed after the PU foam has been 
burned off during the sintering process. 
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Figure 5.3 Comparing different properties of the Bioglass
®
-based scaffolds from different batches (see 
Table 5.1): (a) densities; (b) average compressive strength and (c) porosities (* p < 0.05, n = 6). The 
graphs represent one single experiment with 6 replicates. 
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Figure 5.4 A typical compressive stress-strain curve of the 45S5 Bioglass
®
-based scaffold sintered at 
1100
o
C for 2 h (Batch 6). 
 
   
 
Figure 5.5 SEM images showing the porous structure and strut microstructure of 45S5 Bioglass
®
 scaffold 
sintered at 1100
o
C for 2 hours (Batch 6): (a) at low; (b) at high magnification and (c) the hollow tube 
(pointed by arrow) inside a strut that was generated after PU foam was burned off. 
a b 
1 
2 
3 
c 
103 
 
Figure 5.6 (a) shows the XRD spectrum for the optimised scaffold. XRD analysis determined 
that the scaffold is crystallised, this observation is in an agreement with the TGA-DSC 
analysis (Figure 5.2), as the sintering temperature is above the crystallisation temperatures. 
As-received Bioglass
®
 powder is amorphous, e.g. no XRD pattern was detected (data not 
shown here). As shown in Figure 5.6 (b), the peaks from the XRD spectrum of the Bioglass
®
 
scaffold (Figure 5.6 (b.1)) match a combination of diffraction patterns of two sodium calcium 
silicate crystalline phases: Na6Ca3Si6O18 (PDF #01.077.2189, Figure 5.6 (b.2)) and 
Na2Ca2Si3O9 (PDF #00.022.1455, Figure 5.6 (b.3)), with Na6Ca3Si6O18 being the major phase. 
This result is partially in agreement with previous studies [3, 5, 234], in which only 
Na2Ca2Si3O9 was observed. This difference in crystal structure could be due to the fact that 
the highest sintering temperature in the present study is 100
o
C higher than that used in the 
previous studies and the sintering time at that stage is 1 hour longer [4]. 
 
The present 45S5 Bioglass
®
-based scaffolds are in fact highly crystalline glass-ceramics 
considering that a residual glassy phase remains in the structure due to the fact that 
crystallinity of the sintered 45S5 Bioglass
®
 materials cannot reach 100% [3, 4, 218]. From 
the components of 45S5 Bioglass
®
 and the main crystalline found in the sintered structure, 
Na6Ca3Si6O18 (Table 5.2), one can find that the Na6Ca3Si6O18 phase would demand too much 
SiO2 (50.45 mol% > 46.13 mol%) and Na2O (50.45 mol.% > 46.123 mol.%) to fully 
crystallise from Bioglass
®
. Eventually SiO2 is depleted when the crystallinity reaches 91.44% 
(46.13 / 50.45 x 100), which can be considered the maximum crystallinity achievable by the 
sintered 45S5 Bioglass
®
 composition. 
 
Table 5.2 Components of 45S5 Bioglass
®
 and crystalline phase Na6Ca3Si6O18 (mol%). 
 45S5 Bioglass
®
 Na6Ca3Si6O18 (714.72 g/mol) 
SiO2 (60.09 g/mol) 46.13 50.45 
Na2O (61.98 g/mol) 24.35 26.02 
CaO (56.08 g/mol) 26.91 23.54 
P2O5 (141.94 g/mol) 2.60 0 
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Figure 5.6 (a) XRD spectrum of as fabricated Bioglass
®
 scaffold (Batch 6); (b) XRD spectrum peaks of as-
sintered Bioglass
®
 scaffold (b.1) matches the literature standard peaks of Na6Ca3Si6O18 (b.2) and 
Na2Ca2Si3O9 (b.3). 
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5.2.3 Microcomputed tomography (µCT) analysis 
 
In addition to SEM, X-ray micro-computed tomography (µCT) was also used to analyse the 
size and extent of interconnected of pores in the 45S5 Bioglass
®
 scaffold. It was also used to 
calculate the surface area of the scaffold. This analysis using µCT was carried out for the first 
time in this type of scaffold in this investigation. 
 
The raw scanning data from µCT was processed in Amira
®
 software (VSG, US) in order to 
produce the 3D and 2D images that are shown in Figure 5.7 and Figure 5.8, respectively. 
Figure 5.7 shows the typical porous structure of the glass-ceramic foam from different angles, 
one from the side view (Figure 5.7 (a)), and one from 45
o
 southeast of a bird view (Figure 5.7 
(b)). As expected, the figures shows that the scaffold has a highly interconnected porous 
structure, and the pore sizes is agree with SEM observation, e.g. in the range between 400 – 
600 µm. The images also show the uneven morphologies on the surface of the struts, however, 
any feature on the surface that is less than ~1 µm in diameter we not resolved due to the trade 
off between field of view (i.e. measuring sufficient volume) and resolutionin the µCT scans. 
The strut thickness is also varying as seen also by SEM. It has been reported that pore sizes in 
the range of 200–500 µm is the optimum size for the attachment and proliferation of 
osteoblasts [235]. In this study, the pore size was found to be within the ideal range. 
 
It has also been reported that interconnects (or openings) between pores must be over 50 µm 
in diameter to favour new bone ingrowths inside the pores they connect [236]. These 
interconnects provide the passages for cell seeding and subsequent bone growth, as well as 
routes for the vascularisation required to keep the new bone tissue healthy [236]. From Figure 
5.8, which is an image of a 2D transverse slide of the scaffold it can be clearly seen that the 
interconnects are greater than 50 µm, and in most cases greater than 100 µm. From this same 
figure we can also observe that the struts are of a range of thicknesses, but in general about 
50 µm in thickness. These values for pore, interconnect and strut thickness all correlate well 
with the SEM observations. 
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Figure 5.7 Portion of X-ray micro computed tomography (µCT) images of 45S5 Bioglass
®
- based scaffold 
(Batch 6) from different viewing angles showing the interconnected porosity. 
 
 
 
 
 
600 µm 
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The surface area that was calculated using Amira
®
 software was found to be 1.31 x 10
-3
 m
2
 
for a 1 x 10
-9 
m
3
 scaffold. The scaffold fabricated using a sol-gel process and then sintered at 
1000
o
C for 2 hours by Jones et al. in a previous study [237] exhibited a porosity of 82% and a 
bulk density of 0.58 gcm
-3
, its surface area, that was determined by nitrogen adsorption 
method, was 12.8 m
2
g
-1
. Therefore, for a scaffold that was 1 x 10
-9 
m
3
 in size, a surface area 
of 7.56 x 10
-3
 m
2
 is calculated, which is about 5 times higher than the surface area of the 
scaffold presented in this study. This could due to the large pore size and thinner strut of the 
present scaffold (therefore fewer struts in a given volume), however the higher porosity of the 
present scaffold is very ideal for bone tissue engineering as discussed elsewhere [4, 221]. 
 
 
Figure 5.8 2D Transverse slices from the µCT datasets of the 45S5 Bioglass
®
-based scaffold (Batch 6). 
One of the interconnects is indicated by the arrows. 
 
5.2.4 Bioactivity assessment in SBF 
 
Hydroxyapatite (HA) is the major inorganic component in spongy bone. The formation of 
HA on the surface of 45S5 Bioglass
®
 scaffold after immersion in simulated body fluid (SBF) 
is used as the marker for the scaffold bioactivity [4]. Therefore it is important to investigate 
whether PVA-made scaffolds have the same bioactivity as the PDLLA-made scaffolds 
developed earlier [4]. Both scaffolds and sintered Bioglass
®
 pellets were used in this part of 
study; they were immersed in SBF at 37
o
C for certain periods of time, and the SBF was 
refreshed every three days. Scaffold samples were used for SEM, XRD and FTIR analysis, 
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while the pellets were used mainly for EDX analysis as well as SEM (as EDX requires a flat 
specimen surface). SEM was used to observe the presence of HA crystals on the scaffold 
surfaces. Moreover, EDX was performed in order to confirm the elements present on the 
surface after different times of immersion in SBF. FTIR and XRD analysis were carried out 
to double confirm the HA formation and the HA formation rate. 
 
Figure 5.9 (a-d) show SEM images of the optimised 45S5 Bioglass
®
 scaffolds after 
immersion in SBF for 1 week (Figure 5.9 (a)) and 4 weeks (Figure 5.9 (b-d)) at different 
magnifications. The formation of HA crystals was observed after immersing the scaffolds in 
SBF for 1 week, a needle-like crystalline structure (Figure 5.9 (c)) appeared on the surface of 
the scaffold in the form of clusters, one of which is indicated by the circle in Figure 5.9 (a). 
By week 4 (Figure 5.9 (b)), the surface of the scaffold was fully covered by HA crystals, and 
at this stage, the HA crystals were packed in a cauliflower-liked shape across the whole 
surface. Figure 5.9 (d) shows a cross session of the scaffold strut after immersing in SBF for 
4 weeks. It can be observed that the thickness of the HA layer was about 2 µm, and an 
interface between the original glass-ceramic matrix and the HA layer is pointed out by the 
two arrows. The HA layer formed on the surface of a sintered Bioglass
®
 pellet is shown in 
Figure 5.9 (e). The cracks in the HA layer were also observed on the scaffolds (images are 
not shown here), this provides a channel for the inner glass-ceramic substrate to be in direct 
contact with SBF, hence ion exchange occurs, therefore further HA formation is increased 
with increasing immersion time. 
 
EDX analysis was carried out to confirm the elements present on the surface of the sintered 
Bioglass
®
 pellets before and after immersing in SBF. The EDX spectra of the samples 
immersed in SBF at different time points are shown in Figure 5.10. Three measurements were 
taken on one sample, and the averages of three atomic percentages were calculated in order to 
produce Figure 5.11. The original pellet sample (0 h) shows high sodium (Na) and silicon (Si) 
contents, which are from the major components of the 45S5 Bioglass
®
: SiO2 and Na2O. As 
the immersion period increased, Na and Si contents decreased, especially after 1 week, more 
than 50% of Na and Si have been reduced. These were replaced by phosphorus (P) and 
calcium (Ca). This phenomenon is further evidence of the formation of HA, as the chemical 
structure of HA – Ca10(PO4)6(OH)2 contains mainly P and Ca. The time scale of HA 
formation that was found by using EDX is in agreement with SEM observations, as some HA 
crystals were observed after the scaffolds or pellets were immersed in SBF for one week. By 
109 
 
week 4, hardly any Si and Na were detected on the surface of the pellets, it is due to the thick 
HA layer has formed, which covers the whole surface, X-rays were therefore unable to 
penetrate deep enough to detect the Si remaining inside the sample. It should be pointed out 
that carbon (C) contamination is inevitable in practice, and this source of contamination is 
unpredictable [119], therefore, even though there should not be no carbon in neither 
Bioglass
®
 pellets or HA crystal structures, some carbon was still detected by EDX. 
 
     
     
 
Figure 5.9 SEM images showing the hydroxyapatite (HA) layer formed on the surface of Bioglass
®
 
scaffolds after immersing them in SBF for (a) 1 week and (b - d) 4 weeks. Image (e) shows the HA layer 
formed on the surface of sintered Bioglass
®
 pellet after immersing them in SBF for 4 weeks. Image (c) 
shows the HA crystal in high magnification and image (d) shows the cross section of the HA layer. 
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Figure 5.10 EDX spectra of the surfaces of the sintered 45S5 Bioglass
®
 pellets (a) before (0 hr) and after 
immersion in SBF for (b) 3 days, (c) 1 week, (d) 2 weeks and (e) 4 weeks. The specimens were coated with 
gold (Au) for EDX measurement. 
d 
e 
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Figure 5.11 EDX results on the surface of the sintered 45S5 Bioglass® pellets before (0 hr) and after 
immersion in SBF for 3 days, 1 week, 2 weeks and 4 weeks (n = 3). This graph represents one single 
experiment with measurements obtained from 3 random locations on each sample. 
 
In addition, XRD analysis was conducted on 45S5 Bioglass
®
 scaffolds after immersion in 
SBF for 24h, 3 days, 7 days, 2 weeks and 4 weeks in order to determine the possible change 
in the scaffold crystal phases. The XRD spectra are shown in Figure 5.12. Peaks representing 
the sodium calcium silicate phase, Na6Ca3Si6O18, are marked with ‘■’. Upon soaking the 
scaffolds in SBF, HA peaks, marked with ‘●’, started appearing after one week, the 
intensities of the Na6Ca3Si6O18 peaks in the range between 20 and 65
o
 2θ decreased. The 
Na6Ca3Si6O18 peaks became less defined and broader, and only a few major peaks were 
observed. This decrease in peak intensity, which also leads to an amorphous ‘halo’ in the 
spectra, indicates the partial decomposition of the calcium silicate phase, as it occurs when 
HA starts to form. However, it was not until week 2 that the sodium calcium silicate peaks 
were seen to diminish in intensity. By week 4, HA has occupied almost the whole scaffold 
structure, and the sodium calcium silicate peaks had all disappeared. The HA formation rate 
observed in this study is slight faster than that observed in a previous study [3], in which the 
HA crystal peaks were only observed after 2 weeks in SBF, or in another investigation [4] 
where although HA peaks were observed after immersing the scaffold in SBF for 3 days, the 
sodium calcium silicate phase peaks did not start to reduce until 2 weeks of immersion. The 
faster HA formation rate could be due to the slightly difference in sodium calcium silicate 
crystal structure, as Na6Ca3Si6O18 is the primary phase in the present study, and it could 
degrade faster than the phase Na2Ca2Si3O9, which was found in the previous studies. These 
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results indicate that the 45S5 Bioglass
®
 scaffolds developed here are highly bioactive, and the 
increase in sintering time might have led to this change in compression with the previous 
scaffolds [4, 5].  
 
Figure 5.12 XRD patterns of 45S5 Bioglass
® 
scaffolds before (original, 0 h) and after immersion in SBF 
for 24h, 3 days, 7 days, 2 weeks, 3 weeks and 4 weeks (● = HA; ■ = Na6Ca3Si6O18). 
 
In order to determine the exact time point when the HA crystals started to form and grow; 
FTIR (transmission mode) was carried out on scaffolds at a much finer time scale. A FTIR 
spectrum was recorded at every 24 hours after scaffolds have been immersed in SBF, and at 
week 2 and week 4 (a different scaffold from the same batch was used for measurement at 
each time point). An overview of the FTIR spectra is shown in Figure 5.13 where analysis of 
characteristic peaks is illustrated based on data from literature [35, 90, 114, 238-241]. The 
original scaffold (0 h) exhibits the two Si-O-Si stretching bands at 950 and 1050 cm
-1
 as well 
as Si-O-Si bending bands at 450, 530, 576 and 620 cm
-1
 [90, 239]. After an immersion time 
of 3 days, both Si-O-Si bending and stretching bands become less sharp and start to disappear, 
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this indicates the loss of soluble SiO2, which is the starting point of the second stage of HA 
formation according to Hench [33] that is described in Chapter 2, section 2.2.2. as the silica 
network breaks up leading to supersaturation of silanol groups (Si-OH) at the glass solution 
interface [241]. Furthermore, at day 4, new bands at 575 and 620 cm
-1
 which represent the 
Ca-P [240] and Si-O-Si symmetrical vibration bands at 800 cm
-1
 [90] start to appear. The Si-
O-Si symmetrical vibration band is associated with the third stage of HA formation, as 
condensation and repolymerisation of a SiO2-rich layer on the surface depleted in alkalis and 
alkaline-earth cations occur. The Ca-P bands are associated with the fourth stage of HA 
formation where Ca
2+
 and PO4
3-
 ions migrate to the surface through the SiO2-rich layer that 
are formed in stage three, forming a CaO-P2O5-rich film on top of the SiO2-rich layer. This 
observation from day 4 FTIR spectrum indicates that stage three was followed by stage four 
at a fast pace and it occurs between day 3 and day 4 of immersion. At day 5, The Si-O-Si 
stretching bands at 950 and 1050 cm
-1
 have almost disappeared. They were replaced by a P-O 
stretching band at about 1030 cm
-1
. A more pronounced Si-O-Si bending peak at 450 cm
-1
 
was observed. There is also a growth of a C-O bending band at 870 cm
-1
 and C-O stretching 
bands at 1410 and 1500 cm
-1
. The C-O bands are attributed to CO3
2-
, which is proof of a 
hydroxy carbonate apatite (HCA) phase growing [239]. It has been documented that bone 
mineral is actually a carbonate hydroxyapatite phase [242]. The mechanism for bone bonding 
is thought to be cellular activity on the implant surface that causes partial dissolution and 
liberation of Ca and P ions. In addition to released Ca and P ions, Ca, P and other ions, such 
as Mg and CO3, are recruited from the body fluid and combine to form HCA microcrystals on 
the material surface, which bond to the host bone [242]. This is in agreement with our 
observation from the FTIR data, as C-O bands appear after P-O bands. The formation of HA 
and HCA phases shows that the Bioglass
®
-based scaffold presented in this study is both 
bioactive and osteoconductive. By day 6, the P-O bending bands at 564 to 600 cm
-1
 are very 
pronounced, which indicates that the ‘semi-crystalline’ HA layer was growing into a more 
and more crystallised structure. The FTIR results are in agreement with the XRD results, as 
no HA crystalline phase was detected using XRD at day 3 of immersion, only by week one, 
the HA crystal structure started to be observed from the XRD spectrum. From one week 
onwards, the Si-O-Si bending band at 450 cm
-1
 and the Si-O-Si symmetrical vibration band at 
800 cm
-1
 became smaller and smaller, and the P-O stretching and bending bands at 564 to 
600  and 1030 cm
-1
 became more and more sharper and pronounced. This indicates that the 
breaking down of the remained silicon network and the formation of HA crystal layer were 
continuously taking place as the immersion time in SBF was increased. 
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Figure 5.13 FTIR spectra for 45S5 Bioglass
®
 scaffolds before and after immersing in SBF for different 
periods of time showing the formation of HA. 
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5.3 Conclusion 
 
The results presented in this Chapter have shown that PVA is a convenient alternative binder 
for fabricating 45S5 Bioglass
®
 scaffolds via the foam replica method. The scaffolds 
fabricated using this method were seen to exhibit a high interconnected porous structure with 
a porosity of > 90% and pore size varying between 400 and 600 µm in diameter, which is the 
same as the previous studies [4, 5] on scaffolds using PDLLA. The recipe of scaffold 
fabrication was optimised using a trial and error method. Porosity measurements and 
compression strength tests were done in order to determine the best recipe and sintering 
condition. It was decided that the optimal slurry concentration in the replica method was 40 
wt% 45S5 Bioglass
®
 powder, 6 wt% PVA, and sintering at 1100°C for 2 hours. From the 
observations through visual inspection, SEM and µCT, the microstructure of the new scaffold 
was confirmed to be almost identical to that of scaffolds fabricated using PDLLA in the 
previous studies. However, a different crystalline structure of sodium calcium silicate was 
detected via XRD, and by combining FITR technique, it was found that the bioactivity of the 
new scaffold when tested in SBF was slightly better, as the HA formation rate is higher than 
that of scaffolds fabricated previously. Overall, the present scaffold has an ideal structure to 
be used for bone tissue engineering, and they constitute the basic material on which the 
investigations of the present project were based. 
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Chapter 6 Carbon nanotubes coating on the 45S5 Bioglass
®
 
scaffolds using electrophoretic deposition 
 
6.1 Introduction 
 
Carbon nanotubes (CNT) are nanomaterials that are attracting much attention for a wide 
range of technology applications [243]. Numerous materials have been combined with carbon 
nanotubes, including polymers [180], metals [244] and ceramics [179] to form advanced 
composite materials with enhanced functional and mechanical properties. The properties of 
these materials have enabled CNT to be applied in many different fields, e.g. biomedical 
sensors [181], storage of gas [182], electrodes of supercapacitors [183] and field emissions 
devices [184]. Recent developments on the use of CNT in the biomedical field have 
addressed the biocompatibility between cells and CNT for tissue engineering [185, 186]. 
 
Electrophoretic deposition (EPD) is one of the most effective methods developed to 
manipulate CNTs and to produce ordered macroscopic CNT assemblies [6]. In this technique, 
charged particles suspended in a liquid medium migrate under the influence of an electric 
field (electrophoresis) and are deposited onto an electrode [8]. As reviewed in the literature 
[9], EPD is a promising technique for nanomaterial processing, because it involves simple 
equipment, low fabrication costs, short formation time and few substrates’ shape restrictions. 
EPD is very useful to produce coatings and films of homogeneous microstructure and 
controlled thickness on a wide variety of substrates of different shape and dimensions [9]. 
 
Perhaps the first researchers to develop EPD of CNTs, Du et al. [198] demonstrated the 
deposition of CNTs on metallic substrates by EPD using ethanol/acetone as solvents. An 
extensive review describing the different solvent systems and EPD parameters used for 
deposition of ordered arrays of CNTs has been published [192]. Most previous work, 
however, has focused on CNT deposition on planar substrates. It has been previously 
reported that EPD can also be applied to produce uniform CNT coatings on the surfaces of 
3D highly porous bioactive glass scaffolds without impairing the scaffold bioactivity [6]. It 
was observed that the presence of CNTs can induce the ordered formation of a nanostructured 
CNT/HA composite layer when the substrates are immersed in simulated body fluid [6]. 
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However a comprehensive characterisation of novel CNT coated Bioglass
® 
scaffolds has not 
been carried out as yet. The addition of CNT to a bioactive tissue engineering scaffold 
represents the opportunity to develop ‘smart’ scaffolds, which will exhibit an electrically 
conductive nanostructured fibrous surface layer and improved mechanical properties by EPD 
[74, 245]. In this Chapter, the CNT coating on porous Bioglass
®
-based
 
scaffolds using a CNT 
suspension system is investigated. The compressive strength of the coated scaffolds has been 
measured, and the evidence of electrical conductivity of the composite has been shown, 
aiming at improving cell-cell interaction during cell attachment and proliferation. In the 
context of present work, the EPD of CNT on 3D Bioglas
®
 scaffolds was investigated also as a 
way to incorporate a fibrous nanotopography on the 3D porous structure of the Bioglass
®
 
scaffolds. 
 
6.2 Results and discussion 
 
6.2.1 Optimisation of the EPD process to produce ideal coating on 45S5 
Bioglass
®
 scaffold. 
 
The CNTs used in these experiments were purchased from the supplier - Nanocyl (Belgium). 
In order to determine whether or not the CNT would deposit onto the 3D Bioglass
®
 scaffold, 
the surface charges of both materials (CNT and Bioglass
®
 particles) in aqueous suspension 
were analysed. The pH dependent zeta-potential curves of the Bioglass
®
 and CNT are shown 
in Figure 6.1. These values were measured using Agilent 7020 ZetaProbe and ZetaPALS Zeta 
Potential Analyzer, respectively. The initial pH of the CNT suspension is 11.14, and the zeta-
potential of the CNT suspension was determined as -66.97 mV at that point, while Bioglass
® 
particles were seen to be slightly positively charged, although close to the isoelectric point. 
Hence, in principle, if a 45S5 Bioglass
®
 scaffold is suspended in-between the two electrodes 
in the EPD cell, as done in the present EPD experiments (Figure 4.2), the negatively charged 
CNT will migrate to the anode and pass through the porous structure of the scaffold, thus it is 
hypothesised that a significant amount of these migrating CNTs will deposit both onto the 
external and internal surfaces of the scaffold; creating a fairly homogeneous CNT coating 
throughout the 3D porous matrix. 
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Figure 6.1 Zeta-potential versus pH relationship for Bioglass
®
 particles and CNTs in aqueous suspensions 
(■ = Bioglass®, ▲ = CNTs). 
 
An indication of a poor EPD coating procedure would be the non-uniform deposition of CNT 
film, which could be caused by the appearance of small bubbles forming during the EPD 
process. The formation of bubbles is due to electrolysis of water. In an aqueous solution, 
when an electric current is being passed through water, a reduction reaction takes place at the 
negatively charged cathode, with electrons from the cathode being given to hydrogen cations 
to form hydrogen gas. At the positively charged anode, an oxidation reaction occurs, 
generating oxygen gas and giving electrons to the cathode to complete the circuit. Combining 
either half reaction pair yields the same overall decomposition of water into oxygen and 
hydrogen gases. The standard potential of the water electrolysis at standard temperature and 
pressure is 1.24 V at 25 °C, however, in practice, potentials of 3-4 V are often required before 
gas bubbles are formed [246]. It was observed that the higher the voltage that was applied, 
the more bubbles were formed in the same time period, therefore all EPD experiments were 
performed at a minimum voltage that provided a sufficient electric field acting on the CNTs 
minimising the amount of bubble formation due to the electrolysis of water. By a trial-and-
error approach, it was found that 2.8 V was the ideal condition in this case when the distance 
between electrodes was 20 mm (Figure 4.2). 
 
Three concentrations of CNT aqueous suspensions were investigated. These were 1.0 wt% 
(initial concentration), 0.5 wt%, and 0.25 wt%, which were made by diluted the as-received 
pH 
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CNT suspension by adding distilled water. The pH values of the 0.5 wt% and 0.25 wt% CNT 
suspensions are 10.93 and 10.83 respectively. EPD was carried out for 5 min, 10 min, 15 min, 
and 20 min. The separation distance between the electrodes was set as 20 mm; it was due to 
the size of the standard scaffold fabricated were 10 mm in width (Figure 4.2). 
 
In subsequent experiments, the porosities of the scaffolds after coating under the different 
conditions were measured, the quality of the coatings was analysed using SEM, and the 
mechanical properties of these CNT coated scaffolds were measured in order to identify the 
optimised condition to achieve the most balanced coating in terms of highest possible 
remaining porosity, achievable most homogenous coating and the highest possible 
mechanical property. 
 
6.2.2 Characterisation of the macro- and micro-structure of CNT-coated 
45S5 Bioglass
®
 scaffolds 
 
After the CNT-coated samples were left to dry for 24 hours in the fume-hood, an initial 
inspection of scaffold porosity took place. From visual inspection, it was found that under all 
the experimental conditions, the 1 wt% CNT suspension was too viscous and it blocked the 
pores of the scaffold once the composite was dried (Figure 6.2 (a)). This effect is undesirable 
since the maximum scaffold porosity must be kept at a high level for cellular nutrients 
transfer and vascularisation requirements in in-vivo conditions [222]. In order to determine 
how well the CNTs were deposited on the surfaces of the scaffolds in terms of CNT coating 
uniformity, SEM analysis was carried out on the struts in the internal regions of the scaffold. 
Assessing CNT coating thickness is also relevant to prove the effect of the EPS time. The 
minimum thickness of the CNT coating produced using 1 wt% CNT suspension was about 
2 µm, as seen in Figure 6.2 (b). It was found out later that such coating has a negative effect 
on the bioactivity of the composite scaffold, which is discussed in section 6.2.5. We also tried 
just to simply deep the scaffold in the suspension, then take it out immediately, but pores 
were still blocked after the coating was dried, this indicated that the initial CNT suspension 
concentration was not suitable for coating the scaffolds due to the high concentration of the 
surfactant in it. Therefore it was decided that the 1.0%wt CNT suspension would not be 
included in any further experimental investigations concerned in this part of the study. The 
suspension was therefore diluted for further investigation. 
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Figure 6.2 SEM images showing a typical CNT-coated scaffold, obtained by EPD (2.8V, 5 min) using a 1.0 
wt% CNT suspension at (a) low magnification and (b) a cross session of the coating at high magnification. 
 
All samples were cut in half in order to investigate the internal aspect of the sample. If the 
internal scaffold was fully blackened, it was qualitatively confirmed that the scaffold has 
been coated with CNT throughout. The inside of the 0.25 wt% CNT suspension coated 
samples coated under all investigated EPD conditions remained white (white is the natural 
colour of 45S5 Bioglass
®
 scaffiold), indicating a much poorer coating. It was also found that 
increasing the EPD time (> 20 min) and voltage (> 2.8 V) caused increasing formation of gas 
bubbles, which led to inhomogeneous and poorly attached coatings. The interior of 0.25 wt% 
CNT suspension coated scaffolds (2.8 V, 20 min) was investigated under SEM. Figure 6.3 
confirmed that the scaffold was partially coated in some areas, and left almost completely 
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uncoated in other areas (Figure 6.3 (a)). From the higher magnification image (Figure 6.3 (b)), 
one can see that the coated CNTs were randomly distributed on the surface of the scaffold 
individually in some places, which can hardly be classified as a ‘coating’. This was the case 
for all investigated EPD durations, and consequently, it is concluded that the 0.25%wt CNT 
suspension concentration was too dilute to provide a homogenous CNT deposition 
throughout the 3D structure of the scaffolds. 
 
 
 
Figure 6.3 SEM images showing the interior region of a CNT-coated scaffold, obtained by EPD (2.8V, 20 
min) using a 0.25 wt% CNT suspension at (a) low magnification and (b) high magnification. 
 
On the other hand, the 0.5 wt% CNT suspension was found to provide qualitatively the best 
result, as a fairly even CNT coating of around 1.0 μm thickness (determined by SEM) was 
obtained by a 10 min EPD process, as shown in Figure 6.4. These EPD conditions also 
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enabled the open porous structure of the scaffold to be maintained (Figure 6.4 (a)). The SEM 
image of Figure 6.4 (b) shows that the surface of the 45S5 Bioglass
®
 scaffold was well coated 
with a uniform CNT film. This was the case for most of the EPD durations for the 0.5 wt% 
suspension concentration, but samples coated with 10 minute EPD duration were seen to have, 
qualitatively, the most uniform coatings. It was found that conducting EPD using 0.5 wt% 
CNT suspension for 10 min and 2.8 V created the most ideal coating in terms of uniformity in 
thickness and homogeneousness covering of the scaffold surface. The thickness of the CNT 
coating ranged from just below 1.0 µm to a maximum 1.5 μm (Figure 6.4 (c) and (d)). An 
increase in deposition time caused uneven coating thickness throughout the scaffold. TEM 
images of the CNT attached to the scaffold are shown in Figure 6.5. The images were 
obtained using finely grounded CNT-coated scaffold powders, and as one can see the CNTs 
were still well attached and entangled to the scaffold fragments. The multi-wall structure of 
the CNT can be clearly observed in Figure 6.5 (b). The optimal EPD conditions were thus 
confirmed to be with the use of 0.5 wt% CNT suspension concentration: deposition time: 10 
min and voltage: 2.8 V. This condition was then double confirmed to be the optimal one 
when considering also the bioactivity behaviour of the composite scaffold, which is discussed 
in section 6.2.5. 
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Figure 6.4 SEM images showing CNT coated scaffold, obtained by EPD (2.8V, 10 min) using a 0.5 wt% 
CNT suspension at (a) low magnification; (b) higher magnification. Images (c) and (d) are cross sessions 
of the CNT coating indicating coating thickness uniformity. The CNT coating is indicated by the arrows. 
 
c 
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Figure 6.5 TEM images showing CNTs attached to the sintered 45S5 Bioglass
®
 fragments (from a 
fractured and powdered scaffold) fabricated using 0.5 wt% CNT suspension (2.8 V, 10 min) at (a) low 
magnification and (b) high magnification. 
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6.2.2 Numerical determination of porosity after coating 
 
Having established that the 1.0 wt% CNT suspension was too thick for EPD, as CNTs 
blocked the pores of the scaffolds, and that the 0.25 wt% CNT suspension was too diluted, as 
a uniform coating could not be achieved, neither of these two CNT suspensions were 
investigated further in this part of the study (the porosity of the CNT-coated scaffolds using 
0.25 wt% CNT suspension was actually measured before they were used for mechanical 
testing, the results are not shown here, but discussed in the next section). The relative changes 
in porosity of five samples coated using 0.5 wt% CNT suspension under different EPD 
durations were calculated according to Equation 3. The initial porosities of all scaffolds prior 
to coating were also calculated according to Equation 2 and the differences in porosities 
before and after the EPD coatings were determined. The results are shown in Figure 6.6. As 
expected, the shortest EPD duration produced the lowest decrease in porosity, which is about 
1.2% less than the original scaffold porosity. However, there is no significant difference in 
the porosities of the composite scaffolds fabricated under 10 and 15 min EPD duration. In 
both cases, the scaffold porosities were reduced by about 1.5%. An EPD duration of 20 min 
produced the highest reduction in porosity; about 2% of the porosity was lost after coating. 
Therefore, EPD durations longer than 15 min were not ideal, as the scaffold porosity should 
remain at the highest possible level for effective tissue ingrowths and vascularisation [236]. 
Consequently, in terms of maintaining high porosity levels after coating, the 0.5 wt% CNT 
suspension was confirmed to perform well with EPD duration less than 15 min. 
 
 
Figure 6.6 The average porosities of the scaffolds before and after coating under different EPD durations 
using 0.5 wt% CNT suspension (n = 3). Graph represents one single experiment with 3 replicates. 
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6.2.3 Mechanical property testing of CNT-coated 45S5 Bioglass
®
 scaffolds 
 
It is reported in literature that the Young’s modulus of a CNT is of the order of 1000 GPa 
[179]. Therefore, it is generally expected that CNTs can be used effectively as additives to 
increase the strength and stiffness in composite materials [247]. Therefore, it was interesting 
to confirm in the present study if the CNT coating has enhanced the mechanical property of 
the composite scaffold. This was investigated by testing the scaffolds compressive strength. 
 
From SEM observations and porosity analysis, it was determined that the optimised EPD 
condition was: 10 min at 2.8 V using 0.5 wt% CNT suspension. For comparison purposes, 
composite scaffolds coated with 0.25 wt% CNT suspensions were also tested. The average 
compressive strength of five CNT-coated scaffold samples fabricated using the optimised 
EPD condition with the two suspensions (0.5 and 0.25 wt%) were measured and the average 
values were taken. The results are shown in Figure 6.7. The errors presented are the standard 
deviations of the mean. It was expected that scaffolds coated with the higher CNT suspension 
concentration would perform better mechanically, as a larger amount of CNTs should be 
coated onto the surface, the coated CNTs would therefore create a structurally reinforced 
scaffold and increasing amount of CNTs would lead to a higher value of compressive 
strength. However, the results show that there is no significant difference between the 
compressive strength of 0.25 wt% CNT suspension coated samples and that of the 0.5 wt% 
CNT suspension coated samples. For the 0.5 wt% CNT suspension, the average compressive 
strength was 0.4 ± 0.2 MPa, and for the 0.25 wt% CNT suspension, it was 0.5 ± 0.2 MPa. As 
presented in the last Chapter, uncoated samples exhibited a compressive strength of 0.6 ± 0.3 
MPa. This indicates that the CNT coating did not improve the scaffold compressive strength. 
This is because the CNTs are only deposited on the surface of the scaffold forming a 
superficial layer, the CNT are not embedded in the actual structure (e.g. as a rigid inclusion), 
hence they cannot act as reinforcement of the brittle foam struts.  
 
The mechanical property of porous structures is highly affected by the porosity of the 
structure [4]. As well known with increasing in porosity, the compressive strength reduces. 
The porosities of the CNT-coated scaffold samples used for mechanical property testing were 
investigated. It was found that porosities were very similar for composite scaffolds fabricated 
using both suspensions. The decrease in porosity level for the 0.5 wt% CNT suspension was 
about 1.50 ± 0.2% in average, and the decrease in porosity level for the 0.25 wt% CNT 
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suspension was about 1.44 ± 0.2% in average. A significant increase in the mechanical 
property of the composite scaffolds fabricated using the 0.5 wt% CNT suspension was not 
observed, even though they seemed to have lower in porosity. This result confirms that the 
CNT coating, although it affects the porosity of the scaffold slightly, has no effect on the 
mechanical property of the composite scaffolds. 
 
 
Figure 6.7 Comparison of the average compressive strength (MPa) of scaffolds coated with 0.25 wt% 
CNT suspension and with 0.5 wt% CNT suspension (n = 6). Graph represents one single experiment with 
6 replicates. 
 
6.2.5 Bioactivity assessment of CNT-coated 45S5 Bioglass
®
 scaffolds  
 
As mentioned in the previous Chapter, 45S5 Bioglass
®
 is highly surface reactive and can 
rapidly produce a hydroxyapatite (HA) layer that can bond to biological tissue when in 
contact with relevant biological fluids [4]. The formation of HA on the surface of 45S5 
Bioglass
®
 scaffolds after immersion in SBF is commonly used as the marker for the scaffold 
bioactivity [4, 32].  
 
After immersing CNT coated scaffolds (1 wt% and 0.5 wt% CNT suspensions) in SBF for up 
to four weeks, the influence of the presence of CNTs on HA formation was monitored using 
SEM/EDX and XRD. 1 wt% CNT suspensions coated scaffolds were included in this part of 
the study in order to investigate whether the thickness of the CNT coating could affect the 
HA formation rate. XRD was the chosen technique because powdered samples are used, 
enabling assessment of the bulk of the sample. As reported in literature [6, 75, 248], the CNT 
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mesh can induce HA formation in an ordered manner, instead of forming agglomerates. It is 
therefore hoped that the addition of a CNT coating onto the scaffolds will aid in the 
homogenous surface formation of HA by providing a nanoscale topographical template that 
helps disperse the forming HA crystals. 
 
After immersing the 0.5 wt% CNT suspension coated scaffold in SBF for 1 week. Significant 
changes occurred on the surfaces as documented in Figure 6.8 (a). The dissolution of the 
silicate network and the formation of the HA disrupt the CNT coating. It was observed that 
the CNT coating as a whole was ruptured into pieces, which are labelled in the image. After 
being in SBF for two weeks, formation of HA crystals occurred, as seen in Figure 6.8 (b). HA 
crystals have the shape of flakes and an example is indicated in the image. The present of HA 
crystal flakes was confirmed by Point EDX analysis, as shown in Figure 6.9, where elements 
such as phosphorus and calcium can be clearly detected. HA crystals are commonly needle-
liked shaped, however, in the case of CNT-coated scaffolds, the HA crystals are interspersed 
within the CNT mesh. This morphology can be clearly seen in Figure 6.8 (d) due to a higher 
magnification, in this image, we can see that the HA crystals (indicated using arrows) are 
randomly distributed in the CNT layer and some individual CNT can also be seen, as the 
CNTs and HA crystals are all tangled with each other.  
 
Figure 6.8 (d) shows that after 4 weeks of immersion in SBF, homogenously formed HA 
crystals have developed in contact with the CNT coating. Therefore, bioactivity (in the sense 
of HA formation) was promisingly observed on the 0.5 wt% CNT suspension coated 
Bioglass
®
 scaffolds. More encouraging, no large agglomerates of HA crystallites were 
observed on the surface of the CNT coated scaffolds (which are commonly seen on uncoated 
scaffolds, Figure 5.9 in Chapter 5). Thus, one can conclude that the addition of a CNT 
coating has contributed to create a homogenous nanoscale HA layer by acting as a separating 
surface-mesh or template, thus preventing HA crystallites from uncontrolled agglomeration. 
The formation of a nanoscale HA/CNT surface structure should be beneficial for cell 
attachment on these scaffolds [185, 186, 249]. 
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Figure 6.8 SEM images of 0.5wt% CNT suspension coated Bioglass
®
 scaffolds after immersion in SBF for 
(a) 1 week; (b) 2 weeks at low magnification; (c) 2 weeks at higher magnification; (d) 4 weeks showing the 
development of HA crystal formation. 
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Figure 6.9 Point EDX analysis of HA crystal on the CNT-coated scaffold that had been immersed in SBF 
for 2 week. 
 
EDX analysis was carried out to confirm the elements presented on the surface of the 
0.5 wt% CNT suspension coated Bioglass
®
 pellets before (0 h) and after immersion in SBF. 
Ideally, this part of the investigation should be carried out on Bioglass
®
 pellets, as a flat 
surface is required for EDX analysis (Chapter 5), however, good CNT coatings could not be 
produced on the planar pellet surface using EPD, so CNT-coated scaffolds were used. The 
EDX spectra of the CNT-coated scaffold samples immersed in SBF at different time point are 
shown in Figure 6.10. Three measurements were taken at different locations on the top 
134 
 
surface of the scaffolds where the flattest area could be found, and the averages of three 
atomic percentages were calculated. The results are shown in Figure 6.11. The original 
sample (0 h) shows high sodium (Na) and silicon (Si) contents, which are from the 
components of 45S5 Bioglass
®
: SiO2 and Na2O. The major difference with the results 
obtained on non-coated scaffolds (measured using pellet samples, Chapter 5) is the high 
carbon (C) content, which was from the CNT coating as one can expect. As the immersion 
period increased, after three days, the Na and Si contents decreased dramatically, almost all 
Ca was lost, and almost all Si was lost after one week. Similarity in uncoated scaffolds, Na 
and Si were replaced by phosphorus (P) and calcium (Ca), and a concentration of more than 
50% of these two elements after one week was detected. This phenomenon is evidence of HA 
formation, as HA contains a relative large amount of P and Ca. The time scale of HA 
formation found by analysing EDX data is in agreement with SEM analysis, considering that 
the deformation of the CNT coating (Figure 6.8 (a)), which could be caused by the HA 
formation, was observed at week one, in agreement with EDX data. In fact, by week 1, the 
presence of hardly any Si and Na could be detected on the surface of the scaffold, and P and 
Ca have reached a maximum level, as no significant increases were found in these two 
elements afterwards. The same trend was seen with uncoated scaffolds; therefore one can 
concluded that the CNT coating created using the 0.5 wt% CNT suspension has not slowed 
down the HA formation rate and hence it has not impaired the bioactivity of the scaffold. 
 
XRD analysis was conducted on different CNT-coated scaffolds after immersing them in 
SBF for 3 days, 1, 2, 3 and 4 weeks in order to determine possible changes in their crystalline 
phases. An uncoated scaffold, a 1 wt% CNT suspension coated scaffold and a 0.5 wt% CNT 
suspension coated scaffold were studied, the influence of the presence of CNT on HA 
formation was therefore monitored. The XRD spectra are shown in Figure 6.12. Peaks 
representing the sodium calcium silicate phase, Na6Ca3Si6O18, are marked with ‘■’. Upon 
soaking the scaffolds in SBF, HA peaks, marked with ‘●’, started appearing after one week, 
and the intensities of the Na6Ca3Si6O18 peaks in the range between 20 and 65
o
 2θ decreased. 
This decrease in peak intensity, which also leads to an amorphous ‘halo’ in the spectra, 
indicates the partial decomposition of the calcium silicate phase, as it occurs when HA starts 
to form. However, it was not until week 4 that the sodium calcium silicate peaks had 
completely disappeared, and HA occupied almost the whole scaffold structure. These initial 
results indicate that the CNT-coated 45S5 Bioglass
®
 scaffolds are still very bioactive, just as 
the uncoated scaffolds that were investigated in Chapter 5. 
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Figure 6.10 EDX spectra of the surfaces of the 0.5 wt% CNT suspension coated scaffold (a) before (0 hr) 
and after immersion in SBF for (b) 3 days, (c) 1 week, (d) 2 weeks and (e) 4 weeks. The specimens were 
coated with gold (Au) for EDX measurement. 
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Figure 6.11 EDX results of 0.5 wt% CNT suspension coated scaffold after immersion in SBF for certain 
time periods (n = 3). Graph represents one single experiment with measurements obtained from 3 
random locations on each sample. 
 
By comparing the three spectra obtained from the different scaffold samples at week 1 and 
week 4, it was observed that HA peaks appear in all the XRD spectra after 1 week of 
immersion in SBF (they are marked with ‘●’ in Figure 6.13). One can observe from 
Figure 6.13 (a) that the intensity of the HA peaks is strongest for the non-coated sample, 
while the spectrum of the 1.0 wt% CNT suspension coated sample is mainly dominated by 
the sodium calcium silicate phase (Na6Ca3Si6O18). The spectrum of the 0.5 wt% CNT 
suspension coated sample shows intermediate results. This data indicate that the bioactivity 
of the scaffolds was slowed down at the early stages of immersion in SBF by the presence of 
the CNT coating. It was also confirmed the thicker coatings obtained by the thick 1.0 wt% 
CNT suspension impair the ion exchange rate between the scaffold surface and SBF, slowing 
down the chemical conversion that promotes HA formation. More importantly, however, the 
XRD results show that, by week 4, all samples show very similar HA peak intensities in their 
XRD spectra, while the Na6Ca3Si6O18 peaks have almost completely disappeared, as seen in 
Figure 6.13 (b). This demonstrates that the thinner CNT coatings have not impaired the 
bioactivity of the scaffolds in SBF over a four-week time frame. 
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Figure 6.12 XRD spectra of CNT-coated 45S5 Bioglass
®
-based scaffolds (coated using 0.5 wt% CNT 
suspension) after immersion in SBF for 3 days,  1 week, 2 weeks, 3 weeks and 4 weeks (● = HA; ■ = 
Na6Ca3Si6O18). 
 
4 weeks 
3 weeks 
2 weeks 
1 week 
3 days 
CNT-coated, 0 h 
In
te
n
si
ty
  
139 
 
 
 
(a) 1 week 
 
 
(b) 4 weeks 
 
Figure 6.13 Comparison of XRD spectra of uncoated and CNT-coated (with 0.5 wt% and 1.0 wt% CNT 
suspensions) 45S5 Bioglass
®
-based scaffold samples that have been immersed in SBF for (a) 1 week and (b) 
4 weeks at 37°C (● = HA; ■ = Na6Ca3Si6O18). 
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In order to further investigate exactly at which time point the HA crystals started to form and 
grow; FTIR (transmission mode) was carried out on the 0.5 wt% CNT suspension coated 
scaffolds throughout a much defined time scale. A FTIR spectrum was recorded at every 24 
hours after the scaffolds have been immersed in SBF, and at week 2, 3 and 4. An overview of 
the FTIR spectra is shown in Figure 6.14 where the analysis of characteristic peaks is 
illustrated based on data from the literature [35, 90, 114, 238-241].  
 
Similar to uncoated scaffolds, the CNT coated scaffold (0 h) exhibits the two Si-O-Si 
stretching bands at 950 and 1050 cm
-1
 as well as Si-O-Si bending bands at 450, 530, 576 and 
620 cm
-1
 [90, 239]. However, after having been immersed in SBF for only 1 day, both Si-O-
Si bending and stretching bands started to disappear, a single Si-O-Si bending peak at 450 
cm
-1
 was observed. This indicates the loss of soluble SiO2, which is the second stage of HA 
formation (See Chapter 5, section 5.2.4 for more details) as the silica network breaks up 
leading to supersaturation of silanol groups (Si-OH) at the glass solution interface [241]. 
Moreover, new bands at 575 and 620 cm
-1
, which represents the Ca-P [240] and Si-O-Si 
symmetrical vibration bands at 800 cm
-1
 [90], start to appear at day 1. The Si-O-Si 
symmetrical vibration band is associated with the third stage of HA formation and the Ca-P 
bands are associated with the fourth stage of HA formation (See Chapter 5, section 5.2.4 for 
more details). This observation from day 1 FTIR spectrum indicates that all four stages took 
placed within the first 24 hours of immersion. A similar spectrum was obtained at day 4 with 
uncoated scaffolds, which means that HA formation took place much earlier on the CNT-
coated scaffold than on the uncoated scaffolds. However, no HA crystalline structure was 
detected using XRD at day 3, which means that there were chemical reactions that promoted 
HA formation taking place within the first 24 hours of immersion in SBF. The formation of 
new chemical bonds thus occurred in the first 24 hours, but the crystal structure did not 
develop till later. At day 2, The Si-O-Si stretching bands at 950 and 1050 cm
-1
 had almost 
disappeared, they were replaced by a P-O stretching band at about 1030 cm
-1
. At day 3, the 
growth of a C-O bending band at 870 cm
-1
 and C-O stretching bands at 1410 and 1500 cm
-1
 
are detected. The C-O bands are attributed to CO3
2-
, which is proof of hydroxy carbonate 
apatite phase growing. By day 4, the P-O bending bands at 564 to 600 cm
-1
 are very 
pronounced, which indicates that the ‘semi-crystalline’ HA layer was growing into an 
increasingly crystallised structure. The FTIR results are in agreement with the XRD results, 
as no HA crystalline phase was detected using XRD until day 7 of immersion in SBF. Both 
the initial reactions that promoted HA formation and the actual semi-crystalline HA growth 
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occurred about 2 to 3 days earlier on the CNT-coated scaffolds than the uncoated scaffolds, 
although the extent of HA crystallinity seems less compared to the uncoated scaffold at week 
1 of SBF immersion, according to the relative peak intensities observed in XRD spectra 
(Figure 6.13 (a)). This phenomenon was clearly influenced by the presence of the CNT 
coating. The CNT coating has introduced many nano-sized features that were not presented 
on the uncoated scaffold surface. These features acted as nucleation sites for facilitating HA 
crystal growth, as discussed in the literature [250].  
 
From one week SBF immersion onwards, the Si-O-Si bending band at 450 cm
-1
 and Si-O-Si 
symmetrical vibration band at 800 cm
-1
 became smaller, and the P-O stretching and bending 
bands at 564 to 600  and 1030 cm
-1
 became sharper and more pronounced. This indicates that 
the breaking down of the remaining silicon network and the formation of HA crystal layer 
were continuously taking place as the immersion time in SBF increased. The same 
observation was reported for uncoated scaffolds (Chapter 5, section 5.2.4). 
 
The SEM/EDX and XRD analyses provide the evidence that HA can successfully form on 
CNT-coated 45S5 Bioglass
®
 scaffolds in SBF just as well as on uncoated 45S5 Bioglass
®
, the 
CNT coating did not prevent the HA formation. In fact, HA was confirmed to grow at a faster 
rate in the case of optimised CNT-coating, as proven by the FTIR results. By combining the 
results from all techniques employed, it can be confirmed that the optimal CNT coating on 
around 10 x 10 x 10 mm
3
 45S5 Bioglasss
®
 scaffolds can be fabricated using the 0.5 wt% 
CNT suspension under the EPD condition of 20 mm electrode distance at 2.8 V for 10 min. 
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Figure 6.14 FTIR spectra for the 0.5 wt% CNT suspension coated 45S5 Bioglass
®
-based scaffolds before 
and after immersing the SBF for different periods of time. 
 
6.2.6 Removing the surfactants from CNT coating 
 
Surfactants are commonly used to stabilise CNTs in the aqueous media and hence produce 
homogenous dispersed suspensions to be used in EPD [192]. Many surfactants have been 
investigated in the literature, for example, cetyltrimethyl ammonium bromide [251], 
polyacrylic acid [251], C16EO [251] and Triton X-100 [6]. Sodium dodecyl sulphate 
(C12H25SO4Na, SDS), its chemical structure is shown in Figure 6.15, is one of the most 
commonly used surfactant to disperse CNTs in an aqueous solution [252]. Although the 
surfactant used in the as-received CNT suspension was unknown (proprietary information not 
disclosed by the manufacturer), EDX technique confirmed the presence of sulphur (S) and 
sodium (Na) in a dried CNT coating. This experiment was conducted on a dried CNT coating 
on stainless steel (used as the electrodes in the EPD process). The EDX spectrum is shown in 
Figure 6.16. 
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It has been reported that the inherent properties and conductivity of CNTs can be affected by 
the presence of surfactants [76]. SDS is a very hydrophilic surfactant; it can be removed by 
simply immersing the coated material in water for a given period of time. In order to 
investigate this matter, stainless steels foils (10 x 20 mm
2
) that were electrophoretically 
coated with CNTs under the optimised condition as for the scaffold (20 mm electrode 
distance, 2.8V for 10 min in 0.5 wt% CNT suspension) were immersed in 30 ml of distilled 
water in centrifuge tubes, and the water was refreshed every three days. One CNT-coated 
steel piece was removed from the water at each time point, and gently washed with fresh 
distilled water and left to dry in normal atmosphere at room temperature. EDX was then 
carried out on three random locations on the dried CNT coating to identify the remaining 
sulphur and sodium contents in terms of atomic weight percentage. The loss of sulphur and 
sodium in the spectrum indicate the effective removal of the surfactants. The results are 
shown in Figure 6.17. From Figure 6.17, it can be concluded that the sodium ions (in blue) 
were dissolved into the aqueous medium very quickly; the concentration dropped from 0.7% 
to less than 0.1% within 24 hours, and continuously decreased over time. The sulphur on the 
other hand has a much slower dissolution rate. This is because the hydrophobic component of 
SDS molecule (the carbon chain) attached to the sidewalls of CNTs via van der Waals forces 
[253, 254], and above the critical micellar concentration, SDS forms a supramolecular 
structure on the surface of the CNTs through a self-assembly process incorporating the 
rolled-up half-cylinders [255]. Therefore it was more difficult to remove the rest of the SDS 
molecule, which the sulphur was attached to, than the sodium ions. Overall, after a longer 
time period, small amount of surfactants can be completely removed from the CNT coating, 
as the sulphur content has been reduced by about 0.2 at.% after 4 weeks of immersion time. 
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Figure 6.15 The chemical structure of the surfactant: sodium dodecyl sulphate. 
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Figure 6.16 EDX spectrum of a dried CNT film showing the presence of sodium and sulphur. 
 
 
 
Figure 6.17 The decrease in sulphur and sodium contents in terms of atomic percentage (at.%) in a CNT 
coating after immersion in distilled water for a period of time (n = 3). Graph represents one single 
experiment with 3 replicates. 
 
6.2.7 Conductivity measurement of CNT-coated 45S5 Bioglass
®
 scaffolds 
 
The electrical resistance of CNT-coated scaffolds was measured using a multimeter. The 
scaffold was connected to the multimeter by a spring loaded device. Only the 0.5 wt% CNT 
suspension coated scaffold was measured since this scaffold type exhibited the optimised 
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CNT structure, as discussed above. The average of 20 readings (measured on different 
locations of the outer walls of the scaffold) yield a value of 10,375 Ω for the resistivity, 
which is notably lower than the value of the uncoated scaffold, which could not be measured 
due to its extremely high value (Bioglass
®
 being an insulator), exceeding the range of 
measurement of the instrument used. 
 
The electrical resistance of CNT-coated scaffolds after being immersed in SBF was also 
investigated, the same method was conducted, and the results are presented in Figure 6.18. 
One can observe that as the immersion time in SBF increased, the electrical resistance 
decreased, which means the CNT-coated scaffold has a better electrical conductivity after 
being immersed in SBF over a period of time. This could be due to the removal of the 
surfactant from the coating, as mentioned before, which may have affected the conductivity 
of the CNTs. The lower the surfactant content, the more electrical conductive the CNT 
coating is. 
 
It was reported in the literature [256] that the formation of HA could reduce the electrical 
conductivity of the CNT containing Bioglass
®
/polymer composite film, considering that HA 
(being a ceramic) provides an insulating barrier for the electrical current flow, as this layer of 
HA is grown over the surface of the composite sample. The electrical resistance was 
measured by the two probe dc I–V measurement method [233]. Sharpened gold probes were 
brought in contact to the surface of the films with a probe separation distance of 5.0 mm. 
Therefore, after the samples were immersed in SBF for 4 weeks, the probes were not actually 
in direct contact with the composite film but only the HA layer formed on the surface, where 
a low amount of CNTs was present, hence a reduction in electrical conductivity was observed. 
However, in the present study, the CNT coatings were created on the surface of the scaffolds, 
therefore even after HA crystals have formed, they were mixed within the CNT coating 
(Figure 5.11 (d)), and a continuous CNT coating has still remained to provide electrical 
conductivity. Therefore, the phenomenon of HA formation decreasing dramatically the 
electrical conductivity that was reported in the previous study was not observed in the present 
investigation, on the contrary, an increase in electrical conductivity due to the removal of 
surfactant was recorded. 
 
The incorporation of CNT to develop conductive scaffolds may aid in directing cell growth, 
as frequently shown in literature [257-259]. For instance, in the case of bone regeneration and 
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fracture healing the use of an electric field is based on the observation that, when bone is 
subjected to mechanical stresses, deformation of bone is normally accompanied by an 
electrical signal bearing the strain characteristics [258]. Therefore, an electrically conductive 
scaffold, e.g. incorporating carbon nanotubes, can potentially be used for stimulating cell 
growth and bone tissue regeneration by facilitating the physioelectrical signal transfer [259].  
 
 
Figure 6.18 The electric resistance of CNT-coated scaffolds before and after immersing in SBF for given 
time periods (n = 10). Graph represents one single experiment with measurements obtained from 10 
random locations on the samples. 
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6.3 Conclusion 
 
A uniform, multi-walled CNT coating can be achieved throughout the 3D 45S5 Bioglass
®
-
based glass–ceramic scaffolds by electrophoretic deposition. A thickness of up to ~1 µm of 
the CNT coating was obtained on 10 x 10 x 10 mm
3
 scaffolds, using a commercially 
available CNT suspension and EPD at 2.8 V for 10 min. The scaffold mechanical strength 
and bioactivity were not impaired by the presence of CNT. The addition of CNT imparted 
electrical conductivity to the otherwise insulating 3D scaffolds. As surfactants were removed 
from the CNT coating upon immersion the CNT-coated scaffolds in SBF, the electrical 
conductivity increased. CNT-coated scaffolds are promising model systems to test the 
interaction of cells with nanofibrous 3D bioactive substrates and to investigate the effect of 
electrical conduction in bioactive glass based 3D matrices on cellular behaviour for bone 
tissue engineering. 
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Chapter 7 P(3HB) microspheres: introducing drug delivery 
capability in 45S5 Bioglass
®
 scaffolds 
 
7.1 Introduction 
 
One of the major problems or complications associated with the use of implants or scaffolds 
for bone treatment is the occurrence of infections. The aim of the work presented in this 
Chapter is to fabricate a composite scaffold system that incorporates drug (antibiotic) 
delivery capability to prevent infections. 
 
Polymeric drug delivery systems in the form of microspheres are being developed to enable 
controlled release of drugs and to permit the released antibiotic to reach therapeutic 
concentrations intracellularly. P(3HB) is one of the popular polymers considered for 
applications in drug delivery systems. For example, Korsatko and Abnegg [260] showed the 
in vitro and in vivo release of 7-hydroxyethyltheophylline from compressed pellets of the 
drug and P(3HB). The release of the drug in vitro was dependent on the drug loading, as 
expected. Bissery et al. [261] fabricated P(3HB) and PLA microspheres using the solvent 
evaporation (emulsion deposition) technique containing an anticancer agent, lomustine. 
 
It has been reported that a combination of structural scaffolds made by rigid bioactive glasses 
or ceramics and biopolymer coatings can be conveniently used to add a drug delivery 
function to the scaffold [262]. In this strategy, the drug is encapsulated in the polymer phase, 
which uniformly coats the 3-D bioactive glass or ceramic scaffold. The goal is to deliver the 
drug at a controlled rate, which is related to the degradation rate of the polymer, while the 
rigid inorganic scaffold maintains the structural integrity of the construct. 
 
In the present investigation, novel scaffolds based on 45S5 Bioglass
®
 foams combined with 
P(3HB) microspheres (PMSs) as drug carriers have been developed for bone tissue 
engineering. Tetracycline (TTC) has good bacteriostatic power (effective against gram-
positive and gram-negative microorganisms) [263] and therefore this drug was selected as the 
model drug for this study for its well-known broad-spectrum antibiotic and anti-collagenase 
activities in addition to bone resorption and anti-inflammatory action. This antibiotic can be 
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used in drug delivery systems to enhance bone ingrowth and regeneration in the treatment of 
bone defects [264]. 
 
A complete investigation of the processing methods, including the fabrications of PMS, TTC 
encapsulated PMS (TTCMS) and microsphere-coated composite scaffolds are presented in 
this Chapter. The results of microstructure characterization, scaffold mechanical property, 
surface roughness, analysis of bioactivity and drug delivery capability are also presented and 
discussed here, followed by the conclusions. 
 
7.2 Results and discussion 
 
7.2.1 Fabrication and characterisation of PMS  
 
PMSs (with and without tetracycline addition) were fabricated by a solid-in-oil-in-water 
emulsion technique as described in detail below and schematically shown in Figure 7.1. The 
particle size of a PMS used as drug vehicle is a very important parameter as it directly affects 
the physical stability and drug release kinetics. Thus, in this study, the emphasis was on 
producing uniform-sized small PMSs that are ideal for coating purpose by varying a number 
of parameters, such as the PVA concentration, polymer concentration and agitation speed. 
Therefore, several conditions and P(3HB) mixtures were tested, which are listed in Table 7.1, 
and different agitation speeds, 1000 rpm, 500 rpm and 200 rpm were investigated using the 
recipe named Std. in Table 7.1.  
 
 
 
Figure 7.1 Schematic representation of the solid-in-oil-in-water (s/o/w) PMS preparation method [265]. 
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Table 7.1 Different recipes used for optimising the size of the PMSs. 
Mixture No. Amount of P(3HB) (g) 
CHCl3 
(ml) 
1st 
PVA w/v% 
2nd 
PVA w/v% 
1 1 8 1 0.5 
2 (Std.) 2 8 1 0.5 
3 3 8 1 0.5 
4 1 8 0.5 0.05 
5 2 8 0.5 0.05 
6 3 8 0.5 0.05 
 
In this study, it was observed that at a higher P(3HB) concentration (3g in 8ml of CHCl3), the 
solution became much thicker and more viscous, thereby reducing the propensity of the 
spheres to break into smaller spheres. However, at higher concentrations of PVA (1.0% w/v 
for the first PVA solution and 0.5% w/v for the second PVA solution), PVA molecules tend 
to form aggregates on their own, producing stable and uniform emulsions which lead to the 
formation of smaller sized P(3HB) spheres. Agitation speed has great influence on the 
particle sizes of the PMSs. Larger PMSs were produced with the slowest agitation speed; 
their SEM image is shown in Figure 7.2 (c). These PMSs were useful to conduct surface 
analysis. As expected, it was observed under SEM that there are many micro-pores present on 
the surface of these PMSs (Figure 7.2 (d)), therefore it is suggested that the same situation 
occurs with the smaller PMSs produced, only the pores were much smaller (in a nanoscale 
range). The pores represent the sites for drug encapsulation. 
 
After examining all three processing parameters, i.e. stirrer speed, polymer concentration and 
PVA concentration, an ideal uniform average particle size in the range 1.5–2.0 µm was 
achieved. That combination of processing parameters was set as the standard method of PMS 
fabrication (Table 7.1 Std.) throughout this project. These PMSs mentioned in this work from 
this point onwards, are produced using the standard method, expect for the ones that are 
specially described. 
 
The bulk shape and microstructure of the PMSs produced using the Std. method, as observed 
by SEM, are shown in Figure 7.2 (a). The image shows the almost perfect spherical PMSs 
with a fairly uniform surface morphology. The particle size distribution curve in Figure 7.2 (b) 
shows that 50% of the measured particles had a mean particle size ranging from 1.5 to 2.0 µm 
whereas 90% of the PMSs had diameters below 5 µm. The density of the PMS powder 
calculated using Equation 9 was 1.23 g/cm
3
, and the porosity calculated using Equation 8 was 
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34%. The surface area of the PMSs measured by Quantachrome Autosorb
®
 Automated Gas 
Sorption System was 3.55 m
2
/g. The internal microstructure of the PMSs examined using 
TEM is shown in Figure 7.3. An individual PMS was selected and cut to the desired thickness. 
Figure 7.3 (a) shows the cross-section of a typical PMS inside the FIB instrument. TEM 
images of the cross-section of the PMS (Figure 7.3 (b)) indicate that there are many 
nanosized pores inside the PMS, and some of them are connected to the outside of the PMS 
too, the same situation was observed with the larger PMSs from outside the particle using 
SEM (Figure 7.2 (c) and (d)). The pore sizes of the Std. PMSs are in the range of 5 to 20 nm. 
Crystalline structures are shown as the dark areas in the images. From the XRD diffraction 
pattern of an area of crystalline structure, it can be confirmed that the polymer is well 
crystallized, with the crystals randomly oriented. 
 
 
   
 
Figure 7.2 (a) SEM image of the small size PMSs produced; (b) Particle size distribution of the PMSs in 
water; (c) SEM image of the larger size P(3HB) spheres; (d) high magnification of the large P(3HB) 
spheres showing the rough topography of the surface, and the present of the micro-pores. 
 
d c 
Pore 
Am- 
ount 
of 
parti-
cles 
(%) 
153 
 
 
Figure 7.3 (a) Focused ion beam images showing the cross-section of a PMS; (b) TEM image of a cross-
section of a PMS. Arrows indicating the presence of nanopores within the PMS; (c) Randomly oriented 
crystalline structure of P(3HB). 
 
7.2.2 PMS coating optimisation  
 
The first goal in the task of fabricating the PMS-coating on the scaffold was to achieve a 
homogenous and structurally robust coating throughout the three-dimensional structure of the 
scaffold. Slurry-dipping method was selected, as it is a low-cost and efficient method to 
achieve coating composite. 
 
Several methods and conditions for preparing the PMS slurry which would be used to coat 
scaffolds are shown in Table 7.2. The particle size distribution of all prepared slurries was 
measured in order to check whether the PMSs were well dispersed in the respective 
suspensions. 
 
Although agitation method could be used to obtain a well dispersed PMS suspension, 
confirmed by the particle size distribution result, it was found that using an ultrasonic bath 
(sonication method) was a more efficient method that could be used to achieve the same 
result. No difference was found in the particle size distribution curves between the 
suspensions that were prepared using 5 min and 10 min ultrasonic times. However, it is 
suggested that the higher the PMS concentration, the longer the dispersion time in the 
ultrasonic bath should be, in order to obtain the best dispersion result. Figure 7.4 (a) and (b) 
show that there is no benefit in the quality of the coating achieved with the suspension that 
was left in the ultrasonic bath for longer than 5 min. Moreover, no advantage was found when 
using 3 wt% rather than 1 wt% of PMSs in suspension, as shown in Figure 7.4 (c). 
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Table 7.2 Different conditions for coating the 45S5 Bioglass
®
 scaffold with PMSs. In/out means dipping 
the scaffold into the slurry and taking it out straight away. 
Preparation method Agitation 
In ultrasonic bath 
(sonication) 
Time of preparation 3 hours 5 min 10 min 
Particle size distribution 1.5 µm 1.5 µm 1.5 µm 
Suspension 
Concentration 
3 wt% 1 & 3 wt% 1 wt% 
Dipping time 
in/out in/out in/out 
-- 2 min -- 
-- 5 min 5 min 
-- 10 min -- 
 
   
Figure 7.4 SEM images of PMS coatings on 45S5 Bioglass
®
 scaffolds produced using slurry-dipping 
method. (a) 1wt% PMS suspension sonicated for 5 min; (b) 1 wt% PMS suspension sonicated for 10 min; 
(c) 3 wt% PMS suspension sonicated for 5 min. 
 
The effect of dipping time can be assessed by observing the SEM images presented in 
Figure 7.5.  It was found that the optimal dipping time is 5 min, as the SEM images in 
Figure 7.5 (c) confirm. It is observed that a smooth and thick (4.5 – 16 μm) PMS coating 
could be achieved on the surface of the scaffold. The coatings obtained with less than 5 min 
(Figure 7.5 (a) and (b) dipping-time were quite homogeneous too, but not as even as the 5 
min one (Figure 7.5 (c)), and there is no extra benefit, at least by the qualitative examination 
by SEM, when increasing dipping-time to more than 5 min, for example, 10 min 
(Figure 7.5 (d)). 
 
Besides using the slurry-dipping technique to coat the scaffolds, these were also immersed in 
the final PVA emulsion during PMS production and it was expected that the scaffolds would 
be well coated with the PMSs after evaporation of the emulsion. Different conditions of this 
set of experiments are shown in Table 7.3, and the SEM images of resulting scaffolds are 
presented in Figure 7.6. The adding and stirring speeds were kept the same for all conditions 
when fabricating the PMSs and the resulting spheres were all of size in a very narrow size 
distribution. This indicated that the size of the PMSs is independent from the P(3HB) 
a b c 
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concentration in chloroform and from the concentration of the aqueous PVA solutions. It was 
found that not only a homogenous coating could not be achieved, but also etching of the 
Bioglass
®
 surface was observed. The SEM images in Figure 7.6 show that without 
preliminary ultrasonic bath dispersion, the PMSs were agglomerated together on the surfaces 
of the scaffolds. This behaviour was seen for all the different conditions shown in Table 7.3 
and it was caused by the PVA residuals that contributed to join the PMSs together and the 
existence of attractive van der Waals forces between the PMSs as well. Etching on the 
scaffold surface occurred during the drying period of PVA emulsions, in which the scaffolds 
were immersed. Scaffold samples were left in the chloroform and PVA solution mixture 
without the addition of P(3HB) for 12 and 24 hours and Figure 7.6 (d) and (e) illustrate the 
microstructural evolution of the scaffold strut surfaces at these two different times, 
respectively. The images show that the longer the scaffold was immersed in the mixture, the 
more pronounced was the etching, and micro-size features, such as pores and cracks, start 
appearing on the surface. 
 
    
    
Figure 7.5 SEM images showing PMS coating on Bioglass
®
 scaffold. The same suspension was used for 
preparing these samples (1 wt% PMS concentration, 5 min in the ultrasonic bath). (a) in/out; (b) 2 min 
dipping-time; (c) 5 min dipping-time and (d) 10 min dipping-time. 
 
 
a 
c 
b 
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Table 7.3 Six different conditions investigated to fabricate PMS-coating on Bioglass
®
 scaffolds by 
immersing scaffolds in PVA emulsion. 
 Unit Quantities 
Condition  1 2 3 4 5 6 
P(3HB) g 0.1 0.2 0.3 0.1 0.2 0.3 
CHCl3 ml 0.8 0.8 0.8 0.8 0.8 0.8 
1 wt% PVA solution ml 4.0 4.0 4.0 - - - 
0.5 wt% PVA solution ml - - - 4.0 4.0 4.0 
0.1 wt% PVA solution ml 50.0 50.0 50.0 - - - 
0.05 wt% PVA solution ml - - - 50.0 50.0 50.0 
 
   
 
   
Figure 7.6 (a) – (c) SEM images of the resulting coating from condition 1 - 3 in Table 7.3 respectively; (d) 
& (e) Bioglass
®
 scaffolds immersed in chloroform and PVA solution mixture for 12h and 24h, respectively. 
 
After investigating different coating techniques, slurry-dipping method using 1.0 wt% PMS 
slurry that was prepared using an ultrasonic bath (5 min PMS dispersion time and 5 min 
scaffold dipping time) was set to be the standard protocol to fabricate PMS-coated scaffold 
composites in this project. 
 
7.2.3 Mechanical property testing of PMS-coated 45S5 Bioglass
®
 scaffold 
 
The mechanical properties of PMS-coated and uncoated 45S5 Bioglass
®
 scaffolds were 
investigated by the compressive strength test in order to determine the effect of PMS coating 
on the mechanical strength of the scaffolds. The same batch of scaffold was used in this study, 
five replicates of each sample type were measured and the averages of compressive strength 
a b c 
d e 
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were taken.  As expected, the coating decreased the overall porosity of the scaffolds to some 
extent. After coating, the pore structure of the composite scaffold changed slightly with a 
partial reduction in pore diameter (300–400 µm) when compared to the pore structure 
(diameter of 400–600 µm) of the uncoated scaffold. The porosity of the PMS-coated 
scaffolds was calculated using Equation 3, it was found that the porosity of PMS-coated 
scaffold reduced from the original 90% to 70%, as a result of which the compressive strength 
of the coated samples increased. Typical stress vs. strain plots of both samples are shown in 
Figure 7.7. The mean compressive strength of five PMS-coated scaffolds was determined to 
be ~0.15 MPa, which is about double the value obtained from uncoated samples. 
 
Both scaffolds (coated and uncoated) exhibited a typical failure mode for brittle foams, i.e. 
catastrophic failure after maximum stress and densification stages have been reached [4]. As 
expected, the coated scaffold with lower porosity showed a higher maximum strength 
(0.27 MPa) than the uncoated scaffold (0.11 MPa) (Figure 7.7). It should be pointed out that 
shearing could occur during the compression strength test, mainly caused by the edge effects 
imposed on the specimen during the test. If the faces of the sample are not aligned well with 
the loading platen, large stress concentrations can occur, causing local buckling, which in 
turn can lead to shearing, and thus underestimation of both Young’s modulus and 
compression strength could occur [4]. Bretcanu et al. [5] fabricated similar 45S5 Bioglass
®
 
scaffolds with 60 ppi PU foams and sintering at 1100
o
C for 1 h. The compressive strength of 
those samples was on average 0.22 MPa, similar to Chen et al.’s results [4]. When similar 
scaffolds were coated with polymer by dipping them in a P(3HB) polymer solution, it was 
observed that the compressive strengths of coated samples were significantly higher than 
those of the uncoated scaffolds, with values of 0.60 MPa for 45 ppi samples and 1.50 MPa for 
60 ppi samples [5]. This behaviour can be explained considering that the polymer coating 
acts as a ductile bridge holding the glass particles together as the foam struts start to break 
during the test [5, 68, 266]. Incorporation of a polymer coating thus introduces a toughening 
effect, as discussed in the literature [68, 266]. In the present work, however, the PMS coating 
cannot provide such support as a toughening element, since these are individual spheres 
instead of a continuous polymer layer coating and infiltrating the foam struts. Moreover, the 
sphere–sphere interaction is weak, meaning that the spheres cannot act as a structural support 
during the fracture of foam struts. Nevertheless, a significant increase in the average 
compression strength was determined (0.27 vs. 0.11 MPa for coated and uncoated scaffolds, 
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respectively), which is related to the reduction of porosity induced by the presence of the 
PMSs, as mentioned above. 
 
 
Figure 7.7 Mechanical properties of 45S5 Bioglass
®
-based scaffolds. Stress–strain curves of the scaffolds 
(a) with and (b) without PMS coatings. 
 
7.2.4  PMS coating adhesion assessment 
 
These are two possible reasons that may explain how PMSs are able to attach to the surface 
of the scaffold. One is the residual PVA on the surface of PMSs after the fabrication process; 
the PVA acts as glue enabling the PMSs to ‘stick’ to the surface. Another reason is the 
electrostatic effect. It was found that between pH 3 and 10, the zeta-potentials values of 
Bioglass
®
 powder and PMS are opposite when they were dispersed in water, results are 
illustrated in Figure 7.8. Therefore, PMS and Bioglass
®
 have different surface charge during 
the slurry-dipping procedure, hence the PMSs are attracted onto the Bioglass
®
 surface and a 
coating of microspheres is formed during the composite fabrication process. 
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In order to determine how strong the PMS coating is adhered to the glass–ceramic surface, a 
Bioglass
®
-derived glass–ceramic pellet was used (applying the same heat-treatment condition 
used to fabricate the scaffolds) and coated with PMSs (using the same coating condition as 
for the scaffolds). The coated pellet was dried overnight at room temperature. It was then 
gently washed with 30 ml of distilled water using a pipette. The weight of the pellet was 
recorded before and after washing. From SEM images of pellet surfaces (Figure 7.9 (a) and 
(b)) and the weights recorded, it was confirmed that only a few PMSs were detached 
following this treatment. The weight of the coated pellet remained constant considering the 
precision of the balance used (0.001 g). This result indicates, qualitatively, the satisfactory 
adhesion of the PMSs to the glass–ceramic surface, in relation to the further manipulation of 
the scaffold, e.g. for cell seeding and implantation. Anticipating that Bioglass
®
-based 
scaffolds form HA layers on their surface in contact with SBF [4], in order to fully 
investigate the adhesion of the PMS coating, a coated scaffold was immersed in water 
(refreshed every 3 days) for 28 days. Possible PMS detachment from the surface was 
assessed by SEM. From the SEM image shown in Figure 7.9 (c), it is observed that, although 
the coverage of the surface was slightly reduced, a large amount of PMSs still remained 
adhered to the substrate. In fact, depending on the particular application, it is possible that the 
drug release (from PMSs) would be completed by day 28 in vivo; therefore the complete 
attachment of PMSs for long time periods might not be required. 
 
 
 
Figure 7.8 Zeta-potential values of the optimised PMSs and Bioglass
®
 powders in water. 
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Figure 7.9 SEM images of PMS-coated Bioglass
®
 pellets (a) before and (b) after washing with water using 
a pipette. (c) SEM image of a PMS-coated scaffold after being in water for 28 days showing the high level 
of adhesion of the PMSs to the glass-ceramic surface. 
 
7.2.5 Bioactivity study of microsphere-coated Bioglass
®
 scaffolds and 
pellets 
 
Although 45S5 Bioglass
®
 is well known for its high bioactivity, it was important to study 
here the effect of the presence of biodegradable polymer microspheres on the bioactivity of 
the Bioglass
®
-based glass-ceramic scaffolds. The bioactivity of the composite scaffolds was 
assessed by measuring HA formation on the scaffolds’ surface upon their immersion in SBF. 
The results of the SEM investigation carried out on scaffolds after immersion in SBF are 
presented in Figure 7.10. Figure 7.10 (a) shows no formation of HA on a scaffold immersed 
for 24 h in SBF. However, HA was seen to form by day 3, when a needle-like crystalline 
structure appeared on the surface of the scaffold, as illustrated in Figure 7.10 (b) and (c). By 
day 7 (Figure 7.10 (d)), the surface of the scaffold was almost fully covered by HA crystals 
(indicated by the arrow in the image). 
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Figure 7.10 SEM images of PMS-coated Bioglass
®
-based glass-ceramic scaffolds immersed in SBF after (a) 
24 h; (b) 3 days; (c) 7 days; (d) 7 days; (e) 2 weeks; and (f) 3 weeks; PMS-coated Bioglass
®
 pellets 
immersed in SBF after (g) 5 days; (h) 7 days; (i) 7 days and (j) plain Bioglass
®
 pellets immersed in SBF 
after 7 days. 
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Figure 7.11 EDX spectrum (b) of a PMS that was embedded under the HA layer after the scaffold was 
immersed in SBF for 4 weeks. Location of the microsphere (marked as Spectrum 2) is shown in (a). 
 
 
Figure 7.12 XRD spectrum of PMSs. The sharp peaks in the spectrum indicate that the polymer is 
crystallised. 
 
To further investigate HA formation on scaffold surfaces after immersion in SBF, XRD 
analysis was conducted on the composite scaffolds after immersion in SBF for 1 day, 3 days, 
7 days, 2 weeks and 4 weeks. PMSs on their own were also characterized by XRD, since the 
polymer was partially crystallised, its characteristic diffraction pattern was obtained. The 
XRD spectrum of PMS is illustrated in Figure 7.12. XRD spectra of the SBF-immersed PMS- 
and TTCMS-coated scaffolds are shown in Figure 7.13 and Figure 7.14, respectively. All 
scaffolds exhibit XRD patterns characteristic of a glass-ceramic structure, which has been 
discussed in detail in Chapter 5, section 5.2.5. Although a characteristic diffraction pattern 
was obtained on the PMSs (Figure 7.12), due to the relatively small quantity of the PMSs 
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present on the coated scaffolds, the intensity of their diffraction pattern was too low and the 
pattern could not be distinguished from the spectrum of the sintered Bioglass
®
-based glass-
ceramic scaffold, which is dominated by the sodium calcium silicate phase, Na6Ca3Si6O18. 
However by week 4, most of the sodium calcium silicate phase has been converted into HA, 
which exhibits low peak intensity in XRD spectra. The PMS peaks are actually observed in 
the week 4 spectra of both PMS- and TTCMS-coated scaffolds. No significant difference was 
observed between the spectra of PMS- and TTCMS-coated scaffolds, which indicates that the 
low concentration of drug that was encapsulated in the microspheres (see section 7.2.7 for 
more details) has no effect on the formation of HA. 
 
 
Figure 7.13 XRD patterns of PMS-coated 45S5 Bioglass
®
-based glass-ceramic scaffolds after immersion in 
SBF for 24h, 3 days, 7 days, 2 weeks, 3 weeks, 4 weeks, PMSs only and non-coated Bioglass
®
 scaffold. (● = 
HA; ■ = Na6Ca3Si6O18; ♦ = P(3HB)) 
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Figure 7.14 XRD patterns of TTCMS-coated 45S5 Bioglass
®
-based glass-ceramic scaffolds after 
immersion in SBF for 24h, 3 days, 7 days, 2 weeks, 3 weeks, 4 weeks, PMSs only and non-coated Bioglass
®
 
scaffold. (● = HA; ■ = Na6Ca3Si6O18; ♦ = P(3HB)) 
 
In the present study, the presence of prominent XRD peaks corresponding to HA crystals was 
confirmed on the spectra taken from the surface of scaffolds coated with PMSs after 7 days of 
immersion in SBF (Figure 7.13). The same observation was recorded with uncoated scaffolds 
as shown in Chapter 5. The surface morphology of the scaffolds changed after 7 days of 
immersion in SBF, with a layer of HA particles of average thickness 2–5 µm fully covering 
the PMSs on the scaffold surface, as seen in Figure 7.10 (j). This fast growth rate of HA in 
SBF is due to the fact that, even though the scaffolds were coated with PMSs, there was still 
sufficient bioactive glass–ceramic surface in direct contact with the fluid to facilitate the ion-
exchange process between the partially crystallized Bioglass
®
 and the SBF, leading to HA 
formation, as discussed in the literature [5]. Moreover, during the process of HA formation, 
some PMSs could have detached as a consequence of the HA crystals growing on the surface 
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of the scaffold, as seen in Figure 7.10 (c). This effect would expose more surface of the 
scaffold to the SBF, therefore enhancing the HA formation rate. From the images in Figure 
7.10 (e), (g) and (h), it is possible to observe that HA crystals have grown around the PMSs, 
as indicated by arrows. This observation provides good evidence to conclude that most PMSs 
were eventually embedded underneath a relatively thick HA layer (Figure 7.10 (f)). As shown 
in Figure 7.10 (f), a crack (formed when the scaffold was drying after being extracted from 
the SBF solution) reveals that many PMSs are embedded in the HA layer, a PMS is pointed 
out by an arrow in the image. The formation of micro-cracks on both the scaffold and dense 
pellet surfaces is not related to a disadvantage of the dip-coating method. The observed 
surface cracks are caused by shrinkage of the surface layer upon drying after scaffolds (or 
pellets) have been taken out of the SBF solution. This is a common feature in this type of 
bioactive scaffolds [5]. EDX was conducted in order to confirm that the spherical particles 
under the HA layer were in fact PMSs. The EDX spectrum of one of these particles is shown 
in Figure 7.11. As one can observe, there is a large amount of carbon present, gold element 
(Au) comes from the coating, and it is impossible to eliminate the presence of calcium as 
PMSs are surrounded by the HA structure, which is rich in calcium.   
 
It should be noted that, due to the uneven surface of the scaffolds, it is very difficult to 
produce a PMS coating that fully covers the entire surface. SEM observations confirmed that 
some sharp edges of the scaffold had remained uncovered by the PMSs, thus providing 
sufficient bioactive surface to facilitate ion exchange and induce HA formation instead of 
preventing it. Hence, even if 100% coverage of the scaffold surface by PMSs could not be 
achieved, the overall result is satisfactory considering the availability of the required glass–
ceramic surface area in direct contact with SBF to induce bioactive behaviour. 
 
FTIR (transmission mode) was also carried out on microsphere-coated scaffolds throughout a 
much defined time scale to confirm the HA formation. Similarly to the experiments reported 
in Chapter 5, a FTIR spectrum was recorded at every 24 hours after the PMS- and TTCMS-
coated scaffolds have been immersed in SBF (a different scaffold from the same batch was 
used for measurement at each time point). The FTIR spectra for PMS- and TTCMS-coated 
scaffolds are shown in Figure 7.15 and Figure 7.16, respectively.  
 
In the case of PMS-coated scaffolds, after an immersion time of 3 days, both Si-O-Si bending 
and stretching bands become less sharp compared to the original spectrum (0 h) and started to 
166 
 
disappear, especially at day 3, the Si-O-Si stretching bands at 950 cm
-1
 had almost 
disappeared. This indicates the loss of soluble SiO2, which is the starting point of the second 
stage of HA formation that is described in Chapter 1, section 2.2.2. Furthermore, Si-O-Si 
symmetrical vibration bands at 800 cm
-1
 [90] and new bands at 575 and 620 cm
-1
, which 
represent the Ca-P [240], start to appear. These bands are associated with the third and fourth 
stages of HA formation, respectively. FTIR results on samples immersed in SBF from day 1 
to day 3 indicate that the first four stages of HA formation have taken place at a fast pace and 
occur between day 1 and day 3 of immersion. P-O stretching band at 1030 cm
-1
 started to 
appear at day 6. This band could have appeared earlier, but this band was overlapped with 
PMS bands making it difficult to observe. There is also a growth of a C-O bending band at 
870 cm
-1
 and C-O stretching bands at 1410 and 1500 cm
-1
. The C-O bands are attributed to 
CO3
2-
, which is the proof to a HCA phase growing. By day 6, the P-O bending bands at 564 
to 600 cm
-1
 are very pronounced, indicating that the ‘semi-crystalline’ HA layer was growing 
into a more and more crystallised structure. The FTIR results are in agreement with the XRD 
results, as there is no HA crystalline phase detected using XRD by day 3 of immersion, but 
HA is detected after 1 week. This Ca-P formation seems to be slightly delayed in the case of 
TTCMS-coated scaffolds, when compared to PMS-coated samples, it could be due to 
experimental variations such as the amount of material used for FTIR analysis or the presence 
of a thick coating on that particular sample. Overall, the rate of HA formation on TTCMS-
coated samples is almost identical to that of PMS-coated samples, as the P-O bands are 
observed at day 6 of immersion in both cases. It should be pointed out that P(3HB) bands 
have been observed throughout all immersion time points, which also indicates that the 
coating was strongly attached to the surface of the glass-ceramic scaffolds.  
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Figure 7.15 FTIR spectra of PMS-coated 45S5 Bioglass
®
-based scaffolds after immersion in SBF at 
different time points showing the formation of HA. Spectrum of uncoated sample before immersion is 
also shown here for comparison. 
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Figure 7.16 FTIR spectra of TTCMS-coated 45S5 Bioglass
®
-based scaffolds after immersion in SBF at 
different time points showing the formation of HA. Spectrum of uncoated sample before immersion is 
also shown here for comparison. 
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7.2.6 Investigation on the topography of PMS-coated surfaces  
 
SEM images illustrated in Figure 7.17 compare the HA layer formed on uncoated and PMS-
coated scaffolds. As discussed earlier, HA can form on top of the PMS coating and embed 
PMS underneath, as shown by the images in Figure 7.17 the HA layers formed on the PMS-
coated scaffolds (Figure 7.17 (b)) have more ‘spherical’ features and hence look rougher than 
the HA layer on the uncoated scaffold. In order to further study the effect of PMSs on the 
topography of the scaffold surface, white light interferometry (Zygo
®
) analyses were carried 
out. The results are shown in Figure 7.18. This technique measures the surface roughness of a 
flat substrate; therefore, sintered Bioglass
®
 cylindrical pellets (diameter = 10 mm, thickness = 
5 mm) were used as the substrate, which were coated with PMSs following the same 
procedure used to coat scaffolds. Figure 7.18 (a) and (b) show the oblique plots of uncoated 
pellets before and after immersion in SBF for 7 days, while Figure 7.18 (c) and (d) show the 
corresponding images for coated specimens. Individual PMSs on the coated sample surface 
were impossible to identify by this technique, as the size of individual spheres is very close to 
the resolution limit of the instrument, which is not sensitive enough to generate the image of 
each PMS on the surface; therefore, PMSs cannot be clearly identified in Figure 7.18 (c) and 
(d). 
 
   
Figure 7.17 SEM images of (a) HA layer on the uncoated Bioglass
®
 scaffold after 2 weeks in SBF; (b) HA 
layer on the PMS-coated Bioglass
®
 scaffold showing that HA aggregation after 2 weeks in SBF are in the 
form of PMSs indicated that PMS are covered by HA crystals. 
 
a b 
170 
 
 
Figure 7.18 Oblique plots of the 45S5 Bioglass
®
 pellet surfaces: (a) plain Bioglass
®
 pellet; (b) plain 
Bioglass
®
 pellet after immersion in SBF for 7 days; (c) PMS coated Bioglass
®
 pellet and (d) PMS-coated 
Bioglass
®
 pellet after immersion in SBF for 7 days. 
 
For the first time, we investigated the introduction of a desirable micro- and nano-topography 
in 3D using the PMS coating on scaffolds and the subsequent growth of HA crystals upon 
immersion in SBF, as identified by SEM observation at high magnification (Figure 7.10 (i)). 
The values of the roughness parameter, root mean square (RMS), of all surfaces were 
measured. The average of five RMS values obtained from Zygo
®
 measurements was 
determined by analysing white light interferometry data on each sample, the data are shown 
in Figure 7.20. The similarity of the values for uncoated and PMS-coated samples could be 
due to two reasons. One is the fact that the instrument is not sensitive enough to deal with 
curved features as small as the PMSs. The second is the related valleys on the surface of the 
bioactive glass–ceramic pellets investigated which were filled up by the PMSs after the 
coating process. Therefore, they created a new flat surface and the surface roughness did not 
change significantly. This possible behaviour is shown schematically in Figure 7.19. 
However, after 7 days of immersion in SBF, the RMS value of PMS-coated samples was 
significantly higher in comparison to that of the uncoated scaffold. This increased roughness 
plays an important role in enhancing cell attachment, proliferation and bone matrix formation. 
The present investigation also indicates that it should be possible to tailor the surface 
topography of the three-dimensional scaffolds by controlling the diameter of PMSs as HA 
crystals will form on the top of the PMS layer, which thus provides an effective template to 
control the surface roughness of the present scaffolds in three dimensions. 
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Figure 7.19 Schematic diagram showing how PMSs fill up the valleys and uneven surfaces of 45S5 
Bioglass
®
 pellet. 
 
 
Figure 7.20 A comparison of the average root mean square (RMS) values of the indicated sample surfaces 
(* p < 0.05, n = 3). RMS values were determined by Zygo
®
 measurements. Graph represents one single 
experiment with 3 replicates. 
 
7.2.7 Fabrication and characterisation of TTCMS 
 
Tetracycline (TTC)-loaded P(3HB) microspheres (TTCMSs) were produced using the same 
method used for standard PMS. The difference in their fabrication is the addition of TTC 
solution to the 1.0 wt% aqueous polyvinyl alcohol (PVA) solution in the case of TTCMS. 
The final TTC concentration in that PVA solution was set to be 0.2 wt% in order to compare 
to other literature results [265]. By using ultraviolet-visible absorption spectroscopy (UV-
Vis), it was found that there were 2.38 x 10
-3
 µg of TTC in every µg of TTCMS. 
 
TTC is highly hydrophilic and hence difficult to encapsulate in a hydrophilic environment. In 
the present work, the encapsulation efficiency was followed by increasing the viscosity of the 
aqueous solution because of the presence of PVA, preventing the diffusion of the drug from 
PMSs 
Surface of sintered 45S5 Bioglass® pellet 
* 
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within the PMS. The surface area of the TTCMSs measured by Quantachrome Autosorb
®
 
Automated Gas Sorption System was 4.38 m
2
/g, which is higher than that of plain PMS (3.55 
m
2
/g). This increase can be explained by the drugs adsorbed onto the surface of the 
microspheres which block the pores on the surface hence increasing the total surface area of 
the microspheres. 
 
7.2.8 Optimisation of TTCMS coating conditions 
 
TTC is a very hydrophilic drug; using a water based slurry-dipping method to coat the 
scaffolds with TTCMS will cause drug loss during the slurry making process. Therefore a 
non-polar solvent must be selected for coating the scaffolds with TTCMSs in order to prevent 
drug loss, as TTC would not diffuse into the organic phase. Hexane is one of the most non-polar 
solvents; it is easily evaporated. Although it can be harmful by inhalation of large amount and may 
cause impaired fertility and central nervous system depression [267], the slurry-dipping procedure 
was carried out in a fume hood, and the TTCMS-coated scaffolds were only used after they had been 
left in fume hood to dry over night, due to hexane’s easily evaporating nature, therefore, little or no 
hexane will remind, and the materials are hence suitable for biomedical applications. 
 
Several TTCMS hexane slurries with different concentrations were made in order to optimise 
the coating quality, they were: 0.3 wt%, 0.5 wt%, 0.8 wt%, 1 wt% and 1.3 wt%. It was found 
that the microspheres did not disperse as well in hexane as they did in water, because the non-
polar solvent did not support electrical double-layers around the microspheres, so they were 
not stabilised by electrostatic stabilisation as they did in water. Therefore, TTCMSs tend to 
sink to the bottom of the recipient containing the suspension in seconds after either stirring or 
using an ultrasonic bath were stopped; therefore the simple dipping method cannot be used to 
coat the scaffolds with TTCMS. To overcome the problem, the scaffold was hanged in mid-
air using a wire and the TTCMS suspension was dipped onto the scaffolds from different 
direction using a pipette. It was found that 1 ml of 0.8 wt% TTCMS hexane suspension was 
ideal for coating a 0.05g 45S5 Bioglass
®
 scaffold, because it provided a fairly homogenous 
coating throughout the whole scaffold (assessed by SEM). The result is shown in Figure 7.21. 
The TTCMSs were seen to attach both onto the scaffold surfaces and within the crevices 
forming a fairly homogenous coating, as revealed by the SEM micrographs shown in 
Figure 7.21. The thickness of the coating varies from being a single layer, and therefore 
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~2 µm thick, to a multi layer coating. The coatings most commonly observed by SEM were 
around 5–6 µm in thickness. The thickness of the TTCMS coating is important because it 
affects the total amount of drug incorporated into the scaffold, and by using different 
concentration of TTCMS suspension and its amount, it is thus possible to accurately control 
the loaded amount of TTC. 
 
   
Figure 7.21 SEM images of 45S5 Bioglass
®
 scaffolds coated with TTCMSs at different magnifications. 
 
7.2.9 In vitro drug release study 
 
Finally, in vitro drug release studies from TTCMS-coated scaffolds were carried out using 
ultraviolet-visible absorption spectroscopy. For the purpose of comparison, the drug release 
profiles from TTC-dipped 45S5 Bioglass
®
 scaffolds (drug loaded by simply dipping the 
scaffold in a 0.2 wt% TTC solution) and from free PMSs were used as a control to compare 
the release kinetics from the TTCMS-coated scaffolds. The drug release profiles studies were 
carried out in SBF. Data of the release profiles of the controls and TTCMS-coated scaffolds 
clearly show their different behaviour, as presented in Figure 7.22. Compared to the initial 
burst release within the first hour from the TTC-dipped 45S5 Bioglass
®
 scaffold (35%) and 
from the free TTCMSs (56%), the composite scaffold showed a lower initial release of 14%. 
The percentage cumulative TTC release was found to occur in a controlled manner over a 
period of 28 days in the composite scaffold (55%). On the other hand, TTC-dipped scaffolds 
exhibited 70% release over the same period, and a much faster total drug release of 96% over 
a period of just 24 h from the free TTCMSs was observed, as shown in Figure 7.22. 
 
It can be observed from these results that TTC encapsulated within TTCMSs fixed on 
scaffold surfaces was released in a controlled manner, as compared to the rapid release of the 
drug directly adsorbed onto the uncoated scaffold or from the TTCMSs on their own (Figure 
7.22). A rapid burst release of 56% was seen from the free PMSs during the first hour when 
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they were in contact with the medium. This was followed by an almost total drug release 
(96%) over a period of 24 hours.  
 
 
Figure 7.22 Release of TTC from free TTCMS, uncoated 45S5 Bioglass
®
 scaffolds and TTCMS-coated 
composites scaffolds showing difference in release kinetics (n = 3). Graph represents one single 
experiment with 3 replicates. 
 
The release profiles of gentamicin encapsulated in the same PMS/Bioglass
®
 scaffold 
composite were studied by Francis et al. [265]. The percentage cumulative gentamicin release 
was found to occur in a controlled manner over a period of 28 days from the composite 
scaffold (83.91%), which is a more favourable result when compared to the uncoated scaffold, 
which exhibited 74.83% release over a period of 15 days and the much faster total drug 
release of 95.33% over a period of just 24 hours from the free PMSs. 
 
As reported in Francis et al.’s study [265], 60% of the gentamicin was released from free 
PMSs, the possible reason for this burst release could be due to the hydrophilic nature of the 
drug as, however, the larger structure of TTC might result in the slightly slower burst release 
rate (56%) when compared to that of gentamicin, as larger molecules will find it more 
difficult to escape from the nano-pores within the microspheres. Another reason for the 
slower release rate in the case of TTC is the neutralisation of the drug. The TTC used in this 
study is in its most common form: TTC·HCl. A previous study has reported that the release 
rate of TTC·HCl from polyhydroxybutyrate microspheres decreases after the neutralisation of 
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the TTC as a consequence of its solubility decrease [263]. The SO4
2+
 ions in the SBF can 
neutralise the TTC·HCl, the same principle as neutralising it with calcium sulphate solution 
[268, 269], therefore reducing its solubility and hence decreasing its release rate. This effect 
could have reduced the release rates of TTC in all three carrier systems presented in this 
study when comparing to that of gentamicin.  
 
For the TTC-dipped Bioglass
®
 scaffold, an initial burst release of 35% was followed by a 
gradual release of 70% over a period of 28 days. This dual release profile could be due to the 
drug being loosely bound to the surface of the scaffold, which should lead to the initial rapid 
drug release followed by the slower drug release of the entrapped drug within the micro-pores 
present on the scaffold surface. The release mechanism of the 2
nd
 part of the release profile 
can be described as a dissolution-diffusion phenomenon. First, the TTC dissolves into the 
liquid in the micro-pores and then diffused from the bulk into the medium [268]. 
 
In Francis et al.’s study [265], more than 70% of the gentamicin was already released in the 
first 15 days, however, this amount of release was only achieved after 28 days in the case of 
TTC. Besides the neutralisation reason mentioned earlier, this slower release rate was mainly 
affected by the strong affinity of the drug and the calcium content of the 45S5 Bioglass
®
 
scaffold. It has been reported that TTC forms chemically stable chelate complexes with 
calcium ions [263, 268-270], therefore TTC becomes irreversibly bound to the scaffold by 
chelate complexes. In this situation, TTC can therefore only be released into the medium 
when the glass-ceramic matrix is degrading or dissolving into the medium, however, the 
formation of HA on the surface of the Bioglass
®
-based scaffolds does not promote the release 
rate, the remaining drug is still bound to the scaffold as the result of the re-deposition of 
calcium ions during HA formation. Overall, 100% of the TTC adsorbed onto the uncoated 
scaffolds could not be released; the release rate was therefore much slower compared to that 
of gentamicin. A similar phenomenon was observed by Gbureck et al. [271]. Drugs, such as 
vancomycin and ofloxacin, which do not form chelate complexes with tricalcium phosphate 
powder, exhibited 4 times (80%) faster release rates than TTC (20%) in a period of 6 days in 
PBS buffer. Ratier et al. [268] observed that only 65% of neutralised TTC can be released 
from a tricalcium phosphate cement in 6 days of immersion in water. 
 
Compared to the initial burst release in the TTC-dipped scaffolds, the TTCMS-coated 
scaffolds exhibited a much lower initial burst of 14% followed by continuous release over a 
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period of 30 days (Figure 7.22). The release of the drug during the first few hours of 
immersion could be due to the presence of a given quantity of surface bonded drug, which 
diffuses out when in contact with the medium. The relatively slower TTC release from the 
composite scaffold indicates that the TTCMSs, once immobilised on the Bioglass
®
-based 
scaffold, exhibit completely different drug release kinetic as compared to TTCMSs that are 
free to move in suspension. The major reason causing the release rate reduction was the 
formation of TTC-Ca chelate complex in the presence of the Bioglass
®
-based scaffold. The 
second reason could be attributed to the decrease in the surface area exposed to the SBF 
environment in the immobilised TTCMSs. In addition, the apatite layer formed on the surface 
of the composite scaffold should also contribute to determining the kinetics of drug release, 
as the HA layer could embed large amount of the TTCMS hence further reducing the release 
rate. 
 
Although several biodegradable polymer microspheres are being developed [272, 273] for the 
delivery of drugs, key challenges remain, such as achieving higher loadings, lower burst 
release and greater drug stability within the microspheres. Microsphere size generally plays 
an important role in the effectiveness of the released product. The concept introduced in this 
study, loading biodegradable PMSs as drug delivery vehicles into 3D scaffolds, is likely to 
benefit from the wide availability of suitable PMSs. 
 
7.3 Conclusions 
 
The results presented in this Chapter have shown the development of novel multi-functional 
Bioglass
®-
based glass–ceramic scaffolds for bone tissue engineering which exhibit 
topographical features to increase cell attachment and can also act as a carrier for controlled 
drug delivery via the immobilization of PMSs on the scaffold surfaces. Successful PMS 
coating on the glass–ceramic scaffold was achieved using an optimized slurry-dipping 
technique. A qualitative assessment of PMS adhesion to the scaffold surface indicated this to 
be satisfactory considering the expected manipulation of the scaffolds for in vitro tests. The 
resulting composite scaffolds had slightly increased compressive strength and exhibited on 
ordered surface roughness (given by HA crystal formation on the PMSs in contact with SBF), 
and maintained the high bioactivity typical of a silicate glass–ceramic derived from Bioglass®. 
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The novel scaffolds were successfully tested in their TTC delivery capability. The 
encapsulated drug was released in a slow and sustained manner compared to the burst release 
of the drug measured from free TTCMSs and from the uncoated scaffold. Hence, the 
TTCMS-coated scaffold developed here is multifunctional in that it provides structural 
support, adequate surface roughness, bioactivity and controlled drug delivery function, being 
thus of high interest for bone tissue engineering. 
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Chapter 8 Development of 3D scaffolds with different nanoscale 
surface topographies 
 
8.1 Introduction 
 
The work presented in this Chapter was designed to develop nanoscale topography in a 
controlled manner on the 3D 45S5 Bioglass
®
 scaffolds. As pointed out in the literature review, 
besides the CNT-coating created by EPD technique, the other potential methods to achieve 
nanoscale topography on the surface of a 3D scaffold to be explored in this project are 
polymer demixing and chemical etching.    
 
Polymer demxing can lead to randomly organised patterns on inorganic material surfaces. 
The method is based on spontaneous phase separation of a polymer blend under the spin-
casting process onto a substrate [111], such as silicon or glass. Many polymer blends 
prepared for polymer demixing have been reported in previous studies, such as poly(p-
bromostyrene)/poly(deuteriostyrene) [111], poly(styrene-d8)/poly(styrene-co-p-bromox-
styrene) [274], polystyrene/poly(4-bromostyrene) [275] and polystyrene/poly(n-
butylmethacrylate) (PS/PnBMA) [114, 276]. Among them, PS/PnBMA has been used to 
introduce nanoscale features inside nylon tubes for tissue engineering applications, including 
stents and conduits for vascular and nerve regeneration. Therefore, this polymer blend was 
selected to perform polymer demixing on the surfaces of the 3D 45S5 Bioglass
®
 scaffolds in 
this project. 
 
The nanoscale features delivered by different polymer proportions and different 
concentrations of the polymer blend were first investigated on 2D surfaces. The recipe that 
produced the most desired nanoislands in terms of their sizes and how closely they were 
arranged on the surface was chosen and applied to the 3D scaffold. The dipping time and 
drying conditions were investigated too. SEM and AFM were used to characterise the sizes of 
these features on 2D surfaces, and SEM was used also to study the features on the surfaces of 
the 3D scaffolds. 
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The other method presented in this Chapter to induce nanoscale topography in 3D is chemical 
etching. This method involves soaking the scaffolds in an etchant in order to produce 
nanoscale features on the scaffold surface. One of the approaches in chemical etching was 
investigated here, it was based on the method proposed by Chen et al. [119], who 
demonstrated that the morphology of the 3D 45S5 Bioglass
®
 scaffold can be modified by 
simply immersing the scaffold in buffered water (pH=8) for a period of time. The work was 
carried out on both sintered scaffolds and pellets; they were immersed in water with different 
pH for several time periods. The resulting samples were named “water-treated” samples. The 
features on both types of samples were analysed using SEM/EDX. The bioactivity of the 
most desirable water-treated scaffold, determined by the size of the topography features on its 
surface, was analysised using the SBF immersion method, the formation of HA was 
investigated using SEM, XRD and FTIR. 
 
8.2 Results and discussion 
 
8.2.1 Polymer demixing 
 
In polymer demixing technique, by controlling the polymer concentration and the proportions 
of the polymers in solution, different topographies can be produced. The ratio of the polymers 
used has an effect on the topography shape, while the concentration of polymers in the 
casting solution changes the feature sizes [275]. Therefore, different polystyrene to 
poly(butyl methacrylate) ratios were investigated: 0.05:0.95; 1:9; 2:8 (control) and 4:6, and 
different concentrations of each polymer mixture solution were also tested (in weight): 
0.125%, 0.25%, 0.5%, 1% and 2%. Toluene was used in the polymer demixing procedure as 
it is the selected solvent used in the standard procedure by Berry et al [114, 276] , which was 
the procedure followed in the present study. Although toluene is harmful as it may cause 
drowsiness if breathed in over a long period of time [267], it was anticipated that toluene 
evaporates during polymer demixing film formation as films were left to dry overnight or 
longer. All solutions are listed in Table 8.1. The solutions were casted on a glass slice in 
order to analyse the sizes of the islands that could be formed on the dried polymer films. 
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Table 8.1 Variation of polymer blend solution with different PS : PnBMA proportions and concentrations. 
Concentration 
 
 
 
PS:PnBMA 
proportion 0.125% 0.25% 0.5% 1% 2% 
0.5 : 9.5 0.5:9.5-0.125% 0.5:9.5-0.25% 0.5:9.5-0.5% 0.5:9.5-1% 0.5:9.5-2% 
1 : 9 1:9-0.125% 1:9-0.25% 1:9-0.5% 1:9-1% 1:9-2% 
2 : 8 2:8-0.125% 2:8-0.25% 2:8-0.5% 2:8-1% 2:8-2% 
4 : 6 4:6-0.125% 4:6-0.25% 4:6-0.5% 4:6-1% 4:6-2% 
 
All films were analysed by SEM and AFM, the images are shown in Figure 8.1 to Figure 8.4 
and Figure 8.5 to Figure 8.8, respectively. It was found that only the PS : PnBMA ratios of 1 : 
9 (Figure 8.2 and Figure 8.6) and 2 : 8 (Figure 8.3 and Figure 8.7) could produce regular 
sized islands with the latter ones being more regular in term of the pattern arrangement. Due 
to the lack of PS, PS : PnBMA ratio of 0.5 : 9.5 could not produce pronounced island features, 
see Figure 8.1. The features observed in AFM images, Figure 8.5, were possibly generated 
due to the vibration of the instrument. When PS became more dominant in the formulation, 
films started to form a large area of ‘land’ and left PnBMA forming ‘valleys’ in them (Figure 
8.4). By performing image analysis (Figure 8.9), it was found that in the case of PS : PnBMA 
ratio of 1 : 9, the smallest islands that could be produced were ~100 nm in width and ~120 
nm in height (2% in concentration) or ~1 µm in width and ~20 nm in height (0.25% in 
concentration). In the case of PS : PnBMA ratio of 2 : 8, the smallest islands produced were 
~500 nm in width and ~20 nm in height (0.25% in concentration). From these observations, it 
seems that when the polymer blend is low in concentration, the blend can spread more on the 
2D surface and therefore larger sized and shorter islands were generated. As the 
concentration of the polymer blend increases, the blend becomes thicker and hence more 
viscous, so smaller sized and higher islands can be fabricated. The schematic diagram of this 
behaviour is shown in Figure 8.13 (a). At the same concentration, increasing content of PS in 
the polymer blend lead to wider islands that can spread during formation, considering that the 
island structures are formed by PS. A schematic diagram of this mechanism is illustrated in 
Figure 8.13 (b). Overall, the more concentrated polymer blend with higher amount of PS 
produces rougher surfaces due to the large nanoscale island generated. 
 
The surface roughness is identified by the RMS values obtained using AFM, the results are 
illustrated in Figure 8.10. The skewness (Ssk) and Kurtosis (Skr) results are illustrated in 
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Figure 8.11 and Figure 8.12, respectively. The Skewness values of all specimens are positive, 
which indicate that all features observed using both SEM and AFM are indeed nano-islands, 
e.g. they are small spikes that are above the flat surrounding area. At the PS : PnBMA ratio of 
2 : 8, as the concentration of the polymer blend increased, the islands became more and more 
pronounced. This observation is explained in Figure 8.13. However, at the PS : PnBMA ratio 
of 2 : 8, when the concentration increased to 2%, the islands become much less pronounced 
(low Skewness value). This is due to the increase in the polymer blend viscosity, PnBMA 
hence could not flow well, the resulting distances between the flat areas and the top of the 
islands were therefore very small. 
 
The Kurtosis values show that only at concentration 0.25%, both ratios of polymer blends 
produced flat-topped islands. All the other concentrations at the PS : PnBMA ratio of 1 : 9 
produced sharp, spiky shaped islands. At a PS : PnBMA ratio of 2 : 8, only when the 
concentration increased to 2%, the tip of the nano-islands became sharp. A sharp, spiky 
surface feature can damage cells when they are attached and they can potentially cause cell 
death, therefore, the polymer blend at PS : PnBMA ratio of 2 : 8 and concentration of 1% is 
the most suitable to be used for fabricating these nano-islands. 
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Figure 8.1 SEM images of films casted using different concentration of PS : PnBMA (0.5:9.5) polymer 
demixing blends: (a) 0.5:9.5-0.125%; (b) 0.5:9.5-0.25%; (c) 0.5:9.5-0.5%; (d) 0.5:9.5-1% and (e) 0.5:9.5-
2%. 
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Figure 8.2 SEM images of films casted using different concentration of PS : PnBMA (1:9) polymer 
demixing blends: (a) 1:9-0.125%; (b) 1:9-0.25%; (c) 1:9-0.5%; (d) 1:9-1% and (e) 1:9-2%. 
a 
c d 
e 
b 
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Figure 8.3 SEM images of films casted using different concentration of PS : PnBMA (2:8) polymer 
demixing blends: (a) 2:8-0.125%; (b) 2:8-0.25%; (c) 2:8-0.5%; (d) 2:8-1% and (e) 2:8-2%. 
c d 
a b 
e 
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Figure 8.4 SEM images of films casted using different concentration of PS : PnBMA (4:6) polymer 
demixing blends: (a) 4:6-0.125%; (b) 4:6-0.25%; (c) 4:6-0.5%; (d) 4:6-1% and (e) 4:6-2%. 
e 
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Figure 8.5 AFM images of films casted using different concentration of PS : PnBMA (0.5:9.5) polymer 
demixing blends: (a) 0.5:9.5-0.125% 5x5 µm
2
; (b) 0.5:9.5-0.25% 5x5 µm
2
; (c) 0.5:9.5-0.5% 5x5 µm
2
; (d) 
0.5:9.5-1% 5x5 µm
2
 and (e) 0.5:9.5-2% 5x5 µm
2
. 
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Figure 8.6 AFM images of films casted using different concentration of PS : PnBMA (1:9) polymer 
demixing blends: (a) 1:9-0.125% 5x5 µm
2
; (b) 1:9-0.25% 5x5 µm
2
; (c) 1:9-0.5% 5x5 µm
2
; (d) 1:9-1% 5x5 
µm
2
 and (e) 1:9-2% 5x5 µm
2
. 
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Figure 8.7 AFM images of films casted using different concentration of PS : PnBMA (2:8) polymer 
demixing blends: (a) 2:8-0.125% 5x5 µm
2
; (b) 2:8-0.25% 5x5 µm
2
; (c) 2:8-0.5% 5x5 µm
2
; (d) 2:8-1% 5x5 
µm
2
;
 
(e1) 2:8-2% 5x5 µm
2
 and (e2) 2:8-2% 10x10 µm
2
. 
d 
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Figure 8.8 AFM images of films casted using different concentration of PS : PnBMA (4:6) polymer 
demixing blends: (a) 4:6-0.125% 5x5 µm
2
; (b) 4:6-0.25% 5x5 µm
2
; (c) 4:6-0.5% 5x5 µm
2
; (d1) 4:6-1% 5x5 
µm
2
; (d2) 4:6-1% 10x10 µm
2
, (e1) 4:6-2% 5x5 µm
2
 and (e2) 4:6-2% 45x45 µm
2
. 
e1 
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Figure 8.9 The average height (nm) of the nano-islands produced using PS : PnBMA ratios of 1 :9 and 2 : 
8 in polymer blends at different concentrations, measured using AFM (n = 3). Graph represents one 
single experiment with measurements obtained from 3 random locations on each sample. 
 
 
Figure 8.10 The root mean square (RMS, nm) deviation of the nano-islands produced using PS : PnBMA 
ratios of 1 :9 and 2 : 8 in polymer blends at different concentrations indicating the roughness of the 
resulting polymer films, measured using AFM (n = 3). Graph represents one single experiment with 
measurements obtained from 3 random locations on each sample. 
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Figure 8.11 Skewness (Ssk) values of the nano-islands produced using PS : PnBMA ratios of 1 :9 and 2 : 8 
in polymer blends at different concentrations, measured using AFM (n=3). Graph represents one single 
experiment with measurements obtained from 3 random locations on each sample. 
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Figure 8.12 Kurtosis (Skr) values of the nano-islands produced using PS : PnBMA ratios of 1 :9 and 2 : 8 
in polymer blends at different concentrations, measured using AFM (n=3). Graph represents one single 
experiment with measurements obtained from 3 random locations on each sample. 
 
192 
 
 
 
 
Figure 8.13 Schematic diagrams showing (a) how the concentration of the polymer blend affects the size 
of the casting film and the size of the islands formed, and (b) how the islands are dominantly effected by 
the amount of polystyrene (black blocks) in the polymer blends. The islands grow, merge and eventually 
almost cover the whole casting surface. 
 
Previous studies have shown fibroblast filopodia interacting specifically with 10 nm high 
islands on nanostructured surfaces [112]. Although fibroblasts are seen to interact quickly 
and strongly with these nano-islands, when the height of these features reaches up to above 
27 nm, the cells start to remain motile on top of the islands instead of being strongly in 
contact with the material as they do on a flat surface, as shown by the study conducted by 
Dalby et al. [113]. Dalby et al. [275] demonstrated that 13 nm height island features created 
by polystyrene/poly(4-bromostyrene) polymer demixing method produced the largest human 
endothelial cell reaction compared to 35 and 95 nm features. The smallest islands produced in 
this study are about 20 nm in height. This value could be too high for good cell attachment in 
the long term, e.g. 30 days in culture, but might still have the potential to increase the initial 
cell adhesion. The next step was therefore to apply the blends that can produce the nanoscale 
islands to the 3D 45S5 Bioglass
®
 scaffolds. The scaffolds were dipped in the selected 
polymer blends, and the resulting coatings were analysed using SEM. The results are shown 
in Figure 8.14 and Figure 8.15, which were created by PS : PnBMA polymer blends of ratios 
1 : 9 and 2 : 8, respectively. One can observe from the SEM images that a polymeric layer 
coating, which appears to be very smooth in texture comparing to the glass-ceramic surface, 
has been created on the surface of the scaffold, however, the regular nano-island features that 
were observed on the flat samples could not be seen here. By comparing Figure 8.2 (c) and 
PS : PnBMA 
0.5:9.5 
PS : PnBMA 1:9 
 
PS : PnBMA 2:8 
 
PS : PnBMA 4:6 
 
As concentration 
increases 
a 
b 
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Figure 8.14 (a), it was found that the nano-islands that could be produced using 1:9-0.5% PS : 
PnBMA polymer blend on a flat surface could not be reproduced on the surface of the 3D 
scaffold matrix. The same result was observed in the case of 1:9-1% blend as well (Figure 
8.14 (b) and (c)). It was only when the concentration of the polymer blend increased to 2%, 
that small patches of islands were observed (Figure 8.14 (d)), however, unlike the situation 
on a flat surface, the islands were not distributed evenly throughout the surface, as none of 
the islands were observed on areas that were uneven or sloped. Less concentrated polymer 
blend, such as 0.125% and 0.25% has extremely low viscosity and could not hold on to the 
scaffold surface well, hence homogenous polymeric films could not be obtained on the 
scaffolds using these polymer blends. As shown in Figure 8.14 (a), these polymer blends 
formed inhomogeneous lake-like coatings randomly spread across the scaffold surface. The 
island structure was observed with 2:8-1% polymer blends, however, as in the 1:9-2% case, 
they were only found in patches where the strut surface were less rough. 
 
  
  
 
Figure 8.14 SEM images of films coated on 45S5 Bioglass
®
 scaffolds using different concentration of PS : 
PnBMA (1:9) polymer demixing blends: (a) 1:9-0.5%; (b) 1:9-1% at low magnification; (c) 1:9-1% at 
higher magnification and (d) 1:9-2%. 
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Figure 8.15 SEM images of films coated on 45S5 Bioglass
®
 scaffolds using different concentration of PS : 
PnBMA (2:8) polymer demixing blends: (a) 2:8-0.25%; (b) 2:8-0.5%; (c) 2:8-1% and (d) 2:8-2%. 
 
Although Berry et al. [114, 276] demonstrated that polymer demixing could be used to create 
nano-islands in three dimensional constructs, it seem that the surface of the three dimensional 
structure has to be very smooth for the method to be successful, in their case, inside of a 
nylon tube. In this present study, the 3D Bioglass
®
 scaffolds have very rough and bumpy 
surfaces. The PS/PnBMA polymer demixing technique seems not to be effective to produce a 
polymeric coating on which nano-islands could be homogenously distributed. Nevertheless, 
the technique optimised here is suggested for other bioactive glass scaffold systems, in which, 
due to viscous flow sintering a smooth surface can be created on the struts, e.g. boron-
containing glass scaffolds [277]. 
 
8.2.2 Chemical etching / water treatment 
 
Chemical etching involves soaking the scaffolds in an etchant in order to produce nanoscale 
features on the scaffold surface. The approach investigated here was based on a previous 
a b 
d c 
Polymer 
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method [119], which demonstrated that the morphology of 3D 45S5 Bioglass
®
 scaffolds can 
be modified by simply immersing the scaffold in buffered water for a period of time. The 
approach is also called water treatment in the present study. 
 
Sintered 45S5 Bioglass
®
 pellets (see Chapter 4, section 4.2.2 for fabrication details) were first 
used to investigate the optimal experimental condition of the approach, as it is convenient to 
do basic analyses, e.g. SEM/EDX analysis on flat surfaces. Based on the results presented in 
reference [119], the pellets were immersed in water that was adjusted to either pH 4 or pH 8 
for 1, 2, 3, 4 or 24 hours in order to investigate the changes in surface morphology of these 
pellets. The resulting samples were named water-treated samples. 
 
Figure 8.16 shows SEM images of sintered Bioglass
®
 pellets before (Figure 8.16 (a)) and 
after water-treated at pH 4 the different time periods showing the change of the pellet surface 
over time. Spindle-shaped crystallites reported in reference [119] were not observed on the 
samples. However, they were found on samples that were treated at pH 8, which are shown in 
Figure 8.17. Spindle-shaped crystallites are formed by dissolution of the amorphous glass 
matrix hence revealing and partially etching the crystalline particles embedded in the glass 
matrix in the sintered Bioglass
®
 pellet (or scaffold), as a result the shape of the crystalline 
particles becomes spindle-like [119]. However, this phenomenon was not observed in the 
case of water treatment at pH 4 but only with pH 8. This difference can be explained by the 
pH difference of the etchant (water). Water with lower pH value can etch the alkaline-phase 
of Bioglass
®
 further and faster, therefore the spindle-shaped crystallites could not be 
produced and maintained, as they were almost completely etched away by the more acidic 
etchant. 
 
In the case of pH 8, spindle-shaped crystallites observed on the surface of the Bioglass
®
 
pellets started to appear after 2 hours of treatment (Figure 8.17 (b)), most of them were about 
100 - 150 nm in length and 100 nm in width. The smaller features had 20 - 50 nm in both 
dimensions. As the immersion time increased, the spindle-shaped crystallites became more 
defined and uniformed in shape. After 4 hours, which is the standard procedure in reference 
[119], the crystallites became much sharper (Figure 8.17 (d)). The observation shows that as 
the immersion time increases, the crystallites become sharper and sharper. The reason for this 
behaviour is related to the faster dissolution of the glass phase compared with the crystalline 
phase and the fact that the interfaces between the glass matrix and crystalline particles are 
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favourable sites for dissolution [119], hence only some part of the crystalline particles are 
exposed to the aqueous media. Due to this behaviour, only the exposed parts will be 
dissolved further as immersion time becomes longer, resulting in sharper features. Large 
cracks also start to form on the surface (pointed out by arrow in Figure 8.17 (e), after the 
immersion time has increased to 4 hours, the formation of cracks must be avoided as it will 
lead to reduction on the mechanical strength of the materials. Therefore, it is not ideal to 
carry out the water treatment for longer than 3 hours, and after considering the size and 
regularity of the spindle-shaped crystallites, water treatment at pH 8 for 3 hours seems to be 
the optimal condition. From this point onwards, samples that are described as ‘water-treated’ 
in this thesis are produced using this optimised condition, unless otherwise specified. 
 
Samples that were water-treated at pH 8 over different time periods were analysed using 
EDX to investigate the elemental changes that might take place during water treatment. The 
spectra and atomic percentage results are illustrated in Figure 8.18 and Figure 8.19, 
respectively. It can be concluded form this graph that as the immersion time increases, the 
level of silicon (Si) and sodium (Na) present on the surface of the Bioglass
®
 pellet reduces in 
terms of atomic percentage (the atomic percentages of phosphorus and calcium increase as a 
result). EDX results therefore indicate the dissolution of the glass matrix and provide 
evidence for the explanation of the formation of spindle-shaped crystallites. 
 
It should be pointed out that the surface roughness of the water-treated samples could not be 
measured quantitatively. AFM cannot be conducted on the water-treated surfaces, because 
the material is too hard and the sharp and pointy features on the surfaces are likely to break 
the cantilever and tip of the instrument. In addition, nanoscale features could not be detected 
using white light interferometer (Zygo
®
) neither; as the size of the smallest features this 
instrument can detect is about 1 µm, and the size of the spindle-shaped features are between 
20 to 100 nm. 
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Figure 8.16 SEM images of the surface microstructures of 45S5 Bioglass
®
 pellets: (a) as-sintered (before 
water treatment), (b) water-treated at pH 4 for 1 h, (c) water-treated at pH 4 for 2 h, (d) water-treated at 
pH 4 for 3 h, (e) water-treated at pH 4 for 4 h and (f) water-treated at pH 4 for 24 h. 
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Figure 8.17 SEM images of the surface microstructures of 45S5 Bioglass
®
 pellets: (a) water-treated at pH 
8 for 1 h, (b) water-treated at pH 8 for 2 h, (c) water-treated at pH 8 for 3 h, (d) water-treated at pH 8 for 
4 h at high magnification and (e) water-treated at pH 8 for 4 h at low magnification showing the cracks on 
the surface of the pellet due to long period of water treatment and (f) water-treated at pH 8 for 24 h. 
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Figure 8.18 EDX spectra of the surfaces of the sintered 45S5 Bioglass
®
 pellets (a) before (0 h) and after 
water treatment at pH 8 for (b) 1 h, (c) 2 h, (d) 3 h, (e) 4 h and (f) 24 h. The specimens were coated with 
gold (Au) for EDX measurement. 
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Figure 8.19 EDX results showing the surface composition of the sintered 45S5 Bioglass
®
 pellets 
investigated: before (0 h) and after water treatment at pH 8 for 1, 2, 3, 4 and 24 h. 
 
XRD was used to study the change in the crystalline structure of the sintered Bioglass
®
 
pellets after water treatment. Figure 8.20 and Figure 8.21 show the XRD spectra for all 
investigated samples that were treated with the aqueous etchant at pH 4 and pH 8, 
respectively. Although the sodium calcium silicate crystalline phase present in as-sintered 
Bioglass
®
 scaffolds, Na6Ca3Si6O18 (01-077-2189), dominated on the surface of the sintered 
Bioglass
®
 pellets (Figure 8.20 (a) and Figure 8.21 (a)), a new crystalline phase was detected 
after 2 hours of treatment at pH 4 and 1 hour of treatment at pH 8. As shown in Figure 8.22, 
the peaks from the XRD spectrum of the Bioglass
®
 pellet that was treated at pH 8 for 3 hours 
match the combination of the two crystalline phases. The new sodium calcium silicate phase 
(Figure 8.22 (c)) has the following chemical formula: Na2Ca6(Si2O7)(SiO4)2 (PDF #01-080-
1296). The major XRD spectra peaks of this phase are marked with ‘◙’ in the XRD spectra. 
The stronger acidic condition of pH 4 can dissolve and hence remove more the spindle-
shaped crystallites and the amorphous glass matrix than pH 8. This is why there are more 
crystal particles present on the surface of the Bioglass
®
 pellets with pH 4 treatment than with 
pH 8 treatment after the same time period. Hence more pronounced and stronger peaks are 
present in the spectra, e.g. comparing Figure 8.20 (d) (pH 4, 3 h) and Figure 8.21 (d) (pH 8, 
3h). This is also the reason why the peaks corresponding to the new crystalline phase can 
only be observed after one hour of treatment at pH 8 (Figure 8.21 (b)), but not at pH 4 
(Figure 8.20 (b)). 
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Figure 8.20 XRD spectra of samples (a) as-sintered Bioglass
®
 pellet, (b) water-treated at pH 4 for 1 h, (c) 
water-treated at pH 4 for 2 h, (d) water-treated at pH 4 for 3 h, (e) water-treated at pH 4 for 4 h and (f) 
water-treated at pH 4 for 24 h. (■ = N6Ca3Si6O18 (01-077-2189); ◙ = Na2Ca6(Si2O7)(SiO4)2 (01-080-1296)). 
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Figure 8.21 XRD spectra of samples (a) as-sintered Bioglass
®
 pellet, (b) water-treated at pH 8 for 1 h, (c) 
water-treated at pH 8 for 2 h, (d) water-treated at pH 8 for 3 h, (e) water-treated at pH 8 for 4 h and (f) 
water-treated at pH 8 for 24 h. (■ = N6Ca3Si6O18 (01-077-2189); ◙ = Na2Ca6(Si2O7)(SiO4)2 (01-080-1296)). 
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Figure 8.22 (a) Peaks found in the XRD spectrum of water-treated pellet at pH 8 for 3 h match the 
literature standard peaks of (b) N6Ca3Si6O18 (01-077-2189) and (c) Na2Ca6(Si2O7)(SiO4)2 (01-080-1296). 
 
The optimal water-treatment condition was then applied to Bioglass
®
 scaffolds in order to 
introduce the spindle-shaped morphology on the surface of the 3D matrix. SEM images of the 
resulting scaffold surface and cross section are shown in Figure 8.23 (a) and (b), respectively. 
It was found that a spindle-shaped crystallite layer homogenously covered the surface of the 
scaffold throughout its 3D structure. The thickness of the spindle-shaped crystallite layer is 
seen to be about 0.5 – 1 µm. The exposed regions of the spindle-shaped crystallites are 
slightly sharper than the ones fabricated on the Bioglass
®
 pellet, this could be due to the fact 
that the surface of the scaffold is not as dense as the pellet, which were fabricated by pressing 
the Bioglas
®
 powder under high pressure. Therefore the ion leaching from the interface 
between the glass matrix and crystalline particles can take place easier and more rapidly in 
the scaffold, hence resulting in the sharper shape. 
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The bioactivity of water-treated scaffolds was analysed using the SBF immersion method, the 
formation of HA was investigated using SEM/EDX, XRD and FTIR. 
 
The formation of HA crystals was observed on the surface of water-treated scaffolds after 
immersing them in SBF for 3 days, as shown in Figure 8.23 (d). By week 2, the HA crystals 
were seen to be arranged in a cauliflower-liked shape across the whole surface. Figure 8.23 (e) 
and (f) show the cross section of the water-treated scaffold after immersion in SBF for 2 and 
4 weeks, respectively. It can be observed in these images that the dense glass structure 
(Figure 8.23 (e)) in the strut starts to breakdown as the immersion times increases, as many 
holes stat to appear (Figure 8.23 (f) and (g)). These images indicate the material leaching due 
to ion exchange that also takes places inside the scaffold body over time, not just on the 
surface.  
 
EDX analysis was carried out to confirm the elements present on the surface of the water-
treated Bioglass
®
 pellets before and after immersion in SBF. The EDX spectra of the samples 
immersed in SBF at different time points are shown in Figure 8.24. Three measurements were 
taken on each sample, and the averages of three atomic percentages were calculated in order 
to produce Figure 8.25. The original pellet sample (0 h) shows high sodium (Na) and silicon 
(Si) contents, which are from the components of the 45S5 Bioglass
®
: SiO2 and Na2O. Due to 
the water treatment, the contents of Na and Si are less than in the as-sintered pellet before 
SBF immersion (Figure 8.19). The Na and Si content decrease after immersion. After 3 days, 
more than 50% of the initial concentration of Na and Si has been reduced. These are replaced 
by phosphorus (P) and calcium (Ca), which indicate HA formation. The time scale of HA 
formation identified by using EDX is in agreement with SEM observations, as HA crystals 
were observed after 3 days of immersion in SBF (Figure 8.23 (d)). Higher amounts of P and 
Ca were detected on the water-treated samples in comparison to the as-sintered samples 
(Figure 5.11) at the same time points, which indicates either a higher HA formation rate or 
larger amount of HA deposition on the sample surface. By week 4, similarly as in as-sintered 
pellets (Figure 5.11), hardly any Si and Na were detected on the surface of the pellets, which 
is the result of the thick HA layer formed, covering the whole surface. 
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Figure 8.23 SEM images of (a) surface microstructure of water-treated 45S5 Bioglass
®
 scaffold at pH 8 
for 3 h showing the spindle-shaped crystallites on the surface, (b) a cross section of the water-treated (pH 
8, 3 h) scaffold, (c) a cross section of the water-treated (pH 8, 3 h) scaffold after immersion in SBF for 24 
h, (d) a cross section of the water-treated (pH 8, 3 h) scaffold after immersion in SBF for 3 days at high 
magnification showing the HA crystallites on the surface, (e) a cross section of the water-treated (pH 8, 3 
h) scaffold after immersion in SBF for 7 days, (f) a cross section of the water-treated (pH 8, 3 h) scaffold 
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after immersion in SBF for 2 weeks and (g) a cross section of the water-treated (pH 8, 3 h) scaffold after 
immersion in SBF for 4 weeks. 
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Figure 8.24 EDX spectra of the surfaces of the water-treated (pH 8, 3 h) 45S5 Bioglass
®
 pellets (a) before 
(0 h) and after (b) 3 days, (c) 1 week, (d) 2 weeks and (e) 4 weeks. The specimens were coated with gold 
(Au) for EDX measurement. 
d 
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Figure 8.25 EDX results on the surfaces of the water-treated (pH 8, 3 h) 45S5 Bioglass
®
 pellets before (0 h) 
and after immersion in SBF for 3 days, 1 week, 2 weeks and 4 weeks (n = 3). Graph represents one single 
experiment with measurements obtained from 3 random locations on each sample. 
 
The SEM/EDX analysis provided thus initial evidence that HA formation is faster on the 
water-treated Bioglass
®
 scaffolds than on the as-sintered scaffolds, as the HA crystalline 
structure and was detected after 3 days of immersion time with the water-treated scaffolds 
while it was only 1 week with the as-sintered scaffolds. More evidence of this phenomenon 
was obtained by XRD and FTIR analysis. The possible reasons for this behaviour are 
explained further below. 
 
In addition, XRD analysis was conducted on water-treated Bioglass
®
 scaffolds after 
immersion in SBF for 24h, 3 days, 7 days, 2 weeks and 4 weeks in order to determine the 
change in their crystalline phases. The XRD spectra are shown in Figure 8.26. Peaks 
representing Na6Ca3Si6O18 are marked with ‘■’, Na2Ca6(Si2O7)(SiO4)2 are marked with ‘◙’ 
and HA are marked with ‘●’. Na2Ca6(Si2O7)(SiO4)2 peaks were not observed in the spectra of 
water-treated scaffold possibly due to the relatively low amount present compared to the 
whole scaffold, as the XRD analysis was conducted using powders obtained by crushing the 
scaffolds. Unlike the XRD analysis conducted on pellet samples, that only measured on the 
surface, the XRD spectra of scaffolds represent the whole scaffold matrix, of which the  
Na2Ca6(Si2O7)(SiO4)2 content was significantly less than the major Na6Ca3Si6O18 phase. After 
3 days of immersion, the intensities of the Na6Ca3Si6O18 peaks in the range between 20 and 
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 2θ decreased by 50%, and the peaks representing the Na2Ca6(Si2O7)(SiO4)2 phase were 
detected. HA peaks also started to appear at this point. This is in agreement with the SEM 
observation (Figure 8.23 (d)). After 1 week, only some of the major Na6Ca3Si6O18 peaks were 
observed. The decrease in peak intensity indicates the partial decomposition of the calcium 
silicate phase, and HA peaks can be clearly observed at this point. By week 4, HA has 
occupied almost the whole scaffold structure, and the sodium calcium silicate peaks had all 
disappeared. XRD analysis reveals thus that the transformation of the sodium calcium silicate 
crystalline phase to HA was accelerated from between 1 and 2 weeks in as-sintered scaffolds 
(see Chapter 5, section 5.2.4 for more detail) to between 3 to 7 days in water-treated scaffolds, 
and that the buffered aqueous treatment played a critical role in the acceleration of the 
reaction. The same acceleration of the HA formation on the water-treated Bioglass
®
 pellet 
was reported by Chen et al. [119], and our observation is in agreement with the results 
obtained by them. 
 
FTIR (transmission mode) was also carried out on the water-treated scaffolds throughout a 
much defined time scale to provide further evidence of HA formation. Similarly as for the 
experiment conducted in Chapter 5, a FTIR spectrum was recorded at every 24 hours after the 
water-treated scaffolds have been immersed in SBF (a different scaffold from the same batch 
was used for measurement at each time point). The FTIR spectra are shown in Figure 8.27. 
After an immersion time of just 24 h, both Si-O-Si bending and stretching bands become less 
sharp compared to the original spectrum (0 h), especially the Si-O-Si stretching bands at 950 
cm
-1
 had almost disappeared. This result indicates the loss of soluble SiO2, which is the 
starting point of the second stage of HA formation as described in Chapter 2, section 2.2.2. 
Furthermore, Si-O-Si symmetrical vibration bands at 800 cm
-1
 [90] and new bands at 575 and 
620 cm
-1
, which represents the Ca-P [240], start to appear. These bands are associated with 
the third and fourth stages of HA formation, respectively. The observation from 0 h to day 1 
indicates that all first four stages of HA formation have taken place at a much faster pace 
compared to as-sintered scaffolds (see Chapter 5, section 5.2.4 for more detail). The P-O 
stretching band at 1030 cm
-1
 started to appear at day 2, the same bands were only observed 
with as-sintered scaffold by day 6. In addition, also the growth of a C-O bending band at 870 
cm
-1
 and of C-O stretching bands at 1410 and 1500 cm
-1
 at day 2 is observed. The C-O bands 
are attributed to CO3
2-
, which is the proof for the formation of a HCA phase. By day 3, the P-
O bending bands at 564 to 600 cm
-1
 are very pronounced, which indicates that the ‘semi-
crystalline’ HA layer was growing into an increasingly crystallised structure. This 
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observation made on the spectrum corresponding to day 3 is in agreement with the SEM 
(Figure 8.23 (d)) and XRD (Figure 8.26, 3 days) results, as HA was detected using both 
techniques. From 3 days onwards, the Si-O-Si bending band at 450 cm
-1
 and the Si-O-Si 
symmetrical vibration band at 800 cm
-1
 became smaller, and the P-O stretching and bending 
bands at 564 to 600 and 1030 cm
-1
 became increasingly sharper and more pronounced. This 
indicates that the breaking down of the remaining silica network and the formation of the 
crystalline HA crystal layer continuously taking place as the immersion time in SBF 
increased. 
 
 
Figure 8.26 XRD spectra of water-treated (pH 8, 3 h) scaffolds before (0 h) and after immersion in SBF 
for 24 h, 3 days, 7 days, 2 weeks and 4 weeks showing the formation of HA over time. (■ = N6Ca3Si6O18 
(01-077-2189); ◙ = Na2Ca6(Si2O7)(SiO4)2 (01-080-1296); ● = HA). 
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Figure 8.27 FTIR spectra of as-sintered Bioglass® scaffolds and water-treated (pH 8, 3 h) scaffolds after 
immersion in SBF for different periods of time showing the formation of HA. 
 
All characterisation techniques employed thus confirm that the HA formation on the scaffold 
was accelerated by the water treatment. This phenomenon is in agreement with the previous 
study [119]. The water-treated samples have many micro-gaps between the glass matrix and 
crystalline particles. When the water-treated samples are immersed in SBF, the fluid can 
rapidly penetrate deep into the scaffolds through the gaps, and leaching of sodium and silicon 
ions from the material can take place immediately (not just at the surface like in non-treated 
scaffolds). In the report of Chen at al. [119], the authors describe the mechanism of 
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dissolution of individual crystallite. The process starts with the ion exchange, which occurs at 
certain favourable micro-locations within the crystalline phase (e.g. dislocations and sub-
grain boundaries), this leads to the breakdown of the as-sintered crystalline particles into finer 
parts, and further ion exchange can therefore take place as the number of the point defects 
increases. This distortion of the lattice can develop to such extent that an amorphous structure 
develops eventually and HA forms (following Hench’s mechanism [33]. This process can be 
followed observing the SEM images presented in Figure 8.23 (e – g). The cross section of a 
strut seems to be dense at day 7 of immersion (Figure 8.23 (e)), it has then started to 
breakdown as the immersion time increased and many cavities have formed as the result of 
the leaching of the glass matrix and breaking down of the individual crystallites (Figure 
8.23 (f) and (g)). 
 
8.3 Conclusion 
 
Two techniques that have the potential to introduce nanoscale topography on the surface of 
3D scaffolds in order to enhance initial cell attachment Bioglass
®
-based scaffolds have been 
explored in this Chapter. The first technique was based on polymer coating and demixing 
method. It was found that polymer demixing technique using PS/PnBMA polymer blends that 
have a PS : PnBMA ratio of 1 : 9 or 2 : 8 at the right concentrations could create nano-islands 
on 2D flat surfaces, however the approach could not be adopted for 3D structures due to the 
uneven (rough) surfaces of the as-sintered scaffolds. The second technique consisted in the 
chemical leaching of the scaffolds by water treatment. Surface modification using water 
treatment at pH 8 for 3 hours could create uniform sized spindle-shaped crystallites (~150 nm 
in length and 100 nm in width) on both 2D surfaces and throughout the 3D structure of 
scaffolds. A new sodium calcium silicate crystalline phase, Na2Ca6(Si2O7)(SiO4)2 was 
introduced by the water treatment. HA formation was accelerated by the buffered aqueous 
treatment, which indicted the enhanced bioactivity of water-treated scaffolds. 
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Chapter 9 Conclusions and future work 
 
9.1 Summary and conclusions 
 
The goal of this project was to create a new family of multi-functional 45S5 Bioglass
®
-based 
glass-ceramic scaffolds for bone tissue engineering applications. The foam replica technique 
was used to produce robust and reproducible scaffolds of high interconnected porosity. 
Additional features such as nanoscale surface topography, electrical conductivity and drug 
delivery capability were designed and incorporated into the basic scaffolds using a range of 
methods developed in this project in order to deliver scaffolds with multi-functionality. 
 
The first part of the project was focused on investigating the possibility of using PVA as 
alternative binder to the more expensive PDLLA (which had been used so far) for fabricating 
45S5 Bioglass
®
-based scaffolds via the foam replica method in order to reduce fabrication 
costs. The scaffolds fabricated using PVA exhibited a high interconnected porous structure 
with a porosity of > 90% and pore size varying between 400 and 600 µm. From the results of 
porosity measurements and compressive strength tests, it was determined that the optimal 
slurry used in the replica method should contain 40 wt% 45S5 Bioglass
®
 powder  (of 8 µm) 
and 6 wt% PVA in water. Sintering was carried out at 1100°C for 2 hours. The resulting 
scaffolds have appropriate pore size to promote cell adhesion, transport of nutrients, and 
removal of wastes as well as to enable vascularization. The struts of the scaffolds produced 
using this method were partially crystallised, i.e. exhibiting a glass-ceramic structure. Sodium 
calcium silicate, Na6Ca3Si6O18, was the main crystalline phase detected via XRD, and by 
combining SEM/EDX and FITR technique, it was found that the bioactivity of the new 
scaffolds when tested in SBF was slightly better than that of scaffolds fabricated previously 
using PDLLA as binder, confirming that the HA formation rate is higher in the scaffolds 
reported in the present study. Therefore, scaffolds produced using PVA as the binder provide 
suitable initial mechanical support while maintaining bioactivity, which are two important 
requirements for bone tissue engineering. 
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The scaffolds were then coated with multi-walled CNTs by electrophoretic deposition (EPD) 
in order to add electrical conductivity as a novel property to the scaffold, which should 
enhance cell-to-cell signalling and hence cell proliferation. Moreover, CNTs were used to 
introduce nanoscale topography on the 3D scaffold surfaces to improve initial cell attachment. 
By placing the scaffolds in between the two electrodes of the EPD cell, a fairly uniform CNT 
coating of up to 1 µm thickness was achieved on the strut surfaces throughout the whole three 
dimensional (3D) scaffold structure. A 0.5 wt% commercially available CNT aqueous 
suspension was used and EPD was carried out at 2.8 V for 10 min. By conducting 
compressive strength tests and immersion studies in SBF, it was found that the scaffold 
mechanical strength and bioactivity were not impaired by the presence of CNTs. The results 
of the SBF study showed that the addition of CNT coating by EPD has contributed to create a 
homogenous nanoscale HA surface layer by acting as a nanoscale surface mesh or fibrous 
template, thus preventing in homogeneous growing of HA crystallites to form uncontrolled 
agglomerations, which was the case with uncoated scaffolds. For the first time, the present 
study confirmed that addition of CNTs imparted electrical conductivity to the otherwise 
insulating 3D Bioglass
®
-based scaffolds. However, it has been reported that potential 
cytotoxicity of a large local amount of CNTs can cause the surrounding cells and tissues to 
die, and CNTs are not biodegradable in vivo, therefore this composite scaffold is not ideal to 
be actually used as a implant in vivo. In this study, we propose that the CNT-coated scaffolds 
are promising model systems to test the interaction of cells with nanofibrous 3D bioactive 
substrates and to investigate for the first time the effect of electrical conduction in 3D 
matrices made of bioactive glass-ceramic on cellular behavior. Since the CNT-coating in the 
present composite is safely immobilised on the surface of the scaffold, the possible 
cytotoxicity related to the presence of CNTs has been maintained at a minimum (usually free 
CNTs are known to be cytotoxic [243]). In an alternative application, it would be possible to 
use the scaffold in vitro, for example in a bioreactor, to grow the required tissue, and then to 
remove the CNTs by washing. 
 
In order to add drug delivery capability to the scaffold, drug delivery vehicles, i.e. 
biodegradable P(3HB) microspheres (PMSs) (size ~1.5 μm), fabricated using an oil-in-water 
emulsion solvent extraction/evaporation technique, were coated onto the 3D scaffold. A 
simple slurry-dipping method, using a 1 wt% aqueous suspension of PMSs, dispersed by an 
ultrasonic bath, was used to coat the scaffold, producing a uniform PMS coating throughout 
the three-dimensional scaffold structure. Compressive strength tests confirmed that the 
216 
 
microsphere coating slightly enhanced the scaffold mechanical strength. One shortcoming of 
this type of coating is the possible poor adhesion of the microspheres to the scaffold surface, 
as microspheres could fall off during handling or once the scaffolds are implanted in vivo. 
Some initial investigations have been made in the present study that showed large amount of 
microspheres were still attached to the scaffold surfaces even after immersing the composite 
in SBF or water for four weeks. However a quantitative analysis of the microsphere 
attachment to scaffold surfaces should be carried out for the optimisation of these scaffolds. It 
was also confirmed that the PMS-coating did not inhibit the bioactivity of the scaffolds, as 
determined by a SBF immersion study for up to four weeks. However, the topography of the 
HA surface layer was affected, as PMSs were embedded underneath the in-situ formed HA 
layer, hence the surface roughness increased compared to uncoated scaffolds, potentially 
enhancing cell adhesion. Finally, tetracycline as a model therapeutic drug was successfully 
encapsulated in the PMSs to demonstrate the drug delivery capability of the composite 
scaffold. The TTCMS coating on scaffolds was achieved by dispersing the TTCMSs in 
hexane and by adding the microsphere suspension onto the scaffolds manually using a pipette. 
It was found that the release of the drug from the composite scaffolds was slow and it 
progressed in a sustained manner when compared to the observed fast and relatively 
uncontrolled drug release rate from uncoated scaffolds. Thus, this unique multifunctional 
bioactive composite scaffold has the potential to enhance cell attachment and to provide 
controlled delivery of relevant drugs for bone tissue engineering. Although one can argue that 
TTC is not the most suitable model drug to be used in this case, as the release rate and 
activity of the drug is affected by the calcium ions presented in the SBF and released from the 
Bioglass
®
 scaffold, a parallel study carried out by our collaborator using gentamicin [265] 
showed the same releasing trend, hence confirming the potential use of TTCMS-coated 
scaffold as a controlled and local drug delivery vehicle. It is unclear at this stage whether the 
drug released from the TTCMSs prepared in the current study (using 0.2 wt% TTC PVA 
solution) is effective enough to kill the bacteria, suggested experiments to investigate this 
issue are discussed in the Future Work section. The present approach could be extended to a 
range of tissue engineering applications due to its high versatility, given by the chosen 
combination of different biomaterials and processing technologies. 
 
Two more methods to achieve nanoscale topography on the surface of 3D scaffolds were 
investigated in this project: polymer demixing and water treatment of scaffold surfaces. It 
was found that polymer demixing technique using PS/PnBMA polymer blends that have PS : 
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PnBMA ratios of 1 : 9 or 2 : 8 could create nano-islands on 2D flat surfaces, however the 
approach could not be transferred to 3D structures due to the uneven surface of the as-
sintered glass-ceramic scaffold. On the other hand, surface modification using water 
treatment at pH 8 for 3 hours could create uniform sized spindle-shaped crystallites (~150 nm 
in length and 100 nm in width) on both 2D surfaces and throughout the 3D structure of 
scaffolds. A new sodium calcium silicate crystalline phase, Na2Ca6(Si2O7)(SiO4)2, developed 
in the strut as a consequence of the water treatment. HA formation was accelerated by the 
buffered aqueous treatment, which indicted the good bioactivity of water-treated scaffolds. It 
is known that cells might not attach and proliferate well on sharp and pointy surfaces as such 
topography can damage cells and lead to cell death [104]. The water-treated scaffold surface 
does exhibit such sharp surface contours; therefore further investigation of cellular response 
on water-treated scaffold surfaces is essential. 
 
Overall, the work presented in this thesis has further developed and improved existing 
technologies for bioactive glass-ceramic scaffolds and has examined the potential of using 
them to fabricate novel multi-functional Bioglass
®
-based glass-ceramic scaffolds. It was 
found that out of the three potential techniques investigated, i.e. CNT-coating, polymer 
demixing and water surface treatment, CNT-coating is the only one that can deliver the right 
nanoscale features on the surface of the scaffold in order to enhance initial cell attachment. 
This composite scaffold has high potential to be used as a model system to study cellular 
response on electrical conductive and bioactive surface for bone tissue engineering. 
Summarising this part of the results, we have narrowed down the number of techniques that 
could be used to develop nanoscale topography on Bioglass
®
-based glass-ceramic scaffold. 
The results obtained provide guidance for future developments in the subject of fabricating 
nanoscale topography on the surface of 3D silicate based scaffolds. The other part of the 
work showed that controllable drug delivery capability can be achieved with this type of 
scaffold combined with polymer drug carriers. It was found that polymeric microsphere 
coating was an effective approach to incorporate drug delivery capability into the scaffold. 
Besides the intended drug delivery function, the coating also affected the surface roughness 
and has the potential to improve material-cell interaction. Other scaffold systems reported in 
the literature that incorporate a drug delivery function do not seem to improve the surface 
roughness of the scaffolds, which is an important factor for initial cell attachment. By varying 
the microspheres loading, important bioactive molecules relevant for cell proliferation, 
including growth factors and proteins, can also be delivery locally. The delivery rate and 
218 
 
amount can also be controlled by varying the physical size and pore size of the microspheres 
as well as the material itself, as the fabrication method is versatile and it can be applied to 
other polymers that have faster or slower degradation rates, as required for a particular 
application. Thus the current study has showcased the initial encouraging application of 
microsphere coating on 3D scaffolds as controlled drug delivery platforms and it has opened 
avenues for future research in the field of scaffolds with controlled drug delivery capability. 
 
9.2 Future work 
 
Based on the results achieved and discussed in the present project, the future work that is 
suggested to be carried out to further investigate the suitability of the scaffold systems created 
in this project are presented and discussed in this section. 
 
9.2.1 Enhancing the mechanical property of Bioglass
®
-based scaffold 
 
Clearly, the major weakness of the present scaffolds, i.e. their relatively low mechanical 
strength, needs to be improved in order to realistically consider their use in load-bearing 
applications. Recent developments in the field of inorganic/organic hybrid Bioglass
®
 
scaffolds [278, 279] have shown an improvement on scaffold mechanical competence, 
however, those technologies are not compatible with the foam replica method developed here, 
as the organic phase will be burned off at high temperature during sintering. Hybrid scaffolds 
have only been fabricated by sol-gel techniques so far. As an alternative, post-sintering 
polymer coating and infiltration of the Bioglass
®
-based glass-ceramic scaffolds has been 
proven to be a convenient alternative to improve mechanical properties of scaffolds. For 
example, it was reported in the literature that by penetrating biodegradable polymers (e.g. 
PDLLA, P(3HB)) into a partially sintered glass-ceramic scaffold, the compressive strength of 
scaffolds can be improved up to seven times. Further polymer selections might improve the 
mechanical strength even further. More flexible (softer) polymers than PDLLA or P(3HB), 
e.g. poly(3-hydroxyoctanoate) (P(3HO)), have the ability of ‘bridging’ the scaffold fragments 
together during fracture of the struts, therefore this type of composite would be used for 
applications requiring high fracture toughness, and even in soft tissue engineering 
applications exploiting the polymer flexibility and the ion releasing from the Bioglass
®
. 
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Therefore it will worthwhile investigating further biodegradable polymer/glass-ceramic 
composite scaffolds for bone TE. The type of polymer used and the coating techniques and 
conditions will be the major factors that will determine the applications of these novel 
scaffolds. 
 
9.2.2 Further µ-CT investigation of CNT- or PMS-coated scaffolds 
 
The bioactivity of the as-sintered, CNT- and PMS-coated scaffolds should be investigated 
using µ-CT by analysing the change in pore size after the HA layer is formed on the scaffold 
surface. Such study would provide quantitative information to assess the extent of bioactive 
behaviour of scaffolds in relevant in vitro conditions. By encapsulating heavy metal elements 
in PMSs, one can use µ-CT to test how evenly the coating is distributed throughout the 
scaffold and it will be possible also to determine accurately the coating thickness throughout 
the 3D porous structure of the scaffold. Knowing the PMS coating thickness will be required 
to be able to predict with more precision the drug release kinetics from PMSs. 
 
9.2.3 Studies on CNT-coated scaffolds: cytotoxicity assessment and in vitro 
cell culture study under electrical stimulation condition 
 
Assessment of the possible long-term cytotoxicity of CNT-coated scaffolds using different 
methods is required, such as LIVE/DEAD
®
 cell viability assay or MTT test. In vitro cell 
culture studies should be carried out under electrical stimulation using CNT-coated scaffolds, 
as electric fields provide specific signals (stimuli) that direct cell migration [10]. Therefore an 
electrical conductive surface introduced by the CNT coating as proposed in this project might 
have the potential to increase the proliferation and differentiation of cells attached to the 
scaffold, and in fact, it has been demonstrated that external electrical stimulation may 
maximize tissue regeneration in comparison to non-stimulated biomaterials [319, 280]. A 
schematic of the electrical simulation experiment suggested for future work using the current 
developed scaffolds is shown in Figure 9.1. The cell-seeded conductive scaffold is placed in a 
stainless steel case, which is connected to a power supply by silver (or copper) wire. The case 
is their placed in a well containing cell culture medium (e.g. Dulbecco’s Modified Eagle’s 
Medium (DMEM)). The AlarmaBlue
®
 assay can then be carried out to monitor proliferation 
at different time points. 
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Figure 9.1 Schematic diagram of the electrical stimulation experiment suggested for in vitro cell culture 
investigations on CNT-coated scaffolds. A controlled electric field is applied to the scaffold through a 
silver wire to stimulate cell in DMEM.  
 
9.2.4 Degradation study of PMSs 
 
Although the biodegradability of P(3HB) has been well studied in the past, there is a need to 
investigate the specific biodegradability of PMS in relevant physiological environment as the 
size of the spheres, hence the change in their surface area, can affect biodegradability. A 
larger surface area will provide more contact between the spheres and the medium; hence the 
polymer will degrade faster. This study could be carried out with or without scaffolds in a 
long-term study in either SBF or DMEM. The in vitro degradation rates can be assessed by 
three methods: (1) assessment of surface morphology using SEM, (2) measurement of weight 
loss and (3) monitoring the decrease in weight average molecular weight using gel 
permeation chromatography (a decrease in the weight average molecular weight of the 
polymer indicates the degradation) [281]. 
 
9.2.5 Drug or growth factor release study 
 
The drug delivery ability of P(3HB) microspheres should be further investigated. Different 
drugs, such as vancomycin for its very strong antibiotic effect, can be used to study the 
release rate, since the size and chemical structure of drugs affect their release kinetics. PMS 
can also be used to deliver growth factors, such as bone morphogenetic proteins (BMPs), as 
they have the ability to induce the formation of bone and cartilage. BMP3, 7 and 8A can be 
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used in this part of study. BMP3 is known for its ability to induce bone and cartilage 
formation, BMP7 plays a key role in osteoblast differentiation and BMP8a is involved in 
bone and cartilage development and homeostasis. The release rate of BMPs from PMS should 
be studied. A vital criterion for the application of the materials as drug delivery systems is 
that the released biomolecules or drugs must maintain their biological activity; therefore 
antimicrobial tests, such as Kirby-Bauer antibiotic testing (KB testing), should be carried out 
together with drug release studies. Antibiotics released from the microspheres at different 
time points should be added to agar plates where a known quantity of bacteria is grown. By 
measuring the zone of inhibition (an area where bacteria are not capable of growing) around 
the sites where the antibiotics are added in the plate, it is possible to measure the efficiencies 
of the released antibiotics. 
 
Polymeric coatings on 3D Bioglass
®
-based scaffolds can lead to other potential applications 
besides their initial intended use to improve the mechanical property of scaffolds. One of the 
21
st
 century challenges for biomaterials is control of infection [282], therefore localised 
control of bacteria and inflammation is very important. As it has been reported in this thesis, 
a drug delivery capability can be imparted to scaffolds using polymer microsphere coatings, 
however, an initial drug burst release was observed. Depending on the application, this initial 
drug release should be controlled or sometimes minimised as much as possible in order to 
provide larger amounts of drug release for longer periods of time. This can be achieved by 
using a second polymer coating on top of the mircosphere coating, as shown in Figure 9.2. A 
polymer with a fast degradation rate is ideal for this application, such as poly D, L-lactic-
glycolic acid co-polymer (PLGA) or gelatine [283]. The 2nd polymer coating can act as a 
barrier, thus preventing the fast initial release; the controlled drug release from the 
microsphere coating can thus start after the 2nd polymer coating has degraded. The 2nd 
coating could be itself a vehicle for the delivery of other drugs or growth factors, which need 
to be released promptly after implantation. 
 
 
 
 
 
 
 
Figure 9.2 Schematic diagram showing the possible cross session of a scaffold strut with the 2nd 
biopolymer coating on top of the microsphere coating. 
2
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9.2.6 Investigation of the freeze-drying polymeric coating technique to 
create nanofibrous topography on the surface of Bioglass
®
-based scaffolds 
 
In terms of developing nanoscale topography on the surface of glass-ceramic scaffolds, 
freeze-drying a polymeric coating is another potential approach that could be used to 
fabricate in-situ nano-fibrous topography on surface of Bioglass
®
 scaffolds. This technique 
has been established by Ma et al. [159], and used to fabricate polymeric scaffolds with 
nanofibrous surfaces for bone tissue engineering. PDLLA can be coated onto the glass-
ceramic scaffold and freeze-dried to produce nanofiber features on the surface based on the 
thermally induced phase separation technique. The uneven surface of the as-sintered scaffolds 
could lead to an uneven polymer coating, a similar situation that was found in the present 
research with the polymer demixing technique, in this case, only a non-homogeneous coating 
can be made. However, the features fabricated using in-situ freeze-drying are much more 
controllable than in polymer demixing method, and the size of these nanofibers (ranging from 
50 to 500 nm in diameter) have been shown to be much more suitable for improving cell 
attachment than the nano-islands produced by polymer demixing technique. Therefore, 
freeze-drying of polymer coatings on Bioglass
®
-based scaffolds should be investigated in the 
future as promising method but the problem of producing a continuous coating must be 
tackled. 
 
9.2.7 In-depth protein attachment studies 
 
In-depth protein attachment study should be carried out in order to provide an idea about how 
the materials interact with common proteins. Protein attachment studies should be carried out 
in both PBS and DMEM, and a variety of proteins, such as bovine serum albumin, 
thrombospondin, vitronectin, fibronectin and collagen, can be used. By using sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) assessment and Bicinchoninic acid 
(BCA) assay, one can find out at different time points, what proteins are attached and the 
amount of them. These assays can provide explanations for cell attachment on the different 
scaffold systems. 
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